#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=fMRI study of neural sensitization to hedonic stimuli in long‐term, daily cannabis users
#Text=Abstract
#Text=Although there is emergent evidence illustrating neural sensitivity to cannabis cues in cannabis users, the specificity of this effect to cannabis cues as opposed to a generalized hyper‐sensitivity to hedonic stimuli has not yet been directly tested.
1-1	0-4	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[1]	
1-2	5-10	study	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[1]	
1-3	11-13	of	_	
1-4	14-20	neural	_	
1-5	21-34	sensitization	_	
1-6	35-37	to	_	
1-7	38-45	hedonic	_	
1-8	46-53	stimuli	_	
1-9	54-56	in	_	
1-10	57-66	long‐term	_	
1-11	66-67	,	_	
1-12	68-73	daily	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[2]	
1-13	74-82	cannabis	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[2]	
1-14	83-88	users	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[2]	
1-15	89-97	Abstract	_	
1-16	98-106	Although	_	
1-17	107-112	there	_	
1-18	113-115	is	_	
1-19	116-124	emergent	_	
1-20	125-133	evidence	_	
1-21	134-146	illustrating	_	
1-22	147-153	neural	_	
1-23	154-165	sensitivity	_	
1-24	166-168	to	_	
1-25	169-177	cannabis	_	
1-26	178-182	cues	_	
1-27	183-185	in	_	
1-28	186-194	cannabis	_	
1-29	195-200	users	_	
1-30	200-201	,	_	
1-31	202-205	the	_	
1-32	206-217	specificity	_	
1-33	218-220	of	_	
1-34	221-225	this	_	
1-35	226-232	effect	_	
1-36	233-235	to	_	
1-37	236-244	cannabis	_	
1-38	245-249	cues	_	
1-39	250-252	as	_	
1-40	253-260	opposed	_	
1-41	261-263	to	_	
1-42	264-265	a	_	
1-43	266-277	generalized	_	
1-44	278-295	hyper‐sensitivity	_	
1-45	296-298	to	_	
1-46	299-306	hedonic	_	
1-47	307-314	stimuli	_	
1-48	315-318	has	_	
1-49	319-322	not	_	
1-50	323-326	yet	_	
1-51	327-331	been	_	
1-52	332-340	directly	_	
1-53	341-347	tested	_	
1-54	347-348	.	_	

#Text=Using fMRI, we presented 53 daily, long‐term cannabis users and 68 non‐using controls visual and tactile cues for cannabis, a natural reward, and, a sensory‐perceptual control object to evaluate brain response to hedonic stimuli in cannabis users.
2-1	349-354	Using	_	
2-2	355-359	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
2-3	359-360	,	_	
2-4	361-363	we	_	
2-5	364-373	presented	_	
2-6	374-376	53	_	
2-7	377-382	daily	_	
2-8	382-383	,	_	
2-9	384-393	long‐term	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[3]	
2-10	394-402	cannabis	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[3]|http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[4]	
2-11	403-408	users	http://maven.renci.org/NeuroBridge/neurobridge#CannabisAbuse[4]	
2-12	409-412	and	_	
2-13	413-415	68	_	
2-14	416-425	non‐using	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
2-15	426-434	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
2-16	435-441	visual	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]	
2-17	442-445	and	_	
2-18	446-453	tactile	_	
2-19	454-458	cues	_	
2-20	459-462	for	_	
2-21	463-471	cannabis	_	
2-22	471-472	,	_	
2-23	473-474	a	_	
2-24	475-482	natural	_	
2-25	483-489	reward	_	
2-26	489-490	,	_	
2-27	491-494	and	_	
2-28	494-495	,	_	
2-29	496-497	a	_	
2-30	498-516	sensory‐perceptual	_	
2-31	517-524	control	_	
2-32	525-531	object	_	
2-33	532-534	to	_	
2-34	535-543	evaluate	_	
2-35	544-549	brain	_	
2-36	550-558	response	_	
2-37	559-561	to	_	
2-38	562-569	hedonic	_	
2-39	570-577	stimuli	_	
2-40	578-580	in	_	
2-41	581-589	cannabis	_	
2-42	590-595	users	_	
2-43	595-596	.	_	

#Text=The results showed an interaction between group and reward type such that the users had greater response during cannabis cues relative to natural reward cues (i.e., fruit) in the orbitofrontal cortex, striatum, anterior cingulate gyrus, and ventral tegmental area compared to non‐users (cluster‐threshold z = 2.3, P < 0.05).
3-1	597-600	The	_	
3-2	601-608	results	_	
3-3	609-615	showed	_	
3-4	616-618	an	_	
3-5	619-630	interaction	_	
3-6	631-638	between	_	
3-7	639-644	group	_	
3-8	645-648	and	_	
3-9	649-655	reward	_	
3-10	656-660	type	_	
3-11	661-665	such	_	
3-12	666-670	that	_	
3-13	671-674	the	_	
3-14	675-680	users	_	
3-15	681-684	had	_	
3-16	685-692	greater	_	
3-17	693-701	response	_	
3-18	702-708	during	_	
3-19	709-717	cannabis	_	
3-20	718-722	cues	_	
3-21	723-731	relative	_	
3-22	732-734	to	_	
3-23	735-742	natural	_	
3-24	743-749	reward	_	
3-25	750-754	cues	_	
3-26	755-756	(	_	
3-27	756-759	i.e	_	
3-28	759-760	.	_	
3-29	760-761	,	_	
3-30	762-767	fruit	_	
3-31	767-768	)	_	
3-32	769-771	in	_	
3-33	772-775	the	_	
3-34	776-789	orbitofrontal	_	
3-35	790-796	cortex	_	
3-36	796-797	,	_	
3-37	798-806	striatum	_	
3-38	806-807	,	_	
3-39	808-816	anterior	_	
3-40	817-826	cingulate	_	
3-41	827-832	gyrus	_	
3-42	832-833	,	_	
3-43	834-837	and	_	
3-44	838-845	ventral	_	
3-45	846-855	tegmental	_	
3-46	856-860	area	_	
3-47	861-869	compared	_	
3-48	870-872	to	_	
3-49	873-882	non‐users	_	
3-50	883-884	(	_	
3-51	884-901	cluster‐threshold	_	
3-52	902-903	z	_	
3-53	904-905	=	_	
3-54	906-909	2.3	_	
3-55	909-910	,	_	
3-56	911-912	P	_	
3-57	913-914	<	_	
3-58	915-919	0.05	_	
3-59	919-920	)	_	
3-60	920-921	.	_	

#Text=In the users, there were positive brain‐behavior correlations between neural response to cannabis cues in fronto‐striatal‐temporal regions and subjective craving, marijuana‐related problems, withdrawal symptoms, and levels of THC metabolites (cluster‐threshold z = 2.3, P < 0.05).
4-1	922-924	In	_	
4-2	925-928	the	_	
4-3	929-934	users	_	
4-4	934-935	,	_	
4-5	936-941	there	_	
4-6	942-946	were	_	
4-7	947-955	positive	_	
4-8	956-970	brain‐behavior	_	
4-9	971-983	correlations	_	
4-10	984-991	between	_	
4-11	992-998	neural	_	
4-12	999-1007	response	_	
4-13	1008-1010	to	_	
4-14	1011-1019	cannabis	_	
4-15	1020-1024	cues	_	
4-16	1025-1027	in	_	
4-17	1028-1052	fronto‐striatal‐temporal	_	
4-18	1053-1060	regions	_	
4-19	1061-1064	and	_	
4-20	1065-1075	subjective	_	
4-21	1076-1083	craving	_	
4-22	1083-1084	,	_	
4-23	1085-1102	marijuana‐related	_	
4-24	1103-1111	problems	_	
4-25	1111-1112	,	_	
4-26	1113-1123	withdrawal	_	
4-27	1124-1132	symptoms	_	
4-28	1132-1133	,	_	
4-29	1134-1137	and	_	
4-30	1138-1144	levels	_	
4-31	1145-1147	of	_	
4-32	1148-1151	THC	_	
4-33	1152-1163	metabolites	_	
4-34	1164-1165	(	_	
4-35	1165-1182	cluster‐threshold	_	
4-36	1183-1184	z	_	
4-37	1185-1186	=	_	
4-38	1187-1190	2.3	_	
4-39	1190-1191	,	_	
4-40	1192-1193	P	_	
4-41	1194-1195	<	_	
4-42	1196-1200	0.05	_	
4-43	1200-1201	)	_	
4-44	1201-1202	.	_	

#Text=These findings demonstrate hyper‐responsivity, and, specificity of brain response to cannabis cues in long‐term cannabis users that are above that of response to natural reward cues.
5-1	1203-1208	These	_	
5-2	1209-1217	findings	_	
5-3	1218-1229	demonstrate	_	
5-4	1230-1248	hyper‐responsivity	_	
5-5	1248-1249	,	_	
5-6	1250-1253	and	_	
5-7	1253-1254	,	_	
5-8	1255-1266	specificity	_	
5-9	1267-1269	of	_	
5-10	1270-1275	brain	_	
5-11	1276-1284	response	_	
5-12	1285-1287	to	_	
5-13	1288-1296	cannabis	_	
5-14	1297-1301	cues	_	
5-15	1302-1304	in	_	
5-16	1305-1314	long‐term	_	
5-17	1315-1323	cannabis	_	
5-18	1324-1329	users	_	
5-19	1330-1334	that	_	
5-20	1335-1338	are	_	
5-21	1339-1344	above	_	
5-22	1345-1349	that	_	
5-23	1350-1352	of	_	
5-24	1353-1361	response	_	
5-25	1362-1364	to	_	
5-26	1365-1372	natural	_	
5-27	1373-1379	reward	_	
5-28	1380-1384	cues	_	
5-29	1384-1385	.	_	

#Text=These observations are concordant with incentive sensitization models suggesting sensitization of mesocorticolimbic regions and disruption of natural reward processes following drug use.
6-1	1386-1391	These	_	
6-2	1392-1404	observations	_	
6-3	1405-1408	are	_	
6-4	1409-1419	concordant	_	
6-5	1420-1424	with	_	
6-6	1425-1434	incentive	_	
6-7	1435-1448	sensitization	_	
6-8	1449-1455	models	_	
6-9	1456-1466	suggesting	_	
6-10	1467-1480	sensitization	_	
6-11	1481-1483	of	_	
6-12	1484-1501	mesocorticolimbic	_	
6-13	1502-1509	regions	_	
6-14	1510-1513	and	_	
6-15	1514-1524	disruption	_	
6-16	1525-1527	of	_	
6-17	1528-1535	natural	_	
6-18	1536-1542	reward	_	
6-19	1543-1552	processes	_	
6-20	1553-1562	following	_	
6-21	1563-1567	drug	_	
6-22	1568-1571	use	_	
6-23	1571-1572	.	_	

#Text=Although the cross‐sectional nature of this study does not provide information on causality, the positive correlations between neural response and indicators of cannabis use (i.e., THC levels) suggest that alterations in the reward system are, in part, related to cannabis use.
7-1	1573-1581	Although	_	
7-2	1582-1585	the	_	
7-3	1586-1601	cross‐sectional	_	
7-4	1602-1608	nature	_	
7-5	1609-1611	of	_	
7-6	1612-1616	this	_	
7-7	1617-1622	study	_	
7-8	1623-1627	does	_	
7-9	1628-1631	not	_	
7-10	1632-1639	provide	_	
7-11	1640-1651	information	_	
7-12	1652-1654	on	_	
7-13	1655-1664	causality	_	
7-14	1664-1665	,	_	
7-15	1666-1669	the	_	
7-16	1670-1678	positive	_	
7-17	1679-1691	correlations	_	
7-18	1692-1699	between	_	
7-19	1700-1706	neural	_	
7-20	1707-1715	response	_	
7-21	1716-1719	and	_	
7-22	1720-1730	indicators	_	
7-23	1731-1733	of	_	
7-24	1734-1742	cannabis	_	
7-25	1743-1746	use	_	
7-26	1747-1748	(	_	
7-27	1748-1751	i.e	_	
7-28	1751-1752	.	_	
7-29	1752-1753	,	_	
7-30	1754-1757	THC	_	
7-31	1758-1764	levels	_	
7-32	1764-1765	)	_	
7-33	1766-1773	suggest	_	
7-34	1774-1778	that	_	
7-35	1779-1790	alterations	_	
7-36	1791-1793	in	_	
7-37	1794-1797	the	_	
7-38	1798-1804	reward	_	
7-39	1805-1811	system	_	
7-40	1812-1815	are	_	
7-41	1815-1816	,	_	
7-42	1817-1819	in	_	
7-43	1820-1824	part	_	
7-44	1824-1825	,	_	
7-45	1826-1833	related	_	
7-46	1834-1836	to	_	
7-47	1837-1845	cannabis	_	
7-48	1846-1849	use	_	
7-49	1849-1850	.	_	

#Text=Hum Brain Mapp 37:3431–3443, 2016. © 2016 The Authors Human Brain Mapping Published by Wiley Periodicals, Inc.
8-1	1851-1854	Hum	_	
8-2	1855-1860	Brain	_	
8-3	1861-1865	Mapp	_	
8-4	1866-1868	37	_	
8-5	1868-1869	:	_	
8-6	1869-1873	3431	_	
8-7	1873-1874	–	_	
8-8	1874-1878	3443	_	
8-9	1878-1879	,	_	
8-10	1880-1884	2016	_	
8-11	1884-1885	.	_	
8-12	1886-1887	©	_	
8-13	1888-1892	2016	_	
8-14	1893-1896	The	_	
8-15	1897-1904	Authors	_	
8-16	1905-1910	Human	_	
8-17	1911-1916	Brain	_	
8-18	1917-1924	Mapping	_	
8-19	1925-1934	Published	_	
8-20	1935-1937	by	_	
8-21	1938-1943	Wiley	_	
8-22	1944-1955	Periodicals	_	
8-23	1955-1956	,	_	
8-24	1957-1960	Inc	_	
8-25	1960-1961	.	_	

#Text=INTRODUCTION
#Text=The public health relevance of cannabis use is rising with the changes in legislation in the United States, yet the literature on the transition to problematic use remains unresolved.
9-1	1963-1975	INTRODUCTION	_	
9-2	1976-1979	The	_	
9-3	1980-1986	public	_	
9-4	1987-1993	health	_	
9-5	1994-2003	relevance	_	
9-6	2004-2006	of	_	
9-7	2007-2015	cannabis	_	
9-8	2016-2019	use	_	
9-9	2020-2022	is	_	
9-10	2023-2029	rising	_	
9-11	2030-2034	with	_	
9-12	2035-2038	the	_	
9-13	2039-2046	changes	_	
9-14	2047-2049	in	_	
9-15	2050-2061	legislation	_	
9-16	2062-2064	in	_	
9-17	2065-2068	the	_	
9-18	2069-2075	United	_	
9-19	2076-2082	States	_	
9-20	2082-2083	,	_	
9-21	2084-2087	yet	_	
9-22	2088-2091	the	_	
9-23	2092-2102	literature	_	
9-24	2103-2105	on	_	
9-25	2106-2109	the	_	
9-26	2110-2120	transition	_	
9-27	2121-2123	to	_	
9-28	2124-2135	problematic	_	
9-29	2136-2139	use	_	
9-30	2140-2147	remains	_	
9-31	2148-2158	unresolved	_	
9-32	2158-2159	.	_	

#Text=One of the central components that underlie problematic use is craving.
10-1	2160-2163	One	_	
10-2	2164-2166	of	_	
10-3	2167-2170	the	_	
10-4	2171-2178	central	_	
10-5	2179-2189	components	_	
10-6	2190-2194	that	_	
10-7	2195-2203	underlie	_	
10-8	2204-2215	problematic	_	
10-9	2216-2219	use	_	
10-10	2220-2222	is	_	
10-11	2223-2230	craving	_	
10-12	2230-2231	.	_	

#Text=Although only a handful of published studies have investigated the neural mechanisms underlying craving for cannabis, findings of greater neural response in mesocorticolimbic areas during exposure to cannabis cues have been consistent across different populations of cannabis users [Cousijn et al., 2013a]; [Charboneau, et al., 2013]; [Filbey et al., 2009a]; [Goldman et al., 2013; Lundahl and Johanson, 2011].
11-1	2232-2240	Although	_	
11-2	2241-2245	only	_	
11-3	2246-2247	a	_	
11-4	2248-2255	handful	_	
11-5	2256-2258	of	_	
11-6	2259-2268	published	_	
11-7	2269-2276	studies	_	
11-8	2277-2281	have	_	
11-9	2282-2294	investigated	_	
11-10	2295-2298	the	_	
11-11	2299-2305	neural	_	
11-12	2306-2316	mechanisms	_	
11-13	2317-2327	underlying	_	
11-14	2328-2335	craving	_	
11-15	2336-2339	for	_	
11-16	2340-2348	cannabis	_	
11-17	2348-2349	,	_	
11-18	2350-2358	findings	_	
11-19	2359-2361	of	_	
11-20	2362-2369	greater	_	
11-21	2370-2376	neural	_	
11-22	2377-2385	response	_	
11-23	2386-2388	in	_	
11-24	2389-2406	mesocorticolimbic	_	
11-25	2407-2412	areas	_	
11-26	2413-2419	during	_	
11-27	2420-2428	exposure	_	
11-28	2429-2431	to	_	
11-29	2432-2440	cannabis	_	
11-30	2441-2445	cues	_	
11-31	2446-2450	have	_	
11-32	2451-2455	been	_	
11-33	2456-2466	consistent	_	
11-34	2467-2473	across	_	
11-35	2474-2483	different	_	
11-36	2484-2495	populations	_	
11-37	2496-2498	of	_	
11-38	2499-2507	cannabis	_	
11-39	2508-2513	users	_	
11-40	2514-2515	[	_	
11-41	2515-2522	Cousijn	_	
11-42	2523-2525	et	_	
11-43	2526-2528	al	_	
11-44	2528-2529	.	_	
11-45	2529-2530	,	_	
11-46	2531-2536	2013a	_	
11-47	2536-2537	]	_	
11-48	2537-2538	;	_	
11-49	2539-2540	[	_	
11-50	2540-2550	Charboneau	_	
11-51	2550-2551	,	_	
11-52	2552-2554	et	_	
11-53	2555-2557	al	_	
11-54	2557-2558	.	_	
11-55	2558-2559	,	_	
11-56	2560-2564	2013	_	
11-57	2564-2565	]	_	
11-58	2565-2566	;	_	
11-59	2567-2568	[	_	
11-60	2568-2574	Filbey	_	
11-61	2575-2577	et	_	
11-62	2578-2580	al	_	
11-63	2580-2581	.	_	
11-64	2581-2582	,	_	
11-65	2583-2588	2009a	_	
11-66	2588-2589	]	_	
11-67	2589-2590	;	_	
11-68	2591-2592	[	_	
11-69	2592-2599	Goldman	_	
11-70	2600-2602	et	_	
11-71	2603-2605	al	_	
11-72	2605-2606	.	_	
11-73	2606-2607	,	_	
11-74	2608-2612	2013	_	
11-75	2612-2613	;	_	
11-76	2614-2621	Lundahl	_	
11-77	2622-2625	and	_	
11-78	2626-2634	Johanson	_	
11-79	2634-2635	,	_	
11-80	2636-2640	2011	_	
11-81	2640-2641	]	_	
11-82	2641-2642	.	_	

#Text=This neural response has been related to symptoms of cannabis use disorder (CUD), although, a direct link to the subjective experience of craving has not yet been reported [Cousijn et al., 2013a; Filbey et al., 2009a; Goldman et al., 2013; Lundahl and Johanson, 2011].
12-1	2643-2647	This	_	
12-2	2648-2654	neural	_	
12-3	2655-2663	response	_	
12-4	2664-2667	has	_	
12-5	2668-2672	been	_	
12-6	2673-2680	related	_	
12-7	2681-2683	to	_	
12-8	2684-2692	symptoms	_	
12-9	2693-2695	of	_	
12-10	2696-2704	cannabis	_	
12-11	2705-2708	use	_	
12-12	2709-2717	disorder	_	
12-13	2718-2719	(	_	
12-14	2719-2722	CUD	_	
12-15	2722-2723	)	_	
12-16	2723-2724	,	_	
12-17	2725-2733	although	_	
12-18	2733-2734	,	_	
12-19	2735-2736	a	_	
12-20	2737-2743	direct	_	
12-21	2744-2748	link	_	
12-22	2749-2751	to	_	
12-23	2752-2755	the	_	
12-24	2756-2766	subjective	_	
12-25	2767-2777	experience	_	
12-26	2778-2780	of	_	
12-27	2781-2788	craving	_	
12-28	2789-2792	has	_	
12-29	2793-2796	not	_	
12-30	2797-2800	yet	_	
12-31	2801-2805	been	_	
12-32	2806-2814	reported	_	
12-33	2815-2816	[	_	
12-34	2816-2823	Cousijn	_	
12-35	2824-2826	et	_	
12-36	2827-2829	al	_	
12-37	2829-2830	.	_	
12-38	2830-2831	,	_	
12-39	2832-2837	2013a	_	
12-40	2837-2838	;	_	
12-41	2839-2845	Filbey	_	
12-42	2846-2848	et	_	
12-43	2849-2851	al	_	
12-44	2851-2852	.	_	
12-45	2852-2853	,	_	
12-46	2854-2859	2009a	_	
12-47	2859-2860	;	_	
12-48	2861-2868	Goldman	_	
12-49	2869-2871	et	_	
12-50	2872-2874	al	_	
12-51	2874-2875	.	_	
12-52	2875-2876	,	_	
12-53	2877-2881	2013	_	
12-54	2881-2882	;	_	
12-55	2883-2890	Lundahl	_	
12-56	2891-2894	and	_	
12-57	2895-2903	Johanson	_	
12-58	2903-2904	,	_	
12-59	2905-2909	2011	_	
12-60	2909-2910	]	_	
12-61	2910-2911	.	_	

#Text=Nevertheless, existing studies corroborate the link between greater mesocorticolimbic brain response during exposure to cannabis cues that is related to CUD, suggesting increased motivational processing associated with drug‐seeking behavior in CUDs.
13-1	2912-2924	Nevertheless	_	
13-2	2924-2925	,	_	
13-3	2926-2934	existing	_	
13-4	2935-2942	studies	_	
13-5	2943-2954	corroborate	_	
13-6	2955-2958	the	_	
13-7	2959-2963	link	_	
13-8	2964-2971	between	_	
13-9	2972-2979	greater	_	
13-10	2980-2997	mesocorticolimbic	_	
13-11	2998-3003	brain	_	
13-12	3004-3012	response	_	
13-13	3013-3019	during	_	
13-14	3020-3028	exposure	_	
13-15	3029-3031	to	_	
13-16	3032-3040	cannabis	_	
13-17	3041-3045	cues	_	
13-18	3046-3050	that	_	
13-19	3051-3053	is	_	
13-20	3054-3061	related	_	
13-21	3062-3064	to	_	
13-22	3065-3068	CUD	_	
13-23	3068-3069	,	_	
13-24	3070-3080	suggesting	_	
13-25	3081-3090	increased	_	
13-26	3091-3103	motivational	_	
13-27	3104-3114	processing	_	
13-28	3115-3125	associated	_	
13-29	3126-3130	with	_	
13-30	3131-3143	drug‐seeking	_	
13-31	3144-3152	behavior	_	
13-32	3153-3155	in	_	
13-33	3156-3160	CUDs	_	
13-34	3160-3161	.	_	

#Text=Increased motivational processing to other salient stimuli, such as monetary reward, has also been found in cannabis users [Cousijn et al., 2013b; Filbey et al., 2013; Nestor et al., 2010; Yip et al., 2014; van Hell et al., 2010].
14-1	3162-3171	Increased	_	
14-2	3172-3184	motivational	_	
14-3	3185-3195	processing	_	
14-4	3196-3198	to	_	
14-5	3199-3204	other	_	
14-6	3205-3212	salient	_	
14-7	3213-3220	stimuli	_	
14-8	3220-3221	,	_	
14-9	3222-3226	such	_	
14-10	3227-3229	as	_	
14-11	3230-3238	monetary	_	
14-12	3239-3245	reward	_	
14-13	3245-3246	,	_	
14-14	3247-3250	has	_	
14-15	3251-3255	also	_	
14-16	3256-3260	been	_	
14-17	3261-3266	found	_	
14-18	3267-3269	in	_	
14-19	3270-3278	cannabis	_	
14-20	3279-3284	users	_	
14-21	3285-3286	[	_	
14-22	3286-3293	Cousijn	_	
14-23	3294-3296	et	_	
14-24	3297-3299	al	_	
14-25	3299-3300	.	_	
14-26	3300-3301	,	_	
14-27	3302-3307	2013b	_	
14-28	3307-3308	;	_	
14-29	3309-3315	Filbey	_	
14-30	3316-3318	et	_	
14-31	3319-3321	al	_	
14-32	3321-3322	.	_	
14-33	3322-3323	,	_	
14-34	3324-3328	2013	_	
14-35	3328-3329	;	_	
14-36	3330-3336	Nestor	_	
14-37	3337-3339	et	_	
14-38	3340-3342	al	_	
14-39	3342-3343	.	_	
14-40	3343-3344	,	_	
14-41	3345-3349	2010	_	
14-42	3349-3350	;	_	
14-43	3351-3354	Yip	_	
14-44	3355-3357	et	_	
14-45	3358-3360	al	_	
14-46	3360-3361	.	_	
14-47	3361-3362	,	_	
14-48	3363-3367	2014	_	
14-49	3367-3368	;	_	
14-50	3369-3372	van	_	
14-51	3373-3377	Hell	_	
14-52	3378-3380	et	_	
14-53	3381-3383	al	_	
14-54	3383-3384	.	_	
14-55	3384-3385	,	_	
14-56	3386-3390	2010	_	
14-57	3390-3391	]	_	
14-58	3391-3392	.	_	

#Text=However, because money may be associated with cannabis and could be a secondary cue for cannabis, the specificity of increased motivational processing to cannabis rather than a generalized hyper‐responsivity to all rewards has yet to be directly examined.
15-1	3393-3400	However	_	
15-2	3400-3401	,	_	
15-3	3402-3409	because	_	
15-4	3410-3415	money	_	
15-5	3416-3419	may	_	
15-6	3420-3422	be	_	
15-7	3423-3433	associated	_	
15-8	3434-3438	with	_	
15-9	3439-3447	cannabis	_	
15-10	3448-3451	and	_	
15-11	3452-3457	could	_	
15-12	3458-3460	be	_	
15-13	3461-3462	a	_	
15-14	3463-3472	secondary	_	
15-15	3473-3476	cue	_	
15-16	3477-3480	for	_	
15-17	3481-3489	cannabis	_	
15-18	3489-3490	,	_	
15-19	3491-3494	the	_	
15-20	3495-3506	specificity	_	
15-21	3507-3509	of	_	
15-22	3510-3519	increased	_	
15-23	3520-3532	motivational	_	
15-24	3533-3543	processing	_	
15-25	3544-3546	to	_	
15-26	3547-3555	cannabis	_	
15-27	3556-3562	rather	_	
15-28	3563-3567	than	_	
15-29	3568-3569	a	_	
15-30	3570-3581	generalized	_	
15-31	3582-3600	hyper‐responsivity	_	
15-32	3601-3603	to	_	
15-33	3604-3607	all	_	
15-34	3608-3615	rewards	_	
15-35	3616-3619	has	_	
15-36	3620-3623	yet	_	
15-37	3624-3626	to	_	
15-38	3627-3629	be	_	
15-39	3630-3638	directly	_	
15-40	3639-3647	examined	_	
15-41	3647-3648	.	_	

#Text=A study by Wetherill et al. [2014] comparing neural response to subliminal cannabis cues with subliminal sexual images found greater response to the subliminally presented cannabis cues relative to the sexual images in the insula, ventral striatum, and amygdala [Wetherill et al., 2014].
16-1	3649-3650	A	_	
16-2	3651-3656	study	_	
16-3	3657-3659	by	_	
16-4	3660-3669	Wetherill	_	
16-5	3670-3672	et	_	
16-6	3673-3675	al	_	
16-7	3675-3676	.	_	
16-8	3677-3678	[	_	
16-9	3678-3682	2014	_	
16-10	3682-3683	]	_	
16-11	3684-3693	comparing	_	
16-12	3694-3700	neural	_	
16-13	3701-3709	response	_	
16-14	3710-3712	to	_	
16-15	3713-3723	subliminal	_	
16-16	3724-3732	cannabis	_	
16-17	3733-3737	cues	_	
16-18	3738-3742	with	_	
16-19	3743-3753	subliminal	_	
16-20	3754-3760	sexual	_	
16-21	3761-3767	images	_	
16-22	3768-3773	found	_	
16-23	3774-3781	greater	_	
16-24	3782-3790	response	_	
16-25	3791-3793	to	_	
16-26	3794-3797	the	_	
16-27	3798-3810	subliminally	_	
16-28	3811-3820	presented	_	
16-29	3821-3829	cannabis	_	
16-30	3830-3834	cues	_	
16-31	3835-3843	relative	_	
16-32	3844-3846	to	_	
16-33	3847-3850	the	_	
16-34	3851-3857	sexual	_	
16-35	3858-3864	images	_	
16-36	3865-3867	in	_	
16-37	3868-3871	the	_	
16-38	3872-3878	insula	_	
16-39	3878-3879	,	_	
16-40	3880-3887	ventral	_	
16-41	3888-3896	striatum	_	
16-42	3896-3897	,	_	
16-43	3898-3901	and	_	
16-44	3902-3910	amygdala	_	
16-45	3911-3912	[	_	
16-46	3912-3921	Wetherill	_	
16-47	3922-3924	et	_	
16-48	3925-3927	al	_	
16-49	3927-3928	.	_	
16-50	3928-3929	,	_	
16-51	3930-3934	2014	_	
16-52	3934-3935	]	_	
16-53	3935-3936	.	_	

#Text=It is, therefore, possible that similarly greater response to explicitly presented cannabis cues relative to appetitive cues would be expected.
17-1	3937-3939	It	_	
17-2	3940-3942	is	_	
17-3	3942-3943	,	_	
17-4	3944-3953	therefore	_	
17-5	3953-3954	,	_	
17-6	3955-3963	possible	_	
17-7	3964-3968	that	_	
17-8	3969-3978	similarly	_	
17-9	3979-3986	greater	_	
17-10	3987-3995	response	_	
17-11	3996-3998	to	_	
17-12	3999-4009	explicitly	_	
17-13	4010-4019	presented	_	
17-14	4020-4028	cannabis	_	
17-15	4029-4033	cues	_	
17-16	4034-4042	relative	_	
17-17	4043-4045	to	_	
17-18	4046-4056	appetitive	_	
17-19	4057-4061	cues	_	
17-20	4062-4067	would	_	
17-21	4068-4070	be	_	
17-22	4071-4079	expected	_	
17-23	4079-4080	.	_	

#Text=In this study, to determine how cannabis use relates to potential disruptions in the brain's natural reward processes, we tested the specificity of neural response to cannabis cues relative to natural rewards in long‐term, heavy cannabis users, and non‐using controls.
18-1	4081-4083	In	_	
18-2	4084-4088	this	_	
18-3	4089-4094	study	_	
18-4	4094-4095	,	_	
18-5	4096-4098	to	_	
18-6	4099-4108	determine	_	
18-7	4109-4112	how	_	
18-8	4113-4121	cannabis	_	
18-9	4122-4125	use	_	
18-10	4126-4133	relates	_	
18-11	4134-4136	to	_	
18-12	4137-4146	potential	_	
18-13	4147-4158	disruptions	_	
18-14	4159-4161	in	_	
18-15	4162-4165	the	_	
18-16	4166-4173	brain's	_	
18-17	4174-4181	natural	_	
18-18	4182-4188	reward	_	
18-19	4189-4198	processes	_	
18-20	4198-4199	,	_	
18-21	4200-4202	we	_	
18-22	4203-4209	tested	_	
18-23	4210-4213	the	_	
18-24	4214-4225	specificity	_	
18-25	4226-4228	of	_	
18-26	4229-4235	neural	_	
18-27	4236-4244	response	_	
18-28	4245-4247	to	_	
18-29	4248-4256	cannabis	_	
18-30	4257-4261	cues	_	
18-31	4262-4270	relative	_	
18-32	4271-4273	to	_	
18-33	4274-4281	natural	_	
18-34	4282-4289	rewards	_	
18-35	4290-4292	in	_	
18-36	4293-4302	long‐term	_	
18-37	4302-4303	,	_	
18-38	4304-4309	heavy	_	
18-39	4310-4318	cannabis	_	
18-40	4319-4324	users	_	
18-41	4324-4325	,	_	
18-42	4326-4329	and	_	
18-43	4330-4339	non‐using	_	
18-44	4340-4348	controls	_	
18-45	4348-4349	.	_	

#Text=Based on incentive sensitization models of addiction that propose that drugs sensitize mesocorticolimbic regions and disrupt or segment natural reward processes [Hyman and Malenka, 2001; Robinson and Berridge, 2000] as well as from findings by Wetherill et al [2014], we hypothesized that cannabis users will show greater fMRI BOLD response when exposed to explicitly presented cannabis cues that will be above and beyond response (1) to cues for natural rewards and (2) in non‐users.
19-1	4350-4355	Based	_	
19-2	4356-4358	on	_	
19-3	4359-4368	incentive	_	
19-4	4369-4382	sensitization	_	
19-5	4383-4389	models	_	
19-6	4390-4392	of	_	
19-7	4393-4402	addiction	_	
19-8	4403-4407	that	_	
19-9	4408-4415	propose	_	
19-10	4416-4420	that	_	
19-11	4421-4426	drugs	_	
19-12	4427-4436	sensitize	_	
19-13	4437-4454	mesocorticolimbic	_	
19-14	4455-4462	regions	_	
19-15	4463-4466	and	_	
19-16	4467-4474	disrupt	_	
19-17	4475-4477	or	_	
19-18	4478-4485	segment	_	
19-19	4486-4493	natural	_	
19-20	4494-4500	reward	_	
19-21	4501-4510	processes	_	
19-22	4511-4512	[	_	
19-23	4512-4517	Hyman	_	
19-24	4518-4521	and	_	
19-25	4522-4529	Malenka	_	
19-26	4529-4530	,	_	
19-27	4531-4535	2001	_	
19-28	4535-4536	;	_	
19-29	4537-4545	Robinson	_	
19-30	4546-4549	and	_	
19-31	4550-4558	Berridge	_	
19-32	4558-4559	,	_	
19-33	4560-4564	2000	_	
19-34	4564-4565	]	_	
19-35	4566-4568	as	_	
19-36	4569-4573	well	_	
19-37	4574-4576	as	_	
19-38	4577-4581	from	_	
19-39	4582-4590	findings	_	
19-40	4591-4593	by	_	
19-41	4594-4603	Wetherill	_	
19-42	4604-4606	et	_	
19-43	4607-4609	al	_	
19-44	4610-4611	[	_	
19-45	4611-4615	2014	_	
19-46	4615-4616	]	_	
19-47	4616-4617	,	_	
19-48	4618-4620	we	_	
19-49	4621-4633	hypothesized	_	
19-50	4634-4638	that	_	
19-51	4639-4647	cannabis	_	
19-52	4648-4653	users	_	
19-53	4654-4658	will	_	
19-54	4659-4663	show	_	
19-55	4664-4671	greater	_	
19-56	4672-4676	fMRI	_	
19-57	4677-4681	BOLD	_	
19-58	4682-4690	response	_	
19-59	4691-4695	when	_	
19-60	4696-4703	exposed	_	
19-61	4704-4706	to	_	
19-62	4707-4717	explicitly	_	
19-63	4718-4727	presented	_	
19-64	4728-4736	cannabis	_	
19-65	4737-4741	cues	_	
19-66	4742-4746	that	_	
19-67	4747-4751	will	_	
19-68	4752-4754	be	_	
19-69	4755-4760	above	_	
19-70	4761-4764	and	_	
19-71	4765-4771	beyond	_	
19-72	4772-4780	response	_	
19-73	4781-4782	(	_	
19-74	4782-4783	1	_	
19-75	4783-4784	)	_	
19-76	4785-4787	to	_	
19-77	4788-4792	cues	_	
19-78	4793-4796	for	_	
19-79	4797-4804	natural	_	
19-80	4805-4812	rewards	_	
19-81	4813-4816	and	_	
19-82	4817-4818	(	_	
19-83	4818-4819	2	_	
19-84	4819-4820	)	_	
19-85	4821-4823	in	_	
19-86	4824-4833	non‐users	_	
19-87	4833-4834	.	_	

#Text=Greater activation is expected in mesocorticolimbic regions that regulate motivation, executive function, and reward processing.
20-1	4835-4842	Greater	_	
20-2	4843-4853	activation	_	
20-3	4854-4856	is	_	
20-4	4857-4865	expected	_	
20-5	4866-4868	in	_	
20-6	4869-4886	mesocorticolimbic	_	
20-7	4887-4894	regions	_	
20-8	4895-4899	that	_	
20-9	4900-4908	regulate	_	
20-10	4909-4919	motivation	_	
20-11	4919-4920	,	_	
20-12	4921-4930	executive	_	
20-13	4931-4939	function	_	
20-14	4939-4940	,	_	
20-15	4941-4944	and	_	
20-16	4945-4951	reward	_	
20-17	4952-4962	processing	_	
20-18	4962-4963	.	_	

#Text=Lastly, given the existing literature showing associations between the brain's response to cues and cannabis use behaviors, we also expected that this pattern of neural activation would be related to subjective craving as well as behavioral measures of cannabis use.
21-1	4964-4970	Lastly	_	
21-2	4970-4971	,	_	
21-3	4972-4977	given	_	
21-4	4978-4981	the	_	
21-5	4982-4990	existing	_	
21-6	4991-5001	literature	_	
21-7	5002-5009	showing	_	
21-8	5010-5022	associations	_	
21-9	5023-5030	between	_	
21-10	5031-5034	the	_	
21-11	5035-5042	brain's	_	
21-12	5043-5051	response	_	
21-13	5052-5054	to	_	
21-14	5055-5059	cues	_	
21-15	5060-5063	and	_	
21-16	5064-5072	cannabis	_	
21-17	5073-5076	use	_	
21-18	5077-5086	behaviors	_	
21-19	5086-5087	,	_	
21-20	5088-5090	we	_	
21-21	5091-5095	also	_	
21-22	5096-5104	expected	_	
21-23	5105-5109	that	_	
21-24	5110-5114	this	_	
21-25	5115-5122	pattern	_	
21-26	5123-5125	of	_	
21-27	5126-5132	neural	_	
21-28	5133-5143	activation	_	
21-29	5144-5149	would	_	
21-30	5150-5152	be	_	
21-31	5153-5160	related	_	
21-32	5161-5163	to	_	
21-33	5164-5174	subjective	_	
21-34	5175-5182	craving	_	
21-35	5183-5185	as	_	
21-36	5186-5190	well	_	
21-37	5191-5193	as	_	
21-38	5194-5204	behavioral	_	
21-39	5205-5213	measures	_	
21-40	5214-5216	of	_	
21-41	5217-5225	cannabis	_	
21-42	5226-5229	use	_	
21-43	5229-5230	.	_	

#Text=MATERIALS AND METHODS
#Text=This study was approved by the University of Texas at Dallas and University of Texas Southwestern Medical Center Institutional Review Boards.
22-1	5231-5240	MATERIALS	http://www.case.edu/ProvCaRe/provcare#StudyMethod[7]|http://www.case.edu/ProvCaRe/provcare#StudyMethod[8]	
22-2	5241-5244	AND	http://www.case.edu/ProvCaRe/provcare#StudyMethod[7]|http://www.case.edu/ProvCaRe/provcare#StudyMethod[8]	
22-3	5245-5252	METHODS	http://www.case.edu/ProvCaRe/provcare#StudyMethod[7]|http://www.case.edu/ProvCaRe/provcare#StudyMethod[8]	
22-4	5253-5257	This	http://www.case.edu/ProvCaRe/provcare#StudyMethod[7]|*[9]	
22-5	5258-5263	study	*[9]	
22-6	5264-5267	was	*[9]	
22-7	5268-5276	approved	*[9]	
22-8	5277-5279	by	*[9]	
22-9	5280-5283	the	*[9]	
22-10	5284-5294	University	*[9]	
22-11	5295-5297	of	*[9]	
22-12	5298-5303	Texas	*[9]	
22-13	5304-5306	at	*[9]	
22-14	5307-5313	Dallas	*[9]	
22-15	5314-5317	and	*[9]	
22-16	5318-5328	University	*[9]	
22-17	5329-5331	of	*[9]	
22-18	5332-5337	Texas	*[9]	
22-19	5338-5350	Southwestern	*[9]	
22-20	5351-5358	Medical	*[9]	
22-21	5359-5365	Center	*[9]	
22-22	5366-5379	Institutional	*[9]	
22-23	5380-5386	Review	*[9]	
22-24	5387-5393	Boards	*[9]	
22-25	5393-5394	.	*[9]	

#Text=This study was conducted according to the principles expressed in the Declaration of Helsinki.
23-1	5395-5399	This	*[9]	
23-2	5400-5405	study	*[9]	
23-3	5406-5409	was	*[9]	
23-4	5410-5419	conducted	*[9]	
23-5	5420-5429	according	*[9]	
23-6	5430-5432	to	*[9]	
23-7	5433-5436	the	*[9]	
23-8	5437-5447	principles	*[9]	
23-9	5448-5457	expressed	*[9]	
23-10	5458-5460	in	*[9]	
23-11	5461-5464	the	*[9]	
23-12	5465-5476	Declaration	*[9]	
23-13	5477-5479	of	*[9]	
23-14	5480-5488	Helsinki	*[9]	
23-15	5488-5489	.	*[9]	

#Text=All participants provided informed written consent to participate in the study and were provided monetary compensation for their participation.
24-1	5490-5493	All	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-2	5494-5506	participants	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-3	5507-5515	provided	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-4	5516-5524	informed	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-5	5525-5532	written	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-6	5533-5540	consent	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-7	5541-5543	to	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-8	5544-5555	participate	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-9	5556-5558	in	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-10	5559-5562	the	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-11	5563-5568	study	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-12	5569-5572	and	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-13	5573-5577	were	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-14	5578-5586	provided	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-15	5587-5595	monetary	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-16	5596-5608	compensation	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-17	5609-5612	for	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-18	5613-5618	their	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-19	5619-5632	participation	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
24-20	5632-5633	.	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	

#Text=Participants
#Text=Fifty nine regular cannabis users and 70 non‐users participated in this study.
25-1	5634-5646	Participants	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-2	5647-5652	Fifty	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-3	5653-5657	nine	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-4	5658-5665	regular	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-5	5666-5674	cannabis	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-6	5675-5680	users	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-7	5681-5684	and	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-8	5685-5687	70	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-9	5688-5697	non‐users	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-10	5698-5710	participated	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-11	5711-5713	in	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-12	5714-5718	this	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-13	5719-5724	study	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
25-14	5724-5725	.	*[9]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	

#Text=The study's inclusion criteria were: right‐handedness, English as the primary language, absence of current or history of psychosis, traumatic brain injury, and MRI contraindications (e.g., pregnancy, non‐removal metallic implants, claustrophobia).
26-1	5726-5729	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-2	5730-5737	study's	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-3	5738-5747	inclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-4	5748-5756	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-5	5757-5761	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-6	5761-5762	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-7	5763-5779	right‐handedness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-8	5779-5780	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-9	5781-5788	English	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-10	5789-5791	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-11	5792-5795	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-12	5796-5803	primary	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-13	5804-5812	language	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-14	5812-5813	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-15	5814-5821	absence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-16	5822-5824	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-17	5825-5832	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-18	5833-5835	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-19	5836-5843	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-20	5844-5846	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-21	5847-5856	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-22	5856-5857	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-23	5858-5867	traumatic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-24	5868-5873	brain	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-25	5874-5880	injury	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-26	5880-5881	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-27	5882-5885	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-28	5886-5889	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-29	5890-5907	contraindications	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-30	5908-5909	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-31	5909-5912	e.g	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-32	5912-5913	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-33	5913-5914	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-34	5915-5924	pregnancy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-35	5924-5925	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-36	5926-5937	non‐removal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-37	5938-5946	metallic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-38	5947-5955	implants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-39	5955-5956	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-40	5957-5971	claustrophobia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-41	5971-5972	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
26-42	5972-5973	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	

#Text=All of the participants were screened via urinalysis for other drugs of abuse and were excluded if drugs (other than cannabis) were detected.
27-1	5974-5977	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-2	5978-5980	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-3	5981-5984	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-4	5985-5997	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-5	5998-6002	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-6	6003-6011	screened	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-7	6012-6015	via	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-8	6016-6026	urinalysis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-9	6027-6030	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-10	6031-6036	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-11	6037-6042	drugs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-12	6043-6045	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-13	6046-6051	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-14	6052-6055	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-15	6056-6060	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-16	6061-6069	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-17	6070-6072	if	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-18	6073-6078	drugs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-19	6079-6080	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-20	6080-6085	other	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-21	6086-6090	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-22	6091-6099	cannabis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-23	6099-6100	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-24	6101-6105	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-25	6106-6114	detected	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
27-26	6114-6115	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	

#Text=Participants were excluded for regular tobacco use as defined by smoking more than a pack of cigarettes a month as well as current alcohol dependence based on the Structured Clinical Interview for DSM‐IV (SCID) [First et al., 1997].
28-1	6116-6128	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-2	6129-6133	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-3	6134-6142	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-4	6143-6146	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-5	6147-6154	regular	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-6	6155-6162	tobacco	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-7	6163-6166	use	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-8	6167-6169	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-9	6170-6177	defined	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-10	6178-6180	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-11	6181-6188	smoking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-12	6189-6193	more	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-13	6194-6198	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-14	6199-6200	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-15	6201-6205	pack	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-16	6206-6208	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-17	6209-6219	cigarettes	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-18	6220-6221	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-19	6222-6227	month	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-20	6228-6230	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-21	6231-6235	well	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-22	6236-6238	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-23	6239-6246	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-24	6247-6254	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-25	6255-6265	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-26	6266-6271	based	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-27	6272-6274	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-28	6275-6278	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-29	6279-6289	Structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-30	6290-6298	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-31	6299-6308	Interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-32	6309-6312	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-33	6313-6319	DSM‐IV	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-34	6320-6321	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-35	6321-6325	SCID	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-36	6325-6326	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
28-37	6327-6328	[	_	
28-38	6328-6333	First	_	
28-39	6334-6336	et	_	
28-40	6337-6339	al	_	
28-41	6339-6340	.	_	
28-42	6340-6341	,	_	
28-43	6342-6346	1997	_	
28-44	6346-6347	]	_	
28-45	6347-6348	.	_	

#Text=Cannabis users were recruited based on self‐reported history of regular cannabis use with a minimum of 5,000 lifetime occasions, as well as daily use over the preceding 60 days.
29-1	6349-6357	Cannabis	_	
29-2	6358-6363	users	_	
29-3	6364-6368	were	_	
29-4	6369-6378	recruited	_	
29-5	6379-6384	based	_	
29-6	6385-6387	on	_	
29-7	6388-6401	self‐reported	_	
29-8	6402-6409	history	_	
29-9	6410-6412	of	_	
29-10	6413-6420	regular	_	
29-11	6421-6429	cannabis	_	
29-12	6430-6433	use	_	
29-13	6434-6438	with	_	
29-14	6439-6440	a	_	
29-15	6441-6448	minimum	_	
29-16	6449-6451	of	_	
29-17	6452-6457	5,000	_	
29-18	6458-6466	lifetime	_	
29-19	6467-6476	occasions	_	
29-20	6476-6477	,	_	
29-21	6478-6480	as	_	
29-22	6481-6485	well	_	
29-23	6486-6488	as	_	
29-24	6489-6494	daily	_	
29-25	6495-6498	use	_	
29-26	6499-6503	over	_	
29-27	6504-6507	the	_	
29-28	6508-6517	preceding	_	
29-29	6518-6520	60	_	
29-30	6521-6525	days	_	
29-31	6525-6526	.	_	

#Text=Verification of cannabis use was conducted via quantification of THC metabolites as ng/ml (over creatinine) via gas chromatography (GC)/mass spectroscopy (MS).
30-1	6527-6539	Verification	_	
30-2	6540-6542	of	_	
30-3	6543-6551	cannabis	_	
30-4	6552-6555	use	_	
30-5	6556-6559	was	_	
30-6	6560-6569	conducted	_	
30-7	6570-6573	via	_	
30-8	6574-6588	quantification	_	
30-9	6589-6591	of	_	
30-10	6592-6595	THC	_	
30-11	6596-6607	metabolites	_	
30-12	6608-6610	as	_	
30-13	6611-6613	ng	_	
30-14	6613-6614	/	_	
30-15	6614-6616	ml	_	
30-16	6617-6618	(	_	
30-17	6618-6622	over	_	
30-18	6623-6633	creatinine	_	
30-19	6633-6634	)	_	
30-20	6635-6638	via	_	
30-21	6639-6642	gas	_	
30-22	6643-6657	chromatography	_	
30-23	6658-6659	(	_	
30-24	6659-6661	GC	_	
30-25	6661-6662	)	_	
30-26	6662-6663	/	_	
30-27	6663-6667	mass	_	
30-28	6668-6680	spectroscopy	_	
30-29	6681-6682	(	_	
30-30	6682-6684	MS	_	
30-31	6684-6685	)	_	
30-32	6685-6686	.	_	

#Text=The non‐using controls were recruited based on the absence of daily cannabis use at any period in their lifetime, in addition to no current illicit drug use in the past 60 days.
31-1	6687-6690	The	_	
31-2	6691-6700	non‐using	_	
31-3	6701-6709	controls	_	
31-4	6710-6714	were	_	
31-5	6715-6724	recruited	_	
31-6	6725-6730	based	_	
31-7	6731-6733	on	_	
31-8	6734-6737	the	_	
31-9	6738-6745	absence	_	
31-10	6746-6748	of	_	
31-11	6749-6754	daily	_	
31-12	6755-6763	cannabis	_	
31-13	6764-6767	use	_	
31-14	6768-6770	at	_	
31-15	6771-6774	any	_	
31-16	6775-6781	period	_	
31-17	6782-6784	in	_	
31-18	6785-6790	their	_	
31-19	6791-6799	lifetime	_	
31-20	6799-6800	,	_	
31-21	6801-6803	in	_	
31-22	6804-6812	addition	_	
31-23	6813-6815	to	_	
31-24	6816-6818	no	_	
31-25	6819-6826	current	_	
31-26	6827-6834	illicit	_	
31-27	6835-6839	drug	_	
31-28	6840-6843	use	_	
31-29	6844-6846	in	_	
31-30	6847-6850	the	_	
31-31	6851-6855	past	_	
31-32	6856-6858	60	_	
31-33	6859-6863	days	_	
31-34	6863-6864	.	_	

#Text=Behavioral Data
#Text=We collected (1) the Marijuana Craving Questionnaire (MCQ) [Heishman et al., 2001] to measure basal level craving for cannabis immediately prior to and after the MRI scan and, (2) the Marijuana Withdrawal Checklist, (MWC) [Budney et al., 1999] to measure self‐reported withdrawal symptoms immediately prior to the MRI scan, and, (3) the Marijuana Problems Survey (MPS) [Stephens et al., 2000] to measure problems associated with cannabis use.
32-1	6865-6875	Behavioral	_	
32-2	6876-6880	Data	_	
32-3	6881-6883	We	_	
32-4	6884-6893	collected	_	
32-5	6894-6895	(	_	
32-6	6895-6896	1	_	
32-7	6896-6897	)	_	
32-8	6898-6901	the	_	
32-9	6902-6911	Marijuana	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceCravingScale[11]	
32-10	6912-6919	Craving	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceCravingScale[11]	
32-11	6920-6933	Questionnaire	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceCravingScale[11]	
32-12	6934-6935	(	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceCravingScale[11]	
32-13	6935-6938	MCQ	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceCravingScale[11]	
32-14	6938-6939	)	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceCravingScale[11]	
32-15	6940-6941	[	_	
32-16	6941-6949	Heishman	_	
32-17	6950-6952	et	_	
32-18	6953-6955	al	_	
32-19	6955-6956	.	_	
32-20	6956-6957	,	_	
32-21	6958-6962	2001	_	
32-22	6962-6963	]	_	
32-23	6964-6966	to	_	
32-24	6967-6974	measure	_	
32-25	6975-6980	basal	_	
32-26	6981-6986	level	_	
32-27	6987-6994	craving	_	
32-28	6995-6998	for	_	
32-29	6999-7007	cannabis	_	
32-30	7008-7019	immediately	_	
32-31	7020-7025	prior	_	
32-32	7026-7028	to	_	
32-33	7029-7032	and	_	
32-34	7033-7038	after	_	
32-35	7039-7042	the	_	
32-36	7043-7046	MRI	_	
32-37	7047-7051	scan	_	
32-38	7052-7055	and	_	
32-39	7055-7056	,	_	
32-40	7057-7058	(	_	
32-41	7058-7059	2	_	
32-42	7059-7060	)	_	
32-43	7061-7064	the	_	
32-44	7065-7074	Marijuana	_	
32-45	7075-7085	Withdrawal	_	
32-46	7086-7095	Checklist	_	
32-47	7095-7096	,	_	
32-48	7097-7098	(	_	
32-49	7098-7101	MWC	_	
32-50	7101-7102	)	_	
32-51	7103-7104	[	_	
32-52	7104-7110	Budney	_	
32-53	7111-7113	et	_	
32-54	7114-7116	al	_	
32-55	7116-7117	.	_	
32-56	7117-7118	,	_	
32-57	7119-7123	1999	_	
32-58	7123-7124	]	_	
32-59	7125-7127	to	_	
32-60	7128-7135	measure	_	
32-61	7136-7149	self‐reported	_	
32-62	7150-7160	withdrawal	_	
32-63	7161-7169	symptoms	_	
32-64	7170-7181	immediately	_	
32-65	7182-7187	prior	_	
32-66	7188-7190	to	_	
32-67	7191-7194	the	_	
32-68	7195-7198	MRI	_	
32-69	7199-7203	scan	_	
32-70	7203-7204	,	_	
32-71	7205-7208	and	_	
32-72	7208-7209	,	_	
32-73	7210-7211	(	_	
32-74	7211-7212	3	_	
32-75	7212-7213	)	_	
32-76	7214-7217	the	_	
32-77	7218-7227	Marijuana	_	
32-78	7228-7236	Problems	_	
32-79	7237-7243	Survey	_	
32-80	7244-7245	(	_	
32-81	7245-7248	MPS	_	
32-82	7248-7249	)	_	
32-83	7250-7251	[	_	
32-84	7251-7259	Stephens	_	
32-85	7260-7262	et	_	
32-86	7263-7265	al	_	
32-87	7265-7266	.	_	
32-88	7266-7267	,	_	
32-89	7268-7272	2000	_	
32-90	7272-7273	]	_	
32-91	7274-7276	to	_	
32-92	7277-7284	measure	_	
32-93	7285-7293	problems	_	
32-94	7294-7304	associated	_	
32-95	7305-7309	with	_	
32-96	7310-7318	cannabis	_	
32-97	7319-7322	use	_	
32-98	7322-7323	.	_	

#Text=Information pertaining to self‐reported grams of cannabis use per day was also obtained from the cannabis users.
33-1	7324-7335	Information	_	
33-2	7336-7346	pertaining	_	
33-3	7347-7349	to	_	
33-4	7350-7363	self‐reported	_	
33-5	7364-7369	grams	_	
33-6	7370-7372	of	_	
33-7	7373-7381	cannabis	_	
33-8	7382-7385	use	_	
33-9	7386-7389	per	_	
33-10	7390-7393	day	_	
33-11	7394-7397	was	_	
33-12	7398-7402	also	_	
33-13	7403-7411	obtained	_	
33-14	7412-7416	from	_	
33-15	7417-7420	the	_	
33-16	7421-7429	cannabis	_	
33-17	7430-7435	users	_	
33-18	7435-7436	.	_	

#Text=Behavioral Data Analyses
#Text= T‐tests and chi‐square tests were used in SPSS 21 for descriptive purposes as well as to compare the groups on demographic and substance use variables (Table 1).
34-1	7437-7447	Behavioral	_	
34-2	7448-7452	Data	_	
34-3	7453-7461	Analyses	_	
34-4	7463-7470	T‐tests	_	
34-5	7471-7474	and	_	
34-6	7475-7485	chi‐square	_	
34-7	7486-7491	tests	_	
34-8	7492-7496	were	_	
34-9	7497-7501	used	_	
34-10	7502-7504	in	_	
34-11	7505-7509	SPSS	_	
34-12	7510-7512	21	_	
34-13	7513-7516	for	_	
34-14	7517-7528	descriptive	_	
34-15	7529-7537	purposes	_	
34-16	7538-7540	as	_	
34-17	7541-7545	well	_	
34-18	7546-7548	as	_	
34-19	7549-7551	to	_	
34-20	7552-7559	compare	_	
34-21	7560-7563	the	_	
34-22	7564-7570	groups	_	
34-23	7571-7573	on	_	
34-24	7574-7585	demographic	_	
34-25	7586-7589	and	_	
34-26	7590-7599	substance	_	
34-27	7600-7603	use	_	
34-28	7604-7613	variables	_	
34-29	7614-7615	(	_	
34-30	7615-7620	Table	_	
34-31	7621-7622	1	_	
34-32	7622-7623	)	_	
34-33	7623-7624	.	_	

#Text=Demographic and substance use characteristics of participants
#Text=\tUsers mean (SD)\tNon‐users mean (SD)\tGroup difference\t \tN\t53\t68\t—\t \tAge\t30.66 (7.48)\t31.41(10.20)\tt(118.59) = 0.467; P = 0.641\t \tMales (N, %)\t33, 62.3%\t33, 48.5%\tχ2(1)=2.267; P = 0.132\t \tYears of education\t13.06 (3.05)\t16.83 (2.79)\tt(117) = 7.039; P< 0.001\t \t# Cigarette smoking days/60 days\t1.58 (3.93)\t.34 (2.67)\tt(87.28) = −1.979; P = 0.051\t \t# Drinking days/60 days\t12.42 (16.76)\t7.87 (14.42)\tt(119) = −1.603; P = 0.112\t \tCannabis use\t \tDuration of regular use (years)\t12.46 (7.74)\tn/a\tn/a\t \tLifetime CUD symptom count\t2.47 (2.42)\tn/a\tn/a\t \tMJ grams per day\t2.15 (1.76)\tn/a\tn/a\t \tTHC/creatinine ratio during abstinent state\t2.05 (1.71)\tn/a\tn/a\t \tMarijuana withdrawal checklist (MWC) total score\t9.6 (8.96)\tn/a\tn/a\t \tPre‐scan marijuana craving questionnaire (MCQ) sum\t237.04 (154.48)\tn/a\tn/a\t \tPost‐scan MCQ sum\t250.57 (170.65)\tn/a\tn/a\t \t
#Text=fMRI Data
#Text=fMRI scan acquisition
#Text=The users were scanned following a 72‐h abstinence from cannabis use.
35-1	7625-7636	Demographic	_	
35-2	7637-7640	and	_	
35-3	7641-7650	substance	_	
35-4	7651-7654	use	_	
35-5	7655-7670	characteristics	_	
35-6	7671-7673	of	_	
35-7	7674-7686	participants	_	
35-8	7688-7693	Users	_	
35-9	7694-7698	mean	_	
35-10	7699-7700	(	_	
35-11	7700-7702	SD	_	
35-12	7702-7703	)	_	
35-13	7704-7713	Non‐users	_	
35-14	7714-7718	mean	_	
35-15	7719-7720	(	_	
35-16	7720-7722	SD	_	
35-17	7722-7723	)	_	
35-18	7724-7729	Group	_	
35-19	7730-7740	difference	_	
35-20	7743-7744	N	_	
35-21	7745-7747	53	_	
35-22	7748-7750	68	_	
35-23	7751-7752	—	_	
35-24	7755-7758	Age	_	
35-25	7759-7764	30.66	_	
35-26	7765-7766	(	_	
35-27	7766-7770	7.48	_	
35-28	7770-7771	)	_	
35-29	7772-7777	31.41	_	
35-30	7777-7778	(	_	
35-31	7778-7783	10.20	_	
35-32	7783-7784	)	_	
35-33	7785-7786	t	_	
35-34	7786-7787	(	_	
35-35	7787-7793	118.59	_	
35-36	7793-7794	)	_	
35-37	7795-7796	=	_	
35-38	7797-7802	0.467	_	
35-39	7802-7803	;	_	
35-40	7804-7805	P	_	
35-41	7806-7807	=	_	
35-42	7808-7813	0.641	_	
35-43	7816-7821	Males	_	
35-44	7822-7823	(	_	
35-45	7823-7824	N	_	
35-46	7824-7825	,	_	
35-47	7826-7827	%	_	
35-48	7827-7828	)	_	
35-49	7829-7831	33	_	
35-50	7831-7832	,	_	
35-51	7833-7838	62.3%	_	
35-52	7839-7841	33	_	
35-53	7841-7842	,	_	
35-54	7843-7848	48.5%	_	
35-55	7849-7851	χ2	_	
35-56	7851-7852	(	_	
35-57	7852-7853	1	_	
35-58	7853-7854	)	_	
35-59	7854-7855	=	_	
35-60	7855-7860	2.267	_	
35-61	7860-7861	;	_	
35-62	7862-7863	P	_	
35-63	7864-7865	=	_	
35-64	7866-7871	0.132	_	
35-65	7874-7879	Years	_	
35-66	7880-7882	of	_	
35-67	7883-7892	education	_	
35-68	7893-7898	13.06	_	
35-69	7899-7900	(	_	
35-70	7900-7904	3.05	_	
35-71	7904-7905	)	_	
35-72	7906-7911	16.83	_	
35-73	7912-7913	(	_	
35-74	7913-7917	2.79	_	
35-75	7917-7918	)	_	
35-76	7919-7920	t	_	
35-77	7920-7921	(	_	
35-78	7921-7924	117	_	
35-79	7924-7925	)	_	
35-80	7926-7927	=	_	
35-81	7928-7933	7.039	_	
35-82	7933-7934	;	_	
35-83	7935-7936	P	_	
35-84	7936-7937	<	_	
35-85	7938-7943	0.001	_	
35-86	7946-7947	#	_	
35-87	7948-7957	Cigarette	_	
35-88	7958-7965	smoking	_	
35-89	7966-7970	days	_	
35-90	7970-7971	/	_	
35-91	7971-7973	60	_	
35-92	7974-7978	days	_	
35-93	7979-7983	1.58	_	
35-94	7984-7985	(	_	
35-95	7985-7989	3.93	_	
35-96	7989-7990	)	_	
35-97	7991-7994	.34	_	
35-98	7995-7996	(	_	
35-99	7996-8000	2.67	_	
35-100	8000-8001	)	_	
35-101	8002-8003	t	_	
35-102	8003-8004	(	_	
35-103	8004-8009	87.28	_	
35-104	8009-8010	)	_	
35-105	8011-8012	=	_	
35-106	8013-8014	−	_	
35-107	8014-8019	1.979	_	
35-108	8019-8020	;	_	
35-109	8021-8022	P	_	
35-110	8023-8024	=	_	
35-111	8025-8030	0.051	_	
35-112	8033-8034	#	_	
35-113	8035-8043	Drinking	_	
35-114	8044-8048	days	_	
35-115	8048-8049	/	_	
35-116	8049-8051	60	_	
35-117	8052-8056	days	_	
35-118	8057-8062	12.42	_	
35-119	8063-8064	(	_	
35-120	8064-8069	16.76	_	
35-121	8069-8070	)	_	
35-122	8071-8075	7.87	_	
35-123	8076-8077	(	_	
35-124	8077-8082	14.42	_	
35-125	8082-8083	)	_	
35-126	8084-8085	t	_	
35-127	8085-8086	(	_	
35-128	8086-8089	119	_	
35-129	8089-8090	)	_	
35-130	8091-8092	=	_	
35-131	8093-8094	−	_	
35-132	8094-8099	1.603	_	
35-133	8099-8100	;	_	
35-134	8101-8102	P	_	
35-135	8103-8104	=	_	
35-136	8105-8110	0.112	_	
35-137	8113-8121	Cannabis	_	
35-138	8122-8125	use	_	
35-139	8128-8136	Duration	_	
35-140	8137-8139	of	_	
35-141	8140-8147	regular	_	
35-142	8148-8151	use	_	
35-143	8152-8153	(	_	
35-144	8153-8158	years	_	
35-145	8158-8159	)	_	
35-146	8160-8165	12.46	_	
35-147	8166-8167	(	_	
35-148	8167-8171	7.74	_	
35-149	8171-8172	)	_	
35-150	8173-8174	n	_	
35-151	8174-8175	/	_	
35-152	8175-8176	a	_	
35-153	8177-8178	n	_	
35-154	8178-8179	/	_	
35-155	8179-8180	a	_	
35-156	8183-8191	Lifetime	_	
35-157	8192-8195	CUD	_	
35-158	8196-8203	symptom	_	
35-159	8204-8209	count	_	
35-160	8210-8214	2.47	_	
35-161	8215-8216	(	_	
35-162	8216-8220	2.42	_	
35-163	8220-8221	)	_	
35-164	8222-8223	n	_	
35-165	8223-8224	/	_	
35-166	8224-8225	a	_	
35-167	8226-8227	n	_	
35-168	8227-8228	/	_	
35-169	8228-8229	a	_	
35-170	8232-8234	MJ	_	
35-171	8235-8240	grams	_	
35-172	8241-8244	per	_	
35-173	8245-8248	day	_	
35-174	8249-8253	2.15	_	
35-175	8254-8255	(	_	
35-176	8255-8259	1.76	_	
35-177	8259-8260	)	_	
35-178	8261-8262	n	_	
35-179	8262-8263	/	_	
35-180	8263-8264	a	_	
35-181	8265-8266	n	_	
35-182	8266-8267	/	_	
35-183	8267-8268	a	_	
35-184	8271-8274	THC	_	
35-185	8274-8275	/	_	
35-186	8275-8285	creatinine	_	
35-187	8286-8291	ratio	_	
35-188	8292-8298	during	_	
35-189	8299-8308	abstinent	_	
35-190	8309-8314	state	_	
35-191	8315-8319	2.05	_	
35-192	8320-8321	(	_	
35-193	8321-8325	1.71	_	
35-194	8325-8326	)	_	
35-195	8327-8328	n	_	
35-196	8328-8329	/	_	
35-197	8329-8330	a	_	
35-198	8331-8332	n	_	
35-199	8332-8333	/	_	
35-200	8333-8334	a	_	
35-201	8337-8346	Marijuana	_	
35-202	8347-8357	withdrawal	_	
35-203	8358-8367	checklist	_	
35-204	8368-8369	(	_	
35-205	8369-8372	MWC	_	
35-206	8372-8373	)	_	
35-207	8374-8379	total	_	
35-208	8380-8385	score	_	
35-209	8386-8389	9.6	_	
35-210	8390-8391	(	_	
35-211	8391-8395	8.96	_	
35-212	8395-8396	)	_	
35-213	8397-8398	n	_	
35-214	8398-8399	/	_	
35-215	8399-8400	a	_	
35-216	8401-8402	n	_	
35-217	8402-8403	/	_	
35-218	8403-8404	a	_	
35-219	8407-8415	Pre‐scan	_	
35-220	8416-8425	marijuana	_	
35-221	8426-8433	craving	_	
35-222	8434-8447	questionnaire	_	
35-223	8448-8449	(	_	
35-224	8449-8452	MCQ	_	
35-225	8452-8453	)	_	
35-226	8454-8457	sum	_	
35-227	8458-8464	237.04	_	
35-228	8465-8466	(	_	
35-229	8466-8472	154.48	_	
35-230	8472-8473	)	_	
35-231	8474-8475	n	_	
35-232	8475-8476	/	_	
35-233	8476-8477	a	_	
35-234	8478-8479	n	_	
35-235	8479-8480	/	_	
35-236	8480-8481	a	_	
35-237	8484-8493	Post‐scan	_	
35-238	8494-8497	MCQ	_	
35-239	8498-8501	sum	_	
35-240	8502-8508	250.57	_	
35-241	8509-8510	(	_	
35-242	8510-8516	170.65	_	
35-243	8516-8517	)	_	
35-244	8518-8519	n	_	
35-245	8519-8520	/	_	
35-246	8520-8521	a	_	
35-247	8522-8523	n	_	
35-248	8523-8524	/	_	
35-249	8524-8525	a	_	
35-250	8529-8533	fMRI	_	
35-251	8534-8538	Data	_	
35-252	8539-8543	fMRI	_	
35-253	8544-8548	scan	_	
35-254	8549-8560	acquisition	_	
35-255	8561-8564	The	_	
35-256	8565-8570	users	_	
35-257	8571-8575	were	_	
35-258	8576-8583	scanned	_	
35-259	8584-8593	following	_	
35-260	8594-8595	a	_	
35-261	8596-8598	72	_	
35-262	8598-8599	‐	_	
35-263	8599-8600	h	_	
35-264	8601-8611	abstinence	_	
35-265	8612-8616	from	_	
35-266	8617-8625	cannabis	_	
35-267	8626-8629	use	_	
35-268	8629-8630	.	_	

#Text=Although there is no reliable measure of acute abstinence from cannabis, we measured THC metabolites as ng/ml (over creatinine) (via GC/MS) from the participants before and after approximately 72‐h period to detect reductions in THC metabolites, in addition to self‐report.
36-1	8631-8639	Although	_	
36-2	8640-8645	there	_	
36-3	8646-8648	is	_	
36-4	8649-8651	no	_	
36-5	8652-8660	reliable	_	
36-6	8661-8668	measure	_	
36-7	8669-8671	of	_	
36-8	8672-8677	acute	_	
36-9	8678-8688	abstinence	_	
36-10	8689-8693	from	_	
36-11	8694-8702	cannabis	_	
36-12	8702-8703	,	_	
36-13	8704-8706	we	_	
36-14	8707-8715	measured	_	
36-15	8716-8719	THC	_	
36-16	8720-8731	metabolites	_	
36-17	8732-8734	as	_	
36-18	8735-8737	ng	_	
36-19	8737-8738	/	_	
36-20	8738-8740	ml	_	
36-21	8741-8742	(	_	
36-22	8742-8746	over	_	
36-23	8747-8757	creatinine	_	
36-24	8757-8758	)	_	
36-25	8759-8760	(	_	
36-26	8760-8763	via	_	
36-27	8764-8766	GC	_	
36-28	8766-8767	/	_	
36-29	8767-8769	MS	_	
36-30	8769-8770	)	_	
36-31	8771-8775	from	_	
36-32	8776-8779	the	_	
36-33	8780-8792	participants	_	
36-34	8793-8799	before	_	
36-35	8800-8803	and	_	
36-36	8804-8809	after	_	
36-37	8810-8823	approximately	_	
36-38	8824-8826	72	_	
36-39	8826-8827	‐	_	
36-40	8827-8828	h	_	
36-41	8829-8835	period	_	
36-42	8836-8838	to	_	
36-43	8839-8845	detect	_	
36-44	8846-8856	reductions	_	
36-45	8857-8859	in	_	
36-46	8860-8863	THC	_	
36-47	8864-8875	metabolites	_	
36-48	8875-8876	,	_	
36-49	8877-8879	in	_	
36-50	8880-8888	addition	_	
36-51	8889-8891	to	_	
36-52	8892-8903	self‐report	_	
36-53	8903-8904	.	_	

#Text=All participants were asked to abstain from alcohol for 24 h and from caffeine and cigarettes for the 2‐h before their scheduled scan.
37-1	8905-8908	All	_	
37-2	8909-8921	participants	_	
37-3	8922-8926	were	_	
37-4	8927-8932	asked	_	
37-5	8933-8935	to	_	
37-6	8936-8943	abstain	_	
37-7	8944-8948	from	_	
37-8	8949-8956	alcohol	_	
37-9	8957-8960	for	_	
37-10	8961-8963	24	_	
37-11	8964-8965	h	_	
37-12	8966-8969	and	_	
37-13	8970-8974	from	_	
37-14	8975-8983	caffeine	_	
37-15	8984-8987	and	_	
37-16	8988-8998	cigarettes	_	
37-17	8999-9002	for	_	
37-18	9003-9006	the	_	
37-19	9007-9008	2	_	
37-20	9008-9009	‐	_	
37-21	9009-9010	h	_	
37-22	9011-9017	before	_	
37-23	9018-9023	their	_	
37-24	9024-9033	scheduled	_	
37-25	9034-9038	scan	_	
37-26	9038-9039	.	_	

#Text=Breath alcohol level was also collected to confirm blood alcohol content of 0.000 at the beginning of the scan.
38-1	9040-9046	Breath	_	
38-2	9047-9054	alcohol	_	
38-3	9055-9060	level	_	
38-4	9061-9064	was	_	
38-5	9065-9069	also	_	
38-6	9070-9079	collected	_	
38-7	9080-9082	to	_	
38-8	9083-9090	confirm	_	
38-9	9091-9096	blood	_	
38-10	9097-9104	alcohol	_	
38-11	9105-9112	content	_	
38-12	9113-9115	of	_	
38-13	9116-9121	0.000	_	
38-14	9122-9124	at	_	
38-15	9125-9128	the	_	
38-16	9129-9138	beginning	_	
38-17	9139-9141	of	_	
38-18	9142-9145	the	_	
38-19	9146-9150	scan	_	
38-20	9150-9151	.	_	

#Text=Additionally, all participants were asked to eat a meal before their scan appointment to reduce confounding effects of hunger.
39-1	9152-9164	Additionally	_	
39-2	9164-9165	,	_	
39-3	9166-9169	all	_	
39-4	9170-9182	participants	_	
39-5	9183-9187	were	_	
39-6	9188-9193	asked	_	
39-7	9194-9196	to	_	
39-8	9197-9200	eat	_	
39-9	9201-9202	a	_	
39-10	9203-9207	meal	_	
39-11	9208-9214	before	_	
39-12	9215-9220	their	_	
39-13	9221-9225	scan	_	
39-14	9226-9237	appointment	_	
39-15	9238-9240	to	_	
39-16	9241-9247	reduce	_	
39-17	9248-9259	confounding	_	
39-18	9260-9267	effects	_	
39-19	9268-9270	of	_	
39-20	9271-9277	hunger	_	
39-21	9277-9278	.	_	

#Text=Scanning sessions took place in the Advanced Imaging Research Center (AIRC) on the main University of Texas Southwestern Medical Center (UTSW) campus.
40-1	9279-9287	Scanning	_	
40-2	9288-9296	sessions	_	
40-3	9297-9301	took	_	
40-4	9302-9307	place	_	
40-5	9308-9310	in	_	
40-6	9311-9314	the	_	
40-7	9315-9323	Advanced	_	
40-8	9324-9331	Imaging	_	
40-9	9332-9340	Research	_	
40-10	9341-9347	Center	_	
40-11	9348-9349	(	_	
40-12	9349-9353	AIRC	_	
40-13	9353-9354	)	_	
40-14	9355-9357	on	_	
40-15	9358-9361	the	_	
40-16	9362-9366	main	_	
40-17	9367-9377	University	_	
40-18	9378-9380	of	_	
40-19	9381-9386	Texas	_	
40-20	9387-9399	Southwestern	_	
40-21	9400-9407	Medical	_	
40-22	9408-9414	Center	_	
40-23	9415-9416	(	_	
40-24	9416-9420	UTSW	_	
40-25	9420-9421	)	_	
40-26	9422-9428	campus	_	
40-27	9428-9429	.	_	

#Text=MRI images were collected using a 3T Philips whole body scanner equipped with Quasar gradient subsystem (40 mT/m amplitude, a slew rate of 220 mT/m/ms).
41-1	9430-9433	MRI	_	
41-2	9434-9440	images	_	
41-3	9441-9445	were	_	
41-4	9446-9455	collected	_	
41-5	9456-9461	using	_	
41-6	9462-9463	a	_	
41-7	9464-9466	3T	_	
41-8	9467-9474	Philips	_	
41-9	9475-9480	whole	_	
41-10	9481-9485	body	_	
41-11	9486-9493	scanner	_	
41-12	9494-9502	equipped	_	
41-13	9503-9507	with	_	
41-14	9508-9514	Quasar	_	
41-15	9515-9523	gradient	_	
41-16	9524-9533	subsystem	_	
41-17	9534-9535	(	_	
41-18	9535-9537	40	_	
41-19	9538-9540	mT	_	
41-20	9540-9541	/	_	
41-21	9541-9542	m	_	
41-22	9543-9552	amplitude	_	
41-23	9552-9553	,	_	
41-24	9554-9555	a	_	
41-25	9556-9560	slew	_	
41-26	9561-9565	rate	_	
41-27	9566-9568	of	_	
41-28	9569-9572	220	_	
41-29	9573-9575	mT	_	
41-30	9575-9576	/	_	
41-31	9576-9577	m	_	
41-32	9577-9578	/	_	
41-33	9578-9580	ms	_	
41-34	9580-9581	)	_	
41-35	9581-9582	.	_	

#Text=Structural MRI scans were collected with a MPRAGE sequence with the following parameters: TR/TE/TI = 8.2/3.70/1,100 ms, flip angle = 12°, FOV = 256 × 256 mm, slab thickness = 160 mm (along left‐right direction), voxel size =1 × 1 × 1 mm, total scan time = 3 min 57 s. fMRI scans were collected using a gradient echo, echo‐planar sequence with the intercomissural line (AC‐PC) as a reference (TR: 2.0 s, TE: 29 ms, flip angle: 75°, matrix size: 64 × 64, 39 slices, voxel size: 3.44 × 3.44 × 3.5 mm3).
#Text=fMRI cannabis cue exposure task
#Text=During the fMRI session, the participants completed a cannabis cue‐exposure task modified from the one previously described by Filbey et al. [2009b] to include a cue for a natural reward.
42-1	9583-9593	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging[12]	
42-2	9594-9597	MRI	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging[12]	
42-3	9598-9603	scans	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging[12]	
42-4	9604-9608	were	_	
42-5	9609-9618	collected	_	
42-6	9619-9623	with	_	
42-7	9624-9625	a	_	
42-8	9626-9632	MPRAGE	_	
42-9	9633-9641	sequence	_	
42-10	9642-9646	with	_	
42-11	9647-9650	the	_	
42-12	9651-9660	following	_	
42-13	9661-9671	parameters	_	
42-14	9671-9672	:	_	
42-15	9673-9675	TR	_	
42-16	9675-9676	/	_	
42-17	9676-9678	TE	_	
42-18	9678-9679	/	_	
42-19	9679-9681	TI	_	
42-20	9682-9683	=	_	
42-21	9684-9687	8.2	_	
42-22	9687-9688	/	_	
42-23	9688-9692	3.70	_	
42-24	9692-9693	/	_	
42-25	9693-9698	1,100	_	
42-26	9699-9701	ms	_	
42-27	9701-9702	,	_	
42-28	9703-9707	flip	_	
42-29	9708-9713	angle	_	
42-30	9714-9715	=	_	
42-31	9716-9718	12	_	
42-32	9718-9719	°	_	
42-33	9719-9720	,	_	
42-34	9721-9724	FOV	_	
42-35	9725-9726	=	_	
42-36	9727-9730	256	_	
42-37	9731-9732	×	_	
42-38	9733-9736	256	_	
42-39	9737-9739	mm	_	
42-40	9739-9740	,	_	
42-41	9741-9745	slab	_	
42-42	9746-9755	thickness	_	
42-43	9756-9757	=	_	
42-44	9758-9761	160	_	
42-45	9762-9764	mm	_	
42-46	9765-9766	(	_	
42-47	9766-9771	along	_	
42-48	9772-9782	left‐right	_	
42-49	9783-9792	direction	_	
42-50	9792-9793	)	_	
42-51	9793-9794	,	_	
42-52	9795-9800	voxel	_	
42-53	9801-9805	size	_	
42-54	9806-9807	=	_	
42-55	9807-9808	1	_	
42-56	9809-9810	×	_	
42-57	9811-9812	1	_	
42-58	9813-9814	×	_	
42-59	9815-9816	1	_	
42-60	9817-9819	mm	_	
42-61	9819-9820	,	_	
42-62	9821-9826	total	_	
42-63	9827-9831	scan	_	
42-64	9832-9836	time	_	
42-65	9837-9838	=	_	
42-66	9839-9840	3	_	
42-67	9841-9844	min	_	
42-68	9845-9847	57	_	
42-69	9848-9849	s	_	
42-70	9849-9850	.	_	
42-71	9851-9855	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
42-72	9856-9861	scans	_	
42-73	9862-9866	were	_	
42-74	9867-9876	collected	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging	
42-75	9877-9882	using	_	
42-76	9883-9884	a	_	
42-77	9885-9893	gradient	_	
42-78	9894-9898	echo	_	
42-79	9898-9899	,	_	
42-80	9900-9911	echo‐planar	_	
42-81	9912-9920	sequence	_	
42-82	9921-9925	with	_	
42-83	9926-9929	the	_	
42-84	9930-9945	intercomissural	_	
42-85	9946-9950	line	_	
42-86	9951-9952	(	_	
42-87	9952-9957	AC‐PC	_	
42-88	9957-9958	)	_	
42-89	9959-9961	as	_	
42-90	9962-9963	a	_	
42-91	9964-9973	reference	_	
42-92	9974-9975	(	_	
42-93	9975-9977	TR	_	
42-94	9977-9978	:	_	
42-95	9979-9982	2.0	_	
42-96	9983-9984	s	_	
42-97	9984-9985	,	_	
42-98	9986-9988	TE	_	
42-99	9988-9989	:	_	
42-100	9990-9992	29	_	
42-101	9993-9995	ms	_	
42-102	9995-9996	,	_	
42-103	9997-10001	flip	_	
42-104	10002-10007	angle	_	
42-105	10007-10008	:	_	
42-106	10009-10011	75	_	
42-107	10011-10012	°	_	
42-108	10012-10013	,	_	
42-109	10014-10020	matrix	_	
42-110	10021-10025	size	_	
42-111	10025-10026	:	_	
42-112	10027-10029	64	_	
42-113	10030-10031	×	_	
42-114	10032-10034	64	_	
42-115	10034-10035	,	_	
42-116	10036-10038	39	_	
42-117	10039-10045	slices	_	
42-118	10045-10046	,	_	
42-119	10047-10052	voxel	_	
42-120	10053-10057	size	_	
42-121	10057-10058	:	_	
42-122	10059-10063	3.44	_	
42-123	10064-10065	×	_	
42-124	10066-10070	3.44	_	
42-125	10071-10072	×	_	
42-126	10073-10076	3.5	_	
42-127	10077-10080	mm3	_	
42-128	10080-10081	)	_	
42-129	10081-10082	.	_	
42-130	10083-10087	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[13]	
42-131	10088-10096	cannabis	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[13]	
42-132	10097-10100	cue	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[13]	
42-133	10101-10109	exposure	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[13]	
42-134	10110-10114	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[13]	
42-135	10115-10121	During	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[13]	
42-136	10122-10125	the	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[13]	
42-137	10126-10130	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[13]	
42-138	10131-10138	session	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging[13]	
42-139	10138-10139	,	_	
42-140	10140-10143	the	_	
42-141	10144-10156	participants	_	
42-142	10157-10166	completed	_	
42-143	10167-10168	a	_	
42-144	10169-10177	cannabis	_	
42-145	10178-10190	cue‐exposure	_	
42-146	10191-10195	task	_	
42-147	10196-10204	modified	_	
42-148	10205-10209	from	_	
42-149	10210-10213	the	_	
42-150	10214-10217	one	_	
42-151	10218-10228	previously	_	
42-152	10229-10238	described	_	
42-153	10239-10241	by	_	
42-154	10242-10248	Filbey	_	
42-155	10249-10251	et	_	
42-156	10252-10254	al	_	
42-157	10254-10255	.	_	
42-158	10256-10257	[	_	
42-159	10257-10262	2009b	_	
42-160	10262-10263	]	_	
42-161	10264-10266	to	_	
42-162	10267-10274	include	_	
42-163	10275-10276	a	_	
42-164	10277-10280	cue	_	
42-165	10281-10284	for	_	
42-166	10285-10286	a	_	
42-167	10287-10294	natural	_	
42-168	10295-10301	reward	_	
42-169	10301-10302	.	_	

#Text=The task consisted of two runs, each one with a different pseudorandom order of visual and tactile presentations of: (i) a single cannabis cue (six trials), (ii) a single natural reward cue (six trials), and (iii) a single neutral cue (six trials).
43-1	10303-10306	The	_	
43-2	10307-10311	task	_	
43-3	10312-10321	consisted	_	
43-4	10322-10324	of	_	
43-5	10325-10328	two	_	
43-6	10329-10333	runs	_	
43-7	10333-10334	,	_	
43-8	10335-10339	each	_	
43-9	10340-10343	one	_	
43-10	10344-10348	with	_	
43-11	10349-10350	a	_	
43-12	10351-10360	different	_	
43-13	10361-10373	pseudorandom	_	
43-14	10374-10379	order	_	
43-15	10380-10382	of	_	
43-16	10383-10389	visual	_	
43-17	10390-10393	and	_	
43-18	10394-10401	tactile	_	
43-19	10402-10415	presentations	_	
43-20	10416-10418	of	_	
43-21	10418-10419	:	_	
43-22	10420-10421	(	_	
43-23	10421-10422	i	_	
43-24	10422-10423	)	_	
43-25	10424-10425	a	_	
43-26	10426-10432	single	_	
43-27	10433-10441	cannabis	_	
43-28	10442-10445	cue	_	
43-29	10446-10447	(	_	
43-30	10447-10450	six	_	
43-31	10451-10457	trials	_	
43-32	10457-10458	)	_	
43-33	10458-10459	,	_	
43-34	10460-10461	(	_	
43-35	10461-10463	ii	_	
43-36	10463-10464	)	_	
43-37	10465-10466	a	_	
43-38	10467-10473	single	_	
43-39	10474-10481	natural	_	
43-40	10482-10488	reward	_	
43-41	10489-10492	cue	_	
43-42	10493-10494	(	_	
43-43	10494-10497	six	_	
43-44	10498-10504	trials	_	
43-45	10504-10505	)	_	
43-46	10505-10506	,	_	
43-47	10507-10510	and	_	
43-48	10511-10512	(	_	
43-49	10512-10515	iii	_	
43-50	10515-10516	)	_	
43-51	10517-10518	a	_	
43-52	10519-10525	single	_	
43-53	10526-10533	neutral	_	
43-54	10534-10537	cue	_	
43-55	10538-10539	(	_	
43-56	10539-10542	six	_	
43-57	10543-10549	trials	_	
43-58	10549-10550	)	_	
43-59	10550-10551	.	_	

#Text=Each cue was presented for twentys.
44-1	10552-10556	Each	_	
44-2	10557-10560	cue	_	
44-3	10561-10564	was	_	
44-4	10565-10574	presented	_	
44-5	10575-10578	for	_	
44-6	10579-10586	twentys	_	
44-7	10586-10587	.	_	

#Text=Following the cue exposure period, we measured momentary subjective craving by asking the participants to respond to: “Please rate your urge to use marijuana right now.”
45-1	10588-10597	Following	_	
45-2	10598-10601	the	_	
45-3	10602-10605	cue	_	
45-4	10606-10614	exposure	_	
45-5	10615-10621	period	_	
45-6	10621-10622	,	_	
45-7	10623-10625	we	_	
45-8	10626-10634	measured	_	
45-9	10635-10644	momentary	_	
45-10	10645-10655	subjective	_	
45-11	10656-10663	craving	_	
45-12	10664-10666	by	_	
45-13	10667-10673	asking	_	
45-14	10674-10677	the	_	
45-15	10678-10690	participants	_	
45-16	10691-10693	to	_	
45-17	10694-10701	respond	_	
45-18	10702-10704	to	_	
45-19	10704-10705	:	_	
45-20	10706-10707	“	_	
45-21	10707-10713	Please	_	
45-22	10714-10718	rate	_	
45-23	10719-10723	your	_	
45-24	10724-10728	urge	_	
45-25	10729-10731	to	_	
45-26	10732-10735	use	_	
45-27	10736-10745	marijuana	_	
45-28	10746-10751	right	_	
45-29	10752-10755	now	_	
45-30	10755-10756	.	_	
45-31	10756-10757	”	_	

#Text=Responses were measured using a scale from zero (no urge at all) to ten (extremely high urge) (five s).
46-1	10758-10767	Responses	_	
46-2	10768-10772	were	_	
46-3	10773-10781	measured	_	
46-4	10782-10787	using	_	
46-5	10788-10789	a	_	
46-6	10790-10795	scale	_	
46-7	10796-10800	from	_	
46-8	10801-10805	zero	_	
46-9	10806-10807	(	_	
46-10	10807-10809	no	_	
46-11	10810-10814	urge	_	
46-12	10815-10817	at	_	
46-13	10818-10821	all	_	
46-14	10821-10822	)	_	
46-15	10823-10825	to	_	
46-16	10826-10829	ten	_	
46-17	10830-10831	(	_	
46-18	10831-10840	extremely	_	
46-19	10841-10845	high	_	
46-20	10846-10850	urge	_	
46-21	10850-10851	)	_	
46-22	10852-10853	(	_	
46-23	10853-10857	five	_	
46-24	10858-10859	s	_	
46-25	10859-10860	)	_	
46-26	10860-10861	.	_	

#Text=A twenty s washout period completed each trial.
47-1	10862-10863	A	_	
47-2	10864-10870	twenty	_	
47-3	10871-10872	s	_	
47-4	10873-10880	washout	_	
47-5	10881-10887	period	_	
47-6	10888-10897	completed	_	
47-7	10898-10902	each	_	
47-8	10903-10908	trial	_	
47-9	10908-10909	.	_	

#Text=Responses were recorded using a fiber‐optic pad.
48-1	10910-10919	Responses	_	
48-2	10920-10924	were	_	
48-3	10925-10933	recorded	_	
48-4	10934-10939	using	_	
48-5	10940-10941	a	_	
48-6	10942-10953	fiber‐optic	_	
48-7	10954-10957	pad	_	
48-8	10957-10958	.	_	

#Text=The participants were pseudorandomly given different orders of the runs (e.g., run A, run B or run B, run A).
49-1	10959-10962	The	_	
49-2	10963-10975	participants	_	
49-3	10976-10980	were	_	
49-4	10981-10995	pseudorandomly	_	
49-5	10996-11001	given	_	
49-6	11002-11011	different	_	
49-7	11012-11018	orders	_	
49-8	11019-11021	of	_	
49-9	11022-11025	the	_	
49-10	11026-11030	runs	_	
49-11	11031-11032	(	_	
49-12	11032-11035	e.g	_	
49-13	11035-11036	.	_	
49-14	11036-11037	,	_	
49-15	11038-11041	run	_	
49-16	11042-11043	A	_	
49-17	11043-11044	,	_	
49-18	11045-11048	run	_	
49-19	11049-11050	B	_	
49-20	11051-11053	or	_	
49-21	11054-11057	run	_	
49-22	11058-11059	B	_	
49-23	11059-11060	,	_	
49-24	11061-11064	run	_	
49-25	11065-11066	A	_	
49-26	11066-11067	)	_	
49-27	11067-11068	.	_	

#Text=We presented task stimuli to the participants based on their response to “what is your preferred cannabis use method?”
50-1	11069-11071	We	_	
50-2	11072-11081	presented	_	
50-3	11082-11086	task	_	
50-4	11087-11094	stimuli	_	
50-5	11095-11097	to	_	
50-6	11098-11101	the	_	
50-7	11102-11114	participants	_	
50-8	11115-11120	based	_	
50-9	11121-11123	on	_	
50-10	11124-11129	their	_	
50-11	11130-11138	response	_	
50-12	11139-11141	to	_	
50-13	11142-11143	“	_	
50-14	11143-11147	what	_	
50-15	11148-11150	is	_	
50-16	11151-11155	your	_	
50-17	11156-11165	preferred	_	
50-18	11166-11174	cannabis	_	
50-19	11175-11178	use	_	
50-20	11179-11185	method	_	
50-21	11185-11186	?	_	
50-22	11186-11187	”	_	

#Text=Twenty‐three users selected the pipe, eleven selected the bong, eleven selected the blunt and eight selected the joint.
51-1	11188-11200	Twenty‐three	_	
51-2	11201-11206	users	_	
51-3	11207-11215	selected	_	
51-4	11216-11219	the	_	
51-5	11220-11224	pipe	_	
51-6	11224-11225	,	_	
51-7	11226-11232	eleven	_	
51-8	11233-11241	selected	_	
51-9	11242-11245	the	_	
51-10	11246-11250	bong	_	
51-11	11250-11251	,	_	
51-12	11252-11258	eleven	_	
51-13	11259-11267	selected	_	
51-14	11268-11271	the	_	
51-15	11272-11277	blunt	_	
51-16	11278-11281	and	_	
51-17	11282-11287	eight	_	
51-18	11288-11296	selected	_	
51-19	11297-11300	the	_	
51-20	11301-11306	joint	_	
51-21	11306-11307	.	_	

#Text=For the non‐users, cannabis paraphernalia were matched to what was presented to the users resulting in Twenty‐seven non‐users presented with the pipe, Twenty‐two presented with the bong, three presented with the blunt and eleven presented with the joint.
52-1	11308-11311	For	_	
52-2	11312-11315	the	_	
52-3	11316-11325	non‐users	_	
52-4	11325-11326	,	_	
52-5	11327-11335	cannabis	_	
52-6	11336-11349	paraphernalia	_	
52-7	11350-11354	were	_	
52-8	11355-11362	matched	_	
52-9	11363-11365	to	_	
52-10	11366-11370	what	_	
52-11	11371-11374	was	_	
52-12	11375-11384	presented	_	
52-13	11385-11387	to	_	
52-14	11388-11391	the	_	
52-15	11392-11397	users	_	
52-16	11398-11407	resulting	_	
52-17	11408-11410	in	_	
52-18	11411-11423	Twenty‐seven	_	
52-19	11424-11433	non‐users	_	
52-20	11434-11443	presented	_	
52-21	11444-11448	with	_	
52-22	11449-11452	the	_	
52-23	11453-11457	pipe	_	
52-24	11457-11458	,	_	
52-25	11459-11469	Twenty‐two	_	
52-26	11470-11479	presented	_	
52-27	11480-11484	with	_	
52-28	11485-11488	the	_	
52-29	11489-11493	bong	_	
52-30	11493-11494	,	_	
52-31	11495-11500	three	_	
52-32	11501-11510	presented	_	
52-33	11511-11515	with	_	
52-34	11516-11519	the	_	
52-35	11520-11525	blunt	_	
52-36	11526-11529	and	_	
52-37	11530-11536	eleven	_	
52-38	11537-11546	presented	_	
52-39	11547-11551	with	_	
52-40	11552-11555	the	_	
52-41	11556-11561	joint	_	
52-42	11561-11562	.	_	

#Text=There was missing information on five of the participants.
53-1	11563-11568	There	_	
53-2	11569-11572	was	_	
53-3	11573-11580	missing	_	
53-4	11581-11592	information	_	
53-5	11593-11595	on	_	
53-6	11596-11600	five	_	
53-7	11601-11603	of	_	
53-8	11604-11607	the	_	
53-9	11608-11620	participants	_	
53-10	11620-11621	.	_	

#Text=For the natural reward cues, we selected fruit because of its appetitiveness and because it exists within the natural environment and would have inherent representations in the human brain [Filbey et al., 2012; Jiang et al., 2015].
54-1	11622-11625	For	_	
54-2	11626-11629	the	_	
54-3	11630-11637	natural	_	
54-4	11638-11644	reward	_	
54-5	11645-11649	cues	_	
54-6	11649-11650	,	_	
54-7	11651-11653	we	_	
54-8	11654-11662	selected	_	
54-9	11663-11668	fruit	_	
54-10	11669-11676	because	_	
54-11	11677-11679	of	_	
54-12	11680-11683	its	_	
54-13	11684-11698	appetitiveness	_	
54-14	11699-11702	and	_	
54-15	11703-11710	because	_	
54-16	11711-11713	it	_	
54-17	11714-11720	exists	_	
54-18	11721-11727	within	_	
54-19	11728-11731	the	_	
54-20	11732-11739	natural	_	
54-21	11740-11751	environment	_	
54-22	11752-11755	and	_	
54-23	11756-11761	would	_	
54-24	11762-11766	have	_	
54-25	11767-11775	inherent	_	
54-26	11776-11791	representations	_	
54-27	11792-11794	in	_	
54-28	11795-11798	the	_	
54-29	11799-11804	human	_	
54-30	11805-11810	brain	_	
54-31	11811-11812	[	_	
54-32	11812-11818	Filbey	_	
54-33	11819-11821	et	_	
54-34	11822-11824	al	_	
54-35	11824-11825	.	_	
54-36	11825-11826	,	_	
54-37	11827-11831	2012	_	
54-38	11831-11832	;	_	
54-39	11833-11838	Jiang	_	
54-40	11839-11841	et	_	
54-41	11842-11844	al	_	
54-42	11844-11845	.	_	
54-43	11845-11846	,	_	
54-44	11847-11851	2015	_	
54-45	11851-11852	]	_	
54-46	11852-11853	.	_	

#Text=Similar to the cannabis cues, we presented participants with their self‐selected fruit stimulus based on the their response to “what is your preferred fruit?”
55-1	11854-11861	Similar	_	
55-2	11862-11864	to	_	
55-3	11865-11868	the	_	
55-4	11869-11877	cannabis	_	
55-5	11878-11882	cues	_	
55-6	11882-11883	,	_	
55-7	11884-11886	we	_	
55-8	11887-11896	presented	_	
55-9	11897-11909	participants	_	
55-10	11910-11914	with	_	
55-11	11915-11920	their	_	
55-12	11921-11934	self‐selected	_	
55-13	11935-11940	fruit	_	
55-14	11941-11949	stimulus	_	
55-15	11950-11955	based	_	
55-16	11956-11958	on	_	
55-17	11959-11962	the	_	
55-18	11963-11968	their	_	
55-19	11969-11977	response	_	
55-20	11978-11980	to	_	
55-21	11981-11982	“	_	
55-22	11982-11986	what	_	
55-23	11987-11989	is	_	
55-24	11990-11994	your	_	
55-25	11995-12004	preferred	_	
55-26	12005-12010	fruit	_	
55-27	12010-12011	?	_	
55-28	12011-12012	”	_	

#Text=In the users, fourteen chose a banana, twelve chose an apple, thirteen chose an orange, and thirteen chose grapes.
56-1	12013-12015	In	_	
56-2	12016-12019	the	_	
56-3	12020-12025	users	_	
56-4	12025-12026	,	_	
56-5	12027-12035	fourteen	_	
56-6	12036-12041	chose	_	
56-7	12042-12043	a	_	
56-8	12044-12050	banana	_	
56-9	12050-12051	,	_	
56-10	12052-12058	twelve	_	
56-11	12059-12064	chose	_	
56-12	12065-12067	an	_	
56-13	12068-12073	apple	_	
56-14	12073-12074	,	_	
56-15	12075-12083	thirteen	_	
56-16	12084-12089	chose	_	
56-17	12090-12092	an	_	
56-18	12093-12099	orange	_	
56-19	12099-12100	,	_	
56-20	12101-12104	and	_	
56-21	12105-12113	thirteen	_	
56-22	12114-12119	chose	_	
56-23	12120-12126	grapes	_	
56-24	12126-12127	.	_	

#Text=In the non‐users, sixteen selected a banana, seventeen selected an apple, fifteen selected an orange, and twenty selected grapes.
57-1	12128-12130	In	_	
57-2	12131-12134	the	_	
57-3	12135-12144	non‐users	_	
57-4	12144-12145	,	_	
57-5	12146-12153	sixteen	_	
57-6	12154-12162	selected	_	
57-7	12163-12164	a	_	
57-8	12165-12171	banana	_	
57-9	12171-12172	,	_	
57-10	12173-12182	seventeen	_	
57-11	12183-12191	selected	_	
57-12	12192-12194	an	_	
57-13	12195-12200	apple	_	
57-14	12200-12201	,	_	
57-15	12202-12209	fifteen	_	
57-16	12210-12218	selected	_	
57-17	12219-12221	an	_	
57-18	12222-12228	orange	_	
57-19	12228-12229	,	_	
57-20	12230-12233	and	_	
57-21	12234-12240	twenty	_	
57-22	12241-12249	selected	_	
57-23	12250-12256	grapes	_	
57-24	12256-12257	.	_	

#Text=Lastly, similar to the original task, a pencil was used as a neutral cue for all of the participants.
58-1	12258-12264	Lastly	_	
58-2	12264-12265	,	_	
58-3	12266-12273	similar	_	
58-4	12274-12276	to	_	
58-5	12277-12280	the	_	
58-6	12281-12289	original	_	
58-7	12290-12294	task	_	
58-8	12294-12295	,	_	
58-9	12296-12297	a	_	
58-10	12298-12304	pencil	_	
58-11	12305-12308	was	_	
58-12	12309-12313	used	_	
58-13	12314-12316	as	_	
58-14	12317-12318	a	_	
58-15	12319-12326	neutral	_	
58-16	12327-12330	cue	_	
58-17	12331-12334	for	_	
58-18	12335-12338	all	_	
58-19	12339-12341	of	_	
58-20	12342-12345	the	_	
58-21	12346-12358	participants	_	
58-22	12358-12359	.	_	

#Text=Stimulus presentations were delivered using E‐Prime (Psychology Software Tools).
59-1	12360-12368	Stimulus	_	
59-2	12369-12382	presentations	_	
59-3	12383-12387	were	_	
59-4	12388-12397	delivered	_	
59-5	12398-12403	using	_	
59-6	12404-12411	E‐Prime	_	
59-7	12412-12413	(	_	
59-8	12413-12423	Psychology	_	
59-9	12424-12432	Software	_	
59-10	12433-12438	Tools	_	
59-11	12438-12439	)	_	
59-12	12439-12440	.	_	

#Text=The timing of the stimulus presentation was synchronized with trigger pulses from the magnet to ensure precise temporal integration of stimulus presentation and fMRI data acquisition.
#Text=fMRI Data Analysis
#Text=Pre‐processing
#Text=The functional imaging time series was pre‐processed using SPM8 (Wellcome Department of Imaging Neuroscience, London, UK).
60-1	12441-12444	The	_	
60-2	12445-12451	timing	_	
60-3	12452-12454	of	_	
60-4	12455-12458	the	_	
60-5	12459-12467	stimulus	_	
60-6	12468-12480	presentation	_	
60-7	12481-12484	was	_	
60-8	12485-12497	synchronized	_	
60-9	12498-12502	with	_	
60-10	12503-12510	trigger	_	
60-11	12511-12517	pulses	_	
60-12	12518-12522	from	_	
60-13	12523-12526	the	_	
60-14	12527-12533	magnet	_	
60-15	12534-12536	to	_	
60-16	12537-12543	ensure	_	
60-17	12544-12551	precise	_	
60-18	12552-12560	temporal	_	
60-19	12561-12572	integration	_	
60-20	12573-12575	of	_	
60-21	12576-12584	stimulus	_	
60-22	12585-12597	presentation	_	
60-23	12598-12601	and	_	
60-24	12602-12606	fMRI	_	
60-25	12607-12611	data	_	
60-26	12612-12623	acquisition	_	
60-27	12623-12624	.	_	
60-28	12625-12629	fMRI	_	
60-29	12630-12634	Data	_	
60-30	12635-12643	Analysis	_	
60-31	12644-12658	Pre‐processing	_	
60-32	12659-12662	The	_	
60-33	12663-12673	functional	_	
60-34	12674-12681	imaging	_	
60-35	12682-12686	time	_	
60-36	12687-12693	series	_	
60-37	12694-12697	was	_	
60-38	12698-12711	pre‐processed	_	
60-39	12712-12717	using	_	
60-40	12718-12722	SPM8	_	
60-41	12723-12724	(	_	
60-42	12724-12732	Wellcome	_	
60-43	12733-12743	Department	_	
60-44	12744-12746	of	_	
60-45	12747-12754	Imaging	_	
60-46	12755-12767	Neuroscience	_	
60-47	12767-12768	,	_	
60-48	12769-12775	London	_	
60-49	12775-12776	,	_	
60-50	12777-12779	UK	_	
60-51	12779-12780	)	_	
60-52	12780-12781	.	_	

#Text=Before starting analyses, the first seven volumes of each EPI run were discarded to allow the MR signal to reach steady state.
61-1	12782-12788	Before	_	
61-2	12789-12797	starting	_	
61-3	12798-12806	analyses	_	
61-4	12806-12807	,	_	
61-5	12808-12811	the	_	
61-6	12812-12817	first	_	
61-7	12818-12823	seven	_	
61-8	12824-12831	volumes	_	
61-9	12832-12834	of	_	
61-10	12835-12839	each	_	
61-11	12840-12843	EPI	_	
61-12	12844-12847	run	_	
61-13	12848-12852	were	_	
61-14	12853-12862	discarded	_	
61-15	12863-12865	to	_	
61-16	12866-12871	allow	_	
61-17	12872-12875	the	_	
61-18	12876-12878	MR	_	
61-19	12879-12885	signal	_	
61-20	12886-12888	to	_	
61-21	12889-12894	reach	_	
61-22	12895-12901	steady	_	
61-23	12902-12907	state	_	
61-24	12907-12908	.	_	

#Text=Pre‐processing of these volumes started with motion correction using SPM's realignment module [Friston et al., 1995].
62-1	12909-12923	Pre‐processing	_	
62-2	12924-12926	of	_	
62-3	12927-12932	these	_	
62-4	12933-12940	volumes	_	
62-5	12941-12948	started	_	
62-6	12949-12953	with	_	
62-7	12954-12960	motion	_	
62-8	12961-12971	correction	_	
62-9	12972-12977	using	_	
62-10	12978-12983	SPM's	_	
62-11	12984-12995	realignment	_	
62-12	12996-13002	module	_	
62-13	13003-13004	[	_	
62-14	13004-13011	Friston	_	
62-15	13012-13014	et	_	
62-16	13015-13017	al	_	
62-17	13017-13018	.	_	
62-18	13018-13019	,	_	
62-19	13020-13024	1995	_	
62-20	13024-13025	]	_	
62-21	13025-13026	.	_	

#Text=This was followed by slice timing correction, which corrected for temporal differences in acquisition time of the BOLD signal across slices within each volume.
63-1	13027-13031	This	_	
63-2	13032-13035	was	_	
63-3	13036-13044	followed	_	
63-4	13045-13047	by	_	
63-5	13048-13053	slice	_	
63-6	13054-13060	timing	_	
63-7	13061-13071	correction	_	
63-8	13071-13072	,	_	
63-9	13073-13078	which	_	
63-10	13079-13088	corrected	_	
63-11	13089-13092	for	_	
63-12	13093-13101	temporal	_	
63-13	13102-13113	differences	_	
63-14	13114-13116	in	_	
63-15	13117-13128	acquisition	_	
63-16	13129-13133	time	_	
63-17	13134-13136	of	_	
63-18	13137-13140	the	_	
63-19	13141-13145	BOLD	_	
63-20	13146-13152	signal	_	
63-21	13153-13159	across	_	
63-22	13160-13166	slices	_	
63-23	13167-13173	within	_	
63-24	13174-13178	each	_	
63-25	13179-13185	volume	_	
63-26	13185-13186	.	_	

#Text=The resultant time series was then smoothed using a 6 mm full width half maximum (FWHM) Gaussian kernel.
64-1	13187-13190	The	_	
64-2	13191-13200	resultant	_	
64-3	13201-13205	time	_	
64-4	13206-13212	series	_	
64-5	13213-13216	was	_	
64-6	13217-13221	then	_	
64-7	13222-13230	smoothed	_	
64-8	13231-13236	using	_	
64-9	13237-13238	a	_	
64-10	13239-13240	6	_	
64-11	13241-13243	mm	_	
64-12	13244-13248	full	_	
64-13	13249-13254	width	_	
64-14	13255-13259	half	_	
64-15	13260-13267	maximum	_	
64-16	13268-13269	(	_	
64-17	13269-13273	FWHM	_	
64-18	13273-13274	)	_	
64-19	13275-13283	Gaussian	_	
64-20	13284-13290	kernel	_	
64-21	13290-13291	.	_	

#Text=First‐level analyses
#Text=Preprocessed time series for each participant were analyzed using multiple linear regression as implemented in FILM (FMRIB's Improved Linear Model), a component of FSL.
65-1	13292-13303	First‐level	_	
65-2	13304-13312	analyses	_	
65-3	13313-13325	Preprocessed	_	
65-4	13326-13330	time	_	
65-5	13331-13337	series	_	
65-6	13338-13341	for	_	
65-7	13342-13346	each	_	
65-8	13347-13358	participant	_	
65-9	13359-13363	were	_	
65-10	13364-13372	analyzed	_	
65-11	13373-13378	using	_	
65-12	13379-13387	multiple	_	
65-13	13388-13394	linear	_	
65-14	13395-13405	regression	_	
65-15	13406-13408	as	_	
65-16	13409-13420	implemented	_	
65-17	13421-13423	in	_	
65-18	13424-13428	FILM	_	
65-19	13429-13430	(	_	
65-20	13430-13437	FMRIB's	_	
65-21	13438-13446	Improved	_	
65-22	13447-13453	Linear	_	
65-23	13454-13459	Model	_	
65-24	13459-13460	)	_	
65-25	13460-13461	,	_	
65-26	13462-13463	a	_	
65-27	13464-13473	component	_	
65-28	13474-13476	of	_	
65-29	13477-13480	FSL	_	
65-30	13480-13481	.	_	

#Text=Regressors for the linear model were generated using FEAT by convolving the cue states (Cue Present, Craving Rating, Cue Washout) of each cue type (cannabis cues, neutral object cues and fruit cues) with a double gamma hemodynamic response function.
66-1	13482-13492	Regressors	_	
66-2	13493-13496	for	_	
66-3	13497-13500	the	_	
66-4	13501-13507	linear	_	
66-5	13508-13513	model	_	
66-6	13514-13518	were	_	
66-7	13519-13528	generated	_	
66-8	13529-13534	using	_	
66-9	13535-13539	FEAT	_	
66-10	13540-13542	by	_	
66-11	13543-13553	convolving	_	
66-12	13554-13557	the	_	
66-13	13558-13561	cue	_	
66-14	13562-13568	states	_	
66-15	13569-13570	(	_	
66-16	13570-13573	Cue	_	
66-17	13574-13581	Present	_	
66-18	13581-13582	,	_	
66-19	13583-13590	Craving	_	
66-20	13591-13597	Rating	_	
66-21	13597-13598	,	_	
66-22	13599-13602	Cue	_	
66-23	13603-13610	Washout	_	
66-24	13610-13611	)	_	
66-25	13612-13614	of	_	
66-26	13615-13619	each	_	
66-27	13620-13623	cue	_	
66-28	13624-13628	type	_	
66-29	13629-13630	(	_	
66-30	13630-13638	cannabis	_	
66-31	13639-13643	cues	_	
66-32	13643-13644	,	_	
66-33	13645-13652	neutral	_	
66-34	13653-13659	object	_	
66-35	13660-13664	cues	_	
66-36	13665-13668	and	_	
66-37	13669-13674	fruit	_	
66-38	13675-13679	cues	_	
66-39	13679-13680	)	_	
66-40	13681-13685	with	_	
66-41	13686-13687	a	_	
66-42	13688-13694	double	_	
66-43	13695-13700	gamma	_	
66-44	13701-13712	hemodynamic	_	
66-45	13713-13721	response	_	
66-46	13722-13730	function	_	
66-47	13730-13731	.	_	

#Text=Parameter estimates for the regressors were used to generate z‐maps based on three contrasts of interest: Cue ON cannabis versus Cue ON neutral object; Cue ON cannabis versus Cue ON fruit; and Cue ON fruit versus Cue ON neutral object.
67-1	13732-13741	Parameter	_	
67-2	13742-13751	estimates	_	
67-3	13752-13755	for	_	
67-4	13756-13759	the	_	
67-5	13760-13770	regressors	_	
67-6	13771-13775	were	_	
67-7	13776-13780	used	_	
67-8	13781-13783	to	_	
67-9	13784-13792	generate	_	
67-10	13793-13799	z‐maps	_	
67-11	13800-13805	based	_	
67-12	13806-13808	on	_	
67-13	13809-13814	three	_	
67-14	13815-13824	contrasts	_	
67-15	13825-13827	of	_	
67-16	13828-13836	interest	_	
67-17	13836-13837	:	_	
67-18	13838-13841	Cue	_	
67-19	13842-13844	ON	_	
67-20	13845-13853	cannabis	_	
67-21	13854-13860	versus	_	
67-22	13861-13864	Cue	_	
67-23	13865-13867	ON	_	
67-24	13868-13875	neutral	_	
67-25	13876-13882	object	_	
67-26	13882-13883	;	_	
67-27	13884-13887	Cue	_	
67-28	13888-13890	ON	_	
67-29	13891-13899	cannabis	_	
67-30	13900-13906	versus	_	
67-31	13907-13910	Cue	_	
67-32	13911-13913	ON	_	
67-33	13914-13919	fruit	_	
67-34	13919-13920	;	_	
67-35	13921-13924	and	_	
67-36	13925-13928	Cue	_	
67-37	13929-13931	ON	_	
67-38	13932-13937	fruit	_	
67-39	13938-13944	versus	_	
67-40	13945-13948	Cue	_	
67-41	13949-13951	ON	_	
67-42	13952-13959	neutral	_	
67-43	13960-13966	object	_	
67-44	13966-13967	.	_	

#Text=Group level analyses
#Text=Participant contrast maps were registered to their own MRI T1 weighted MPRAGE structural images, and then co‐registered to the MNI 152 template space using FLIRT (FMRIB's Linear Image Registration Tool).
68-1	13968-13973	Group	_	
68-2	13974-13979	level	_	
68-3	13980-13988	analyses	_	
68-4	13989-14000	Participant	_	
68-5	14001-14009	contrast	_	
68-6	14010-14014	maps	_	
68-7	14015-14019	were	_	
68-8	14020-14030	registered	_	
68-9	14031-14033	to	_	
68-10	14034-14039	their	_	
68-11	14040-14043	own	_	
68-12	14044-14047	MRI	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[14]	
68-13	14048-14050	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[14]	
68-14	14051-14059	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[14]	
68-15	14060-14066	MPRAGE	_	
68-16	14067-14077	structural	_	
68-17	14078-14084	images	_	
68-18	14084-14085	,	_	
68-19	14086-14089	and	_	
68-20	14090-14094	then	_	
68-21	14095-14108	co‐registered	_	
68-22	14109-14111	to	_	
68-23	14112-14115	the	_	
68-24	14116-14119	MNI	_	
68-25	14120-14123	152	_	
68-26	14124-14132	template	_	
68-27	14133-14138	space	_	
68-28	14139-14144	using	_	
68-29	14145-14150	FLIRT	_	
68-30	14151-14152	(	_	
68-31	14152-14159	FMRIB's	_	
68-32	14160-14166	Linear	_	
68-33	14167-14172	Image	_	
68-34	14173-14185	Registration	_	
68-35	14186-14190	Tool	_	
68-36	14190-14191	)	_	
68-37	14191-14192	.	_	

#Text=Group analysis of contrasts was performed in FEAT using FLAME (FMRIB's Local Analysis of Mixed Effects) to estimate a mixed effects model of task‐related activation differences for each of the three contrasts of interest (as a Gaussianized t/F statistic).
69-1	14193-14198	Group	_	
69-2	14199-14207	analysis	_	
69-3	14208-14210	of	_	
69-4	14211-14220	contrasts	_	
69-5	14221-14224	was	_	
69-6	14225-14234	performed	_	
69-7	14235-14237	in	_	
69-8	14238-14242	FEAT	_	
69-9	14243-14248	using	_	
69-10	14249-14254	FLAME	_	
69-11	14255-14256	(	_	
69-12	14256-14263	FMRIB's	_	
69-13	14264-14269	Local	_	
69-14	14270-14278	Analysis	_	
69-15	14279-14281	of	_	
69-16	14282-14287	Mixed	_	
69-17	14288-14295	Effects	_	
69-18	14295-14296	)	_	
69-19	14297-14299	to	_	
69-20	14300-14308	estimate	_	
69-21	14309-14310	a	_	
69-22	14311-14316	mixed	_	
69-23	14317-14324	effects	_	
69-24	14325-14330	model	_	
69-25	14331-14333	of	_	
69-26	14334-14346	task‐related	_	
69-27	14347-14357	activation	_	
69-28	14358-14369	differences	_	
69-29	14370-14373	for	_	
69-30	14374-14378	each	_	
69-31	14379-14381	of	_	
69-32	14382-14385	the	_	
69-33	14386-14391	three	_	
69-34	14392-14401	contrasts	_	
69-35	14402-14404	of	_	
69-36	14405-14413	interest	_	
69-37	14414-14415	(	_	
69-38	14415-14417	as	_	
69-39	14418-14419	a	_	
69-40	14420-14432	Gaussianized	_	
69-41	14433-14434	t	_	
69-42	14434-14435	/	_	
69-43	14435-14436	F	_	
69-44	14437-14446	statistic	_	
69-45	14446-14447	)	_	
69-46	14447-14448	.	_	

#Text=Groups were defined by cannabis usage status (user/non‐user).
70-1	14449-14455	Groups	_	
70-2	14456-14460	were	_	
70-3	14461-14468	defined	_	
70-4	14469-14471	by	_	
70-5	14472-14480	cannabis	_	
70-6	14481-14486	usage	_	
70-7	14487-14493	status	_	
70-8	14494-14495	(	_	
70-9	14495-14499	user	_	
70-10	14499-14500	/	_	
70-11	14500-14508	non‐user	_	
70-12	14508-14509	)	_	
70-13	14509-14510	.	_	

#Text=Contrast maps were generated for each usage status.
71-1	14511-14519	Contrast	_	
71-2	14520-14524	maps	_	
71-3	14525-14529	were	_	
71-4	14530-14539	generated	_	
71-5	14540-14543	for	_	
71-6	14544-14548	each	_	
71-7	14549-14554	usage	_	
71-8	14555-14561	status	_	
71-9	14561-14562	.	_	

#Text=Resulting maps were height‐thresholded at a Z‐value of 2.3.
72-1	14563-14572	Resulting	_	
72-2	14573-14577	maps	_	
72-3	14578-14582	were	_	
72-4	14583-14601	height‐thresholded	_	
72-5	14602-14604	at	_	
72-6	14605-14606	a	_	
72-7	14607-14614	Z‐value	_	
72-8	14615-14617	of	_	
72-9	14618-14621	2.3	_	
72-10	14621-14622	.	_	

#Text=We used FEAT's cluster‐thresholding method, which estimated activated clusters’ significance level (from Gaussian random field theory) compared with the cluster probability threshold [Worsley et al., 1996]) of P ≤ 0.05.
73-1	14623-14625	We	_	
73-2	14626-14630	used	_	
73-3	14631-14637	FEAT's	_	
73-4	14638-14658	cluster‐thresholding	_	
73-5	14659-14665	method	_	
73-6	14665-14666	,	_	
73-7	14667-14672	which	_	
73-8	14673-14682	estimated	_	
73-9	14683-14692	activated	_	
73-10	14693-14701	clusters	_	
73-11	14701-14702	’	_	
73-12	14703-14715	significance	_	
73-13	14716-14721	level	_	
73-14	14722-14723	(	_	
73-15	14723-14727	from	_	
73-16	14728-14736	Gaussian	_	
73-17	14737-14743	random	_	
73-18	14744-14749	field	_	
73-19	14750-14756	theory	_	
73-20	14756-14757	)	_	
73-21	14758-14766	compared	_	
73-22	14767-14771	with	_	
73-23	14772-14775	the	_	
73-24	14776-14783	cluster	_	
73-25	14784-14795	probability	_	
73-26	14796-14805	threshold	_	
73-27	14806-14807	[	_	
73-28	14807-14814	Worsley	_	
73-29	14815-14817	et	_	
73-30	14818-14820	al	_	
73-31	14820-14821	.	_	
73-32	14821-14822	,	_	
73-33	14823-14827	1996	_	
73-34	14827-14828	]	_	
73-35	14828-14829	)	_	
73-36	14830-14832	of	_	
73-37	14833-14834	P	_	
73-38	14835-14836	≤	_	
73-39	14837-14841	0.05	_	
73-40	14841-14842	.	_	

#Text=Because a height‐threshold of z = 2.3 may result in large clusters despite adequately controlling for false‐positives, we also used a cluster defining voxel threshold of P ≤ 0.001 per recommendations by Woo et al. [2014] for the enhancement of anatomical specificity.
74-1	14843-14850	Because	_	
74-2	14851-14852	a	_	
74-3	14853-14869	height‐threshold	_	
74-4	14870-14872	of	_	
74-5	14873-14874	z	_	
74-6	14875-14876	=	_	
74-7	14877-14880	2.3	_	
74-8	14881-14884	may	_	
74-9	14885-14891	result	_	
74-10	14892-14894	in	_	
74-11	14895-14900	large	_	
74-12	14901-14909	clusters	_	
74-13	14910-14917	despite	_	
74-14	14918-14928	adequately	_	
74-15	14929-14940	controlling	_	
74-16	14941-14944	for	_	
74-17	14945-14960	false‐positives	_	
74-18	14960-14961	,	_	
74-19	14962-14964	we	_	
74-20	14965-14969	also	_	
74-21	14970-14974	used	_	
74-22	14975-14976	a	_	
74-23	14977-14984	cluster	_	
74-24	14985-14993	defining	_	
74-25	14994-14999	voxel	_	
74-26	15000-15009	threshold	_	
74-27	15010-15012	of	_	
74-28	15013-15014	P	_	
74-29	15015-15016	≤	_	
74-30	15017-15022	0.001	_	
74-31	15023-15026	per	_	
74-32	15027-15042	recommendations	_	
74-33	15043-15045	by	_	
74-34	15046-15049	Woo	_	
74-35	15050-15052	et	_	
74-36	15053-15055	al	_	
74-37	15055-15056	.	_	
74-38	15057-15058	[	_	
74-39	15058-15062	2014	_	
74-40	15062-15063	]	_	
74-41	15064-15067	for	_	
74-42	15068-15071	the	_	
74-43	15072-15083	enhancement	_	
74-44	15084-15086	of	_	
74-45	15087-15097	anatomical	_	
74-46	15098-15109	specificity	_	
74-47	15109-15110	.	_	

#Text=In addition to simple group level maps, within the cannabis users, group level contrasts were generated for several variables of interest.
75-1	15111-15113	In	_	
75-2	15114-15122	addition	_	
75-3	15123-15125	to	_	
75-4	15126-15132	simple	_	
75-5	15133-15138	group	_	
75-6	15139-15144	level	_	
75-7	15145-15149	maps	_	
75-8	15149-15150	,	_	
75-9	15151-15157	within	_	
75-10	15158-15161	the	_	
75-11	15162-15170	cannabis	_	
75-12	15171-15176	users	_	
75-13	15176-15177	,	_	
75-14	15178-15183	group	_	
75-15	15184-15189	level	_	
75-16	15190-15199	contrasts	_	
75-17	15200-15204	were	_	
75-18	15205-15214	generated	_	
75-19	15215-15218	for	_	
75-20	15219-15226	several	_	
75-21	15227-15236	variables	_	
75-22	15237-15239	of	_	
75-23	15240-15248	interest	_	
75-24	15248-15249	.	_	

#Text=To determine the relationship between the neural response in brain areas and subjective craving, group maps were regressed separately against total MCQ scores (baseline craving) and in‐scanner cannabis craving ratings.
76-1	15250-15252	To	_	
76-2	15253-15262	determine	_	
76-3	15263-15266	the	_	
76-4	15267-15279	relationship	_	
76-5	15280-15287	between	_	
76-6	15288-15291	the	_	
76-7	15292-15298	neural	_	
76-8	15299-15307	response	_	
76-9	15308-15310	in	_	
76-10	15311-15316	brain	_	
76-11	15317-15322	areas	_	
76-12	15323-15326	and	_	
76-13	15327-15337	subjective	_	
76-14	15338-15345	craving	_	
76-15	15345-15346	,	_	
76-16	15347-15352	group	_	
76-17	15353-15357	maps	_	
76-18	15358-15362	were	_	
76-19	15363-15372	regressed	_	
76-20	15373-15383	separately	_	
76-21	15384-15391	against	_	
76-22	15392-15397	total	_	
76-23	15398-15401	MCQ	_	
76-24	15402-15408	scores	_	
76-25	15409-15410	(	_	
76-26	15410-15418	baseline	_	
76-27	15419-15426	craving	_	
76-28	15426-15427	)	_	
76-29	15428-15431	and	_	
76-30	15432-15442	in‐scanner	_	
76-31	15443-15451	cannabis	_	
76-32	15452-15459	craving	_	
76-33	15460-15467	ratings	_	
76-34	15467-15468	.	_	

#Text=To determine if the neural response in brain areas are modulated by cannabis use behavior, group maps were regressed separately against reported grams of cannabis use per day and THC/creatinine levels from the abstinent state.
77-1	15469-15471	To	_	
77-2	15472-15481	determine	_	
77-3	15482-15484	if	_	
77-4	15485-15488	the	_	
77-5	15489-15495	neural	_	
77-6	15496-15504	response	_	
77-7	15505-15507	in	_	
77-8	15508-15513	brain	_	
77-9	15514-15519	areas	_	
77-10	15520-15523	are	_	
77-11	15524-15533	modulated	_	
77-12	15534-15536	by	_	
77-13	15537-15545	cannabis	_	
77-14	15546-15549	use	_	
77-15	15550-15558	behavior	_	
77-16	15558-15559	,	_	
77-17	15560-15565	group	_	
77-18	15566-15570	maps	_	
77-19	15571-15575	were	_	
77-20	15576-15585	regressed	_	
77-21	15586-15596	separately	_	
77-22	15597-15604	against	_	
77-23	15605-15613	reported	_	
77-24	15614-15619	grams	_	
77-25	15620-15622	of	_	
77-26	15623-15631	cannabis	_	
77-27	15632-15635	use	_	
77-28	15636-15639	per	_	
77-29	15640-15643	day	_	
77-30	15644-15647	and	_	
77-31	15648-15651	THC	_	
77-32	15651-15652	/	_	
77-33	15652-15662	creatinine	_	
77-34	15663-15669	levels	_	
77-35	15670-15674	from	_	
77-36	15675-15678	the	_	
77-37	15679-15688	abstinent	_	
77-38	15689-15694	state	_	
77-39	15694-15695	.	_	

#Text=To determine the clinical relevance of the neural response to cannabis cues, group maps were regressed separately against MWC scores and MPS scores.
78-1	15696-15698	To	_	
78-2	15699-15708	determine	_	
78-3	15709-15712	the	_	
78-4	15713-15721	clinical	_	
78-5	15722-15731	relevance	_	
78-6	15732-15734	of	_	
78-7	15735-15738	the	_	
78-8	15739-15745	neural	_	
78-9	15746-15754	response	_	
78-10	15755-15757	to	_	
78-11	15758-15766	cannabis	_	
78-12	15767-15771	cues	_	
78-13	15771-15772	,	_	
78-14	15773-15778	group	_	
78-15	15779-15783	maps	_	
78-16	15784-15788	were	_	
78-17	15789-15798	regressed	_	
78-18	15799-15809	separately	_	
78-19	15810-15817	against	_	
78-20	15818-15821	MWC	_	
78-21	15822-15828	scores	_	
78-22	15829-15832	and	_	
78-23	15833-15836	MPS	_	
78-24	15837-15843	scores	_	
78-25	15843-15844	.	_	

#Text=We expected positive associations between neural response to cues and subjective craving, cannabis use behavior and clinical symptoms of CUD.
79-1	15845-15847	We	_	
79-2	15848-15856	expected	_	
79-3	15857-15865	positive	_	
79-4	15866-15878	associations	_	
79-5	15879-15886	between	_	
79-6	15887-15893	neural	_	
79-7	15894-15902	response	_	
79-8	15903-15905	to	_	
79-9	15906-15910	cues	_	
79-10	15911-15914	and	_	
79-11	15915-15925	subjective	_	
79-12	15926-15933	craving	_	
79-13	15933-15934	,	_	
79-14	15935-15943	cannabis	_	
79-15	15944-15947	use	_	
79-16	15948-15956	behavior	_	
79-17	15957-15960	and	_	
79-18	15961-15969	clinical	_	
79-19	15970-15978	symptoms	_	
79-20	15979-15981	of	_	
79-21	15982-15985	CUD	_	
79-22	15985-15986	.	_	

#Text=RESULTS
#Text=Out of 129 participants, two did not have fMRI data due to technical problems (incomplete scan, missing behavioral data), and, six had motion exceeding 3 mm (in translation) or 3° (in rotation) between TRs during both runs.
80-1	15987-15994	RESULTS	_	
80-2	15995-15998	Out	_	
80-3	15999-16001	of	_	
80-4	16002-16005	129	_	
80-5	16006-16018	participants	_	
80-6	16018-16019	,	_	
80-7	16020-16023	two	_	
80-8	16024-16027	did	_	
80-9	16028-16031	not	_	
80-10	16032-16036	have	_	
80-11	16037-16041	fMRI	_	
80-12	16042-16046	data	_	
80-13	16047-16050	due	_	
80-14	16051-16053	to	_	
80-15	16054-16063	technical	_	
80-16	16064-16072	problems	_	
80-17	16073-16074	(	_	
80-18	16074-16084	incomplete	_	
80-19	16085-16089	scan	_	
80-20	16089-16090	,	_	
80-21	16091-16098	missing	_	
80-22	16099-16109	behavioral	_	
80-23	16110-16114	data	_	
80-24	16114-16115	)	_	
80-25	16115-16116	,	_	
80-26	16117-16120	and	_	
80-27	16120-16121	,	_	
80-28	16122-16125	six	_	
80-29	16126-16129	had	_	
80-30	16130-16136	motion	_	
80-31	16137-16146	exceeding	_	
80-32	16147-16148	3	_	
80-33	16149-16151	mm	_	
80-34	16152-16153	(	_	
80-35	16153-16155	in	_	
80-36	16156-16167	translation	_	
80-37	16167-16168	)	_	
80-38	16169-16171	or	_	
80-39	16172-16173	3	_	
80-40	16173-16174	°	_	
80-41	16175-16176	(	_	
80-42	16176-16178	in	_	
80-43	16179-16187	rotation	_	
80-44	16187-16188	)	_	
80-45	16189-16196	between	_	
80-46	16197-16200	TRs	_	
80-47	16201-16207	during	_	
80-48	16208-16212	both	_	
80-49	16213-16217	runs	_	
80-50	16217-16218	.	_	

#Text=These eight participants were subsequently excluded from further analyses.
81-1	16219-16224	These	_	
81-2	16225-16230	eight	_	
81-3	16231-16243	participants	_	
81-4	16244-16248	were	_	
81-5	16249-16261	subsequently	_	
81-6	16262-16270	excluded	_	
81-7	16271-16275	from	_	
81-8	16276-16283	further	_	
81-9	16284-16292	analyses	_	
81-10	16292-16293	.	_	

#Text=Of the remaining 121, the sample consisted of 53 users and 68 non‐users (Table 1).
82-1	16294-16296	Of	_	
82-2	16297-16300	the	_	
82-3	16301-16310	remaining	_	
82-4	16311-16314	121	_	
82-5	16314-16315	,	_	
82-6	16316-16319	the	_	
82-7	16320-16326	sample	_	
82-8	16327-16336	consisted	_	
82-9	16337-16339	of	_	
82-10	16340-16342	53	_	
82-11	16343-16348	users	_	
82-12	16349-16352	and	_	
82-13	16353-16355	68	_	
82-14	16356-16365	non‐users	_	
82-15	16366-16367	(	_	
82-16	16367-16372	Table	_	
82-17	16373-16374	1	_	
82-18	16374-16375	)	_	
82-19	16375-16376	.	_	

#Text=Behavioral Data
#Text=Substance use
#Text=Among the users, 14 had a DSM‐IV diagnosis of current cannabis dependence based on SCID interview [First et al., 1997].
83-1	16377-16387	Behavioral	_	
83-2	16388-16392	Data	_	
83-3	16393-16402	Substance	_	
83-4	16403-16406	use	_	
83-5	16407-16412	Among	_	
83-6	16413-16416	the	_	
83-7	16417-16422	users	_	
83-8	16422-16423	,	_	
83-9	16424-16426	14	_	
83-10	16427-16430	had	_	
83-11	16431-16432	a	_	
83-12	16433-16439	DSM‐IV	_	
83-13	16440-16449	diagnosis	_	
83-14	16450-16452	of	_	
83-15	16453-16460	current	_	
83-16	16461-16469	cannabis	_	
83-17	16470-16480	dependence	_	
83-18	16481-16486	based	_	
83-19	16487-16489	on	_	
83-20	16490-16494	SCID	_	
83-21	16495-16504	interview	_	
83-22	16505-16506	[	_	
83-23	16506-16511	First	_	
83-24	16512-16514	et	_	
83-25	16515-16517	al	_	
83-26	16517-16518	.	_	
83-27	16518-16519	,	_	
83-28	16520-16524	1997	_	
83-29	16524-16525	]	_	
83-30	16525-16526	.	_	

#Text=Twenty one of the cannabis users and 12 of the non‐users showed some history of alcohol abuse or dependence, and three users and three non‐users showed current symptoms of abuse.
84-1	16527-16533	Twenty	_	
84-2	16534-16537	one	_	
84-3	16538-16540	of	_	
84-4	16541-16544	the	_	
84-5	16545-16553	cannabis	_	
84-6	16554-16559	users	_	
84-7	16560-16563	and	_	
84-8	16564-16566	12	_	
84-9	16567-16569	of	_	
84-10	16570-16573	the	_	
84-11	16574-16583	non‐users	_	
84-12	16584-16590	showed	_	
84-13	16591-16595	some	_	
84-14	16596-16603	history	_	
84-15	16604-16606	of	_	
84-16	16607-16614	alcohol	_	
84-17	16615-16620	abuse	_	
84-18	16621-16623	or	_	
84-19	16624-16634	dependence	_	
84-20	16634-16635	,	_	
84-21	16636-16639	and	_	
84-22	16640-16645	three	_	
84-23	16646-16651	users	_	
84-24	16652-16655	and	_	
84-25	16656-16661	three	_	
84-26	16662-16671	non‐users	_	
84-27	16672-16678	showed	_	
84-28	16679-16686	current	_	
84-29	16687-16695	symptoms	_	
84-30	16696-16698	of	_	
84-31	16699-16704	abuse	_	
84-32	16704-16705	.	_	

#Text=No users or non‐users met criteria for current abuse or dependence for any other substances, although three users showed some history of sedative abuse or dependence, five users some history of abuse or dependence on stimulants, two users for some history of abuse or dependence on opioids, five users for some history of abuse or dependence on cocaine, seven users for history of abuse of hallucinogens, and one user for abuse of other drugs not specified.
85-1	16706-16708	No	_	
85-2	16709-16714	users	_	
85-3	16715-16717	or	_	
85-4	16718-16727	non‐users	_	
85-5	16728-16731	met	_	
85-6	16732-16740	criteria	_	
85-7	16741-16744	for	_	
85-8	16745-16752	current	_	
85-9	16753-16758	abuse	_	
85-10	16759-16761	or	_	
85-11	16762-16772	dependence	_	
85-12	16773-16776	for	_	
85-13	16777-16780	any	_	
85-14	16781-16786	other	_	
85-15	16787-16797	substances	_	
85-16	16797-16798	,	_	
85-17	16799-16807	although	_	
85-18	16808-16813	three	_	
85-19	16814-16819	users	_	
85-20	16820-16826	showed	_	
85-21	16827-16831	some	_	
85-22	16832-16839	history	_	
85-23	16840-16842	of	_	
85-24	16843-16851	sedative	_	
85-25	16852-16857	abuse	_	
85-26	16858-16860	or	_	
85-27	16861-16871	dependence	_	
85-28	16871-16872	,	_	
85-29	16873-16877	five	_	
85-30	16878-16883	users	_	
85-31	16884-16888	some	_	
85-32	16889-16896	history	_	
85-33	16897-16899	of	_	
85-34	16900-16905	abuse	_	
85-35	16906-16908	or	_	
85-36	16909-16919	dependence	_	
85-37	16920-16922	on	_	
85-38	16923-16933	stimulants	_	
85-39	16933-16934	,	_	
85-40	16935-16938	two	_	
85-41	16939-16944	users	_	
85-42	16945-16948	for	_	
85-43	16949-16953	some	_	
85-44	16954-16961	history	_	
85-45	16962-16964	of	_	
85-46	16965-16970	abuse	_	
85-47	16971-16973	or	_	
85-48	16974-16984	dependence	_	
85-49	16985-16987	on	_	
85-50	16988-16995	opioids	_	
85-51	16995-16996	,	_	
85-52	16997-17001	five	_	
85-53	17002-17007	users	_	
85-54	17008-17011	for	_	
85-55	17012-17016	some	_	
85-56	17017-17024	history	_	
85-57	17025-17027	of	_	
85-58	17028-17033	abuse	_	
85-59	17034-17036	or	_	
85-60	17037-17047	dependence	_	
85-61	17048-17050	on	_	
85-62	17051-17058	cocaine	_	
85-63	17058-17059	,	_	
85-64	17060-17065	seven	_	
85-65	17066-17071	users	_	
85-66	17072-17075	for	_	
85-67	17076-17083	history	_	
85-68	17084-17086	of	_	
85-69	17087-17092	abuse	_	
85-70	17093-17095	of	_	
85-71	17096-17109	hallucinogens	_	
85-72	17109-17110	,	_	
85-73	17111-17114	and	_	
85-74	17115-17118	one	_	
85-75	17119-17123	user	_	
85-76	17124-17127	for	_	
85-77	17128-17133	abuse	_	
85-78	17134-17136	of	_	
85-79	17137-17142	other	_	
85-80	17143-17148	drugs	_	
85-81	17149-17152	not	_	
85-82	17153-17162	specified	_	
85-83	17162-17163	.	_	

#Text=Subjective craving
#Text=The cannabis users had a mean baseline (immediately prior to the MRI scan) MCQ score of 237.04 (SD = 154.48) and a post‐scan (immediately after the MRI scan) MCQ score of 250.57 (SD = 170.65).
86-1	17164-17174	Subjective	_	
86-2	17175-17182	craving	_	
86-3	17183-17186	The	_	
86-4	17187-17195	cannabis	_	
86-5	17196-17201	users	_	
86-6	17202-17205	had	_	
86-7	17206-17207	a	_	
86-8	17208-17212	mean	_	
86-9	17213-17221	baseline	_	
86-10	17222-17223	(	_	
86-11	17223-17234	immediately	_	
86-12	17235-17240	prior	_	
86-13	17241-17243	to	_	
86-14	17244-17247	the	_	
86-15	17248-17251	MRI	_	
86-16	17252-17256	scan	_	
86-17	17256-17257	)	_	
86-18	17258-17261	MCQ	_	
86-19	17262-17267	score	_	
86-20	17268-17270	of	_	
86-21	17271-17277	237.04	_	
86-22	17278-17279	(	_	
86-23	17279-17281	SD	_	
86-24	17282-17283	=	_	
86-25	17284-17290	154.48	_	
86-26	17290-17291	)	_	
86-27	17292-17295	and	_	
86-28	17296-17297	a	_	
86-29	17298-17307	post‐scan	_	
86-30	17308-17309	(	_	
86-31	17309-17320	immediately	_	
86-32	17321-17326	after	_	
86-33	17327-17330	the	_	
86-34	17331-17334	MRI	_	
86-35	17335-17339	scan	_	
86-36	17339-17340	)	_	
86-37	17341-17344	MCQ	_	
86-38	17345-17350	score	_	
86-39	17351-17353	of	_	
86-40	17354-17360	250.57	_	
86-41	17361-17362	(	_	
86-42	17362-17364	SD	_	
86-43	17365-17366	=	_	
86-44	17367-17373	170.65	_	
86-45	17373-17374	)	_	
86-46	17374-17375	.	_	

#Text=Although the post‐scan MCQ was greater than baseline MCQ, the difference did not reach a level of significance (Table 1).
87-1	17376-17384	Although	_	
87-2	17385-17388	the	_	
87-3	17389-17398	post‐scan	_	
87-4	17399-17402	MCQ	_	
87-5	17403-17406	was	_	
87-6	17407-17414	greater	_	
87-7	17415-17419	than	_	
87-8	17420-17428	baseline	_	
87-9	17429-17432	MCQ	_	
87-10	17432-17433	,	_	
87-11	17434-17437	the	_	
87-12	17438-17448	difference	_	
87-13	17449-17452	did	_	
87-14	17453-17456	not	_	
87-15	17457-17462	reach	_	
87-16	17463-17464	a	_	
87-17	17465-17470	level	_	
87-18	17471-17473	of	_	
87-19	17474-17486	significance	_	
87-20	17487-17488	(	_	
87-21	17488-17493	Table	_	
87-22	17494-17495	1	_	
87-23	17495-17496	)	_	
87-24	17496-17497	.	_	

#Text=In terms of in‐scanner cue‐induced craving ratings, there were significant group differences found in response to all of the stimuli presentations where the cannabis users reported greater subjective urge to use cannabis following all stimuli types (P < 0.001) (Table 2).
88-1	17498-17500	In	_	
88-2	17501-17506	terms	_	
88-3	17507-17509	of	_	
88-4	17510-17520	in‐scanner	_	
88-5	17521-17532	cue‐induced	_	
88-6	17533-17540	craving	_	
88-7	17541-17548	ratings	_	
88-8	17548-17549	,	_	
88-9	17550-17555	there	_	
88-10	17556-17560	were	_	
88-11	17561-17572	significant	_	
88-12	17573-17578	group	_	
88-13	17579-17590	differences	_	
88-14	17591-17596	found	_	
88-15	17597-17599	in	_	
88-16	17600-17608	response	_	
88-17	17609-17611	to	_	
88-18	17612-17615	all	_	
88-19	17616-17618	of	_	
88-20	17619-17622	the	_	
88-21	17623-17630	stimuli	_	
88-22	17631-17644	presentations	_	
88-23	17645-17650	where	_	
88-24	17651-17654	the	_	
88-25	17655-17663	cannabis	_	
88-26	17664-17669	users	_	
88-27	17670-17678	reported	_	
88-28	17679-17686	greater	_	
88-29	17687-17697	subjective	_	
88-30	17698-17702	urge	_	
88-31	17703-17705	to	_	
88-32	17706-17709	use	_	
88-33	17710-17718	cannabis	_	
88-34	17719-17728	following	_	
88-35	17729-17732	all	_	
88-36	17733-17740	stimuli	_	
88-37	17741-17746	types	_	
88-38	17747-17748	(	_	
88-39	17748-17749	P	_	
88-40	17750-17751	<	_	
88-41	17752-17757	0.001	_	
88-42	17757-17758	)	_	
88-43	17759-17760	(	_	
88-44	17760-17765	Table	_	
88-45	17766-17767	2	_	
88-46	17767-17768	)	_	
88-47	17768-17769	.	_	

#Text=Within the cannabis users, cue‐induced craving following cannabis cue exposure was significantly greater relative to following fruit cue (P < 0.001) and neutral cue (P < 0.001).
89-1	17770-17776	Within	_	
89-2	17777-17780	the	_	
89-3	17781-17789	cannabis	_	
89-4	17790-17795	users	_	
89-5	17795-17796	,	_	
89-6	17797-17808	cue‐induced	_	
89-7	17809-17816	craving	_	
89-8	17817-17826	following	_	
89-9	17827-17835	cannabis	_	
89-10	17836-17839	cue	_	
89-11	17840-17848	exposure	_	
89-12	17849-17852	was	_	
89-13	17853-17866	significantly	_	
89-14	17867-17874	greater	_	
89-15	17875-17883	relative	_	
89-16	17884-17886	to	_	
89-17	17887-17896	following	_	
89-18	17897-17902	fruit	_	
89-19	17903-17906	cue	_	
89-20	17907-17908	(	_	
89-21	17908-17909	P	_	
89-22	17910-17911	<	_	
89-23	17912-17917	0.001	_	
89-24	17917-17918	)	_	
89-25	17919-17922	and	_	
89-26	17923-17930	neutral	_	
89-27	17931-17934	cue	_	
89-28	17935-17936	(	_	
89-29	17936-17937	P	_	
89-30	17938-17939	<	_	
89-31	17940-17945	0.001	_	
89-32	17945-17946	)	_	
89-33	17946-17947	.	_	

#Text=In‐scanner cue‐induced subjective craving ratings
#Text=Cue type\tUsers (N = 53)\tNon‐users (N = 67)a\tGroup difference\t \tCannabis cue\t5.25 (3.17)\t0.13 (0.50)\tt(54.06) = −11.669; P < 0.001\t \tFruit cue\t3.66 (3.17)\t0.04 (0.18)\tt(52.28) = −8.299; P < 0.001\t \tNeutral control cue\t3.12 (3.02)\t0.01 (0.08)\tt(52.06) = −7.480; P < 0.001\t \t
#Text=Data were not available for one of the non‐using controls due to technical difficulties.
90-1	17948-17958	In‐scanner	_	
90-2	17959-17970	cue‐induced	_	
90-3	17971-17981	subjective	_	
90-4	17982-17989	craving	_	
90-5	17990-17997	ratings	_	
90-6	17998-18001	Cue	_	
90-7	18002-18006	type	_	
90-8	18007-18012	Users	_	
90-9	18013-18014	(	_	
90-10	18014-18015	N	_	
90-11	18016-18017	=	_	
90-12	18018-18020	53	_	
90-13	18020-18021	)	_	
90-14	18022-18031	Non‐users	_	
90-15	18032-18033	(	_	
90-16	18033-18034	N	_	
90-17	18035-18036	=	_	
90-18	18037-18039	67	_	
90-19	18039-18040	)	_	
90-20	18040-18041	a	_	
90-21	18042-18047	Group	_	
90-22	18048-18058	difference	_	
90-23	18061-18069	Cannabis	_	
90-24	18070-18073	cue	_	
90-25	18074-18078	5.25	_	
90-26	18079-18080	(	_	
90-27	18080-18084	3.17	_	
90-28	18084-18085	)	_	
90-29	18086-18090	0.13	_	
90-30	18091-18092	(	_	
90-31	18092-18096	0.50	_	
90-32	18096-18097	)	_	
90-33	18098-18099	t	_	
90-34	18099-18100	(	_	
90-35	18100-18105	54.06	_	
90-36	18105-18106	)	_	
90-37	18107-18108	=	_	
90-38	18109-18110	−	_	
90-39	18110-18116	11.669	_	
90-40	18116-18117	;	_	
90-41	18118-18119	P	_	
90-42	18120-18121	<	_	
90-43	18122-18127	0.001	_	
90-44	18130-18135	Fruit	_	
90-45	18136-18139	cue	_	
90-46	18140-18144	3.66	_	
90-47	18145-18146	(	_	
90-48	18146-18150	3.17	_	
90-49	18150-18151	)	_	
90-50	18152-18156	0.04	_	
90-51	18157-18158	(	_	
90-52	18158-18162	0.18	_	
90-53	18162-18163	)	_	
90-54	18164-18165	t	_	
90-55	18165-18166	(	_	
90-56	18166-18171	52.28	_	
90-57	18171-18172	)	_	
90-58	18173-18174	=	_	
90-59	18175-18176	−	_	
90-60	18176-18181	8.299	_	
90-61	18181-18182	;	_	
90-62	18183-18184	P	_	
90-63	18185-18186	<	_	
90-64	18187-18192	0.001	_	
90-65	18195-18202	Neutral	_	
90-66	18203-18210	control	_	
90-67	18211-18214	cue	_	
90-68	18215-18219	3.12	_	
90-69	18220-18221	(	_	
90-70	18221-18225	3.02	_	
90-71	18225-18226	)	_	
90-72	18227-18231	0.01	_	
90-73	18232-18233	(	_	
90-74	18233-18237	0.08	_	
90-75	18237-18238	)	_	
90-76	18239-18240	t	_	
90-77	18240-18241	(	_	
90-78	18241-18246	52.06	_	
90-79	18246-18247	)	_	
90-80	18248-18249	=	_	
90-81	18250-18251	−	_	
90-82	18251-18256	7.480	_	
90-83	18256-18257	;	_	
90-84	18258-18259	P	_	
90-85	18260-18261	<	_	
90-86	18262-18267	0.001	_	
90-87	18271-18275	Data	_	
90-88	18276-18280	were	_	
90-89	18281-18284	not	_	
90-90	18285-18294	available	_	
90-91	18295-18298	for	_	
90-92	18299-18302	one	_	
90-93	18303-18305	of	_	
90-94	18306-18309	the	_	
90-95	18310-18319	non‐using	_	
90-96	18320-18328	controls	_	
90-97	18329-18332	due	_	
90-98	18333-18335	to	_	
90-99	18336-18345	technical	_	
90-100	18346-18358	difficulties	_	
90-101	18358-18359	.	_	

#Text=The participants’ mean subjective craving ratings for cannabis (i.e., response to question “Please rate your urge to use marijuana right now”) following the presentation of each stimulus type on a scale of 0 (no urge at all)−10 (extreme high urge).
#Text=fMRI Data
#Text=Cannabis cues versus neutral object cues
#Text=The users showed greater BOLD response for the cannabis cue compared to the neutral object cue in the parahippocampal gyrus, thalamus, anterior cingulate gyrus, mid‐cingulate gyrus, medial frontal gyrus, inferior frontal gyrus, and cerebellum (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected), and, a small cluster in response to the neutral object cue compared to cannabis cue in the lateral occipital cortex, cuneus and precuneus (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected).
91-1	18360-18363	The	_	
91-2	18364-18376	participants	_	
91-3	18376-18377	’	_	
91-4	18378-18382	mean	_	
91-5	18383-18393	subjective	_	
91-6	18394-18401	craving	_	
91-7	18402-18409	ratings	_	
91-8	18410-18413	for	_	
91-9	18414-18422	cannabis	_	
91-10	18423-18424	(	_	
91-11	18424-18427	i.e	_	
91-12	18427-18428	.	_	
91-13	18428-18429	,	_	
91-14	18430-18438	response	_	
91-15	18439-18441	to	_	
91-16	18442-18450	question	_	
91-17	18451-18452	“	_	
91-18	18452-18458	Please	_	
91-19	18459-18463	rate	_	
91-20	18464-18468	your	_	
91-21	18469-18473	urge	_	
91-22	18474-18476	to	_	
91-23	18477-18480	use	_	
91-24	18481-18490	marijuana	_	
91-25	18491-18496	right	_	
91-26	18497-18500	now	_	
91-27	18500-18501	”	_	
91-28	18501-18502	)	_	
91-29	18503-18512	following	_	
91-30	18513-18516	the	_	
91-31	18517-18529	presentation	_	
91-32	18530-18532	of	_	
91-33	18533-18537	each	_	
91-34	18538-18546	stimulus	_	
91-35	18547-18551	type	_	
91-36	18552-18554	on	_	
91-37	18555-18556	a	_	
91-38	18557-18562	scale	_	
91-39	18563-18565	of	_	
91-40	18566-18567	0	_	
91-41	18568-18569	(	_	
91-42	18569-18571	no	_	
91-43	18572-18576	urge	_	
91-44	18577-18579	at	_	
91-45	18580-18583	all	_	
91-46	18583-18584	)	_	
91-47	18584-18585	−	_	
91-48	18585-18587	10	_	
91-49	18588-18589	(	_	
91-50	18589-18596	extreme	_	
91-51	18597-18601	high	_	
91-52	18602-18606	urge	_	
91-53	18606-18607	)	_	
91-54	18607-18608	.	_	
91-55	18609-18613	fMRI	_	
91-56	18614-18618	Data	_	
91-57	18619-18627	Cannabis	_	
91-58	18628-18632	cues	_	
91-59	18633-18639	versus	_	
91-60	18640-18647	neutral	_	
91-61	18648-18654	object	_	
91-62	18655-18659	cues	_	
91-63	18660-18663	The	_	
91-64	18664-18669	users	_	
91-65	18670-18676	showed	_	
91-66	18677-18684	greater	_	
91-67	18685-18689	BOLD	_	
91-68	18690-18698	response	_	
91-69	18699-18702	for	_	
91-70	18703-18706	the	_	
91-71	18707-18715	cannabis	_	
91-72	18716-18719	cue	_	
91-73	18720-18728	compared	_	
91-74	18729-18731	to	_	
91-75	18732-18735	the	_	
91-76	18736-18743	neutral	_	
91-77	18744-18750	object	_	
91-78	18751-18754	cue	_	
91-79	18755-18757	in	_	
91-80	18758-18761	the	_	
91-81	18762-18777	parahippocampal	_	
91-82	18778-18783	gyrus	_	
91-83	18783-18784	,	_	
91-84	18785-18793	thalamus	_	
91-85	18793-18794	,	_	
91-86	18795-18803	anterior	_	
91-87	18804-18813	cingulate	_	
91-88	18814-18819	gyrus	_	
91-89	18819-18820	,	_	
91-90	18821-18834	mid‐cingulate	_	
91-91	18835-18840	gyrus	_	
91-92	18840-18841	,	_	
91-93	18842-18848	medial	_	
91-94	18849-18856	frontal	_	
91-95	18857-18862	gyrus	_	
91-96	18862-18863	,	_	
91-97	18864-18872	inferior	_	
91-98	18873-18880	frontal	_	
91-99	18881-18886	gyrus	_	
91-100	18886-18887	,	_	
91-101	18888-18891	and	_	
91-102	18892-18902	cerebellum	_	
91-103	18903-18904	(	_	
91-104	18904-18921	cluster‐threshold	_	
91-105	18922-18923	z	_	
91-106	18924-18925	=	_	
91-107	18926-18929	2.3	_	
91-108	18929-18930	,	_	
91-109	18931-18932	P	_	
91-110	18933-18934	<	_	
91-111	18935-18939	0.05	_	
91-112	18940-18953	FWE‐corrected	_	
91-113	18953-18954	)	_	
91-114	18954-18955	,	_	
91-115	18956-18959	and	_	
91-116	18959-18960	,	_	
91-117	18961-18962	a	_	
91-118	18963-18968	small	_	
91-119	18969-18976	cluster	_	
91-120	18977-18979	in	_	
91-121	18980-18988	response	_	
91-122	18989-18991	to	_	
91-123	18992-18995	the	_	
91-124	18996-19003	neutral	_	
91-125	19004-19010	object	_	
91-126	19011-19014	cue	_	
91-127	19015-19023	compared	_	
91-128	19024-19026	to	_	
91-129	19027-19035	cannabis	_	
91-130	19036-19039	cue	_	
91-131	19040-19042	in	_	
91-132	19043-19046	the	_	
91-133	19047-19054	lateral	_	
91-134	19055-19064	occipital	_	
91-135	19065-19071	cortex	_	
91-136	19071-19072	,	_	
91-137	19073-19079	cuneus	_	
91-138	19080-19083	and	_	
91-139	19084-19093	precuneus	_	
91-140	19094-19095	(	_	
91-141	19095-19112	cluster‐threshold	_	
91-142	19113-19114	z	_	
91-143	19115-19116	=	_	
91-144	19117-19120	2.3	_	
91-145	19120-19121	,	_	
91-146	19122-19123	P	_	
91-147	19124-19125	<	_	
91-148	19126-19130	0.05	_	
91-149	19131-19144	FWE‐corrected	_	
91-150	19144-19145	)	_	
91-151	19145-19146	.	_	

#Text=The non‐users showed significant differences in activation in response to cannabis cues compared to the neutral object cues in the substantia nigra, globus pallidus, caudate, thalamus, parahippocampal gyrus, supramarginal gyrus, postcentral gyrus, and cerebellum (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected), and to the neutral object cue compared to the cannabis cue in the lateral occipital cortex, cuneus, precuneus, and the occipital pole (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected).
92-1	19147-19150	The	_	
92-2	19151-19160	non‐users	_	
92-3	19161-19167	showed	_	
92-4	19168-19179	significant	_	
92-5	19180-19191	differences	_	
92-6	19192-19194	in	_	
92-7	19195-19205	activation	_	
92-8	19206-19208	in	_	
92-9	19209-19217	response	_	
92-10	19218-19220	to	_	
92-11	19221-19229	cannabis	_	
92-12	19230-19234	cues	_	
92-13	19235-19243	compared	_	
92-14	19244-19246	to	_	
92-15	19247-19250	the	_	
92-16	19251-19258	neutral	_	
92-17	19259-19265	object	_	
92-18	19266-19270	cues	_	
92-19	19271-19273	in	_	
92-20	19274-19277	the	_	
92-21	19278-19288	substantia	_	
92-22	19289-19294	nigra	_	
92-23	19294-19295	,	_	
92-24	19296-19302	globus	_	
92-25	19303-19311	pallidus	_	
92-26	19311-19312	,	_	
92-27	19313-19320	caudate	_	
92-28	19320-19321	,	_	
92-29	19322-19330	thalamus	_	
92-30	19330-19331	,	_	
92-31	19332-19347	parahippocampal	_	
92-32	19348-19353	gyrus	_	
92-33	19353-19354	,	_	
92-34	19355-19368	supramarginal	_	
92-35	19369-19374	gyrus	_	
92-36	19374-19375	,	_	
92-37	19376-19387	postcentral	_	
92-38	19388-19393	gyrus	_	
92-39	19393-19394	,	_	
92-40	19395-19398	and	_	
92-41	19399-19409	cerebellum	_	
92-42	19410-19411	(	_	
92-43	19411-19428	cluster‐threshold	_	
92-44	19429-19430	z	_	
92-45	19431-19432	=	_	
92-46	19433-19436	2.3	_	
92-47	19436-19437	,	_	
92-48	19438-19439	P	_	
92-49	19440-19441	<	_	
92-50	19442-19446	0.05	_	
92-51	19447-19460	FWE‐corrected	_	
92-52	19460-19461	)	_	
92-53	19461-19462	,	_	
92-54	19463-19466	and	_	
92-55	19467-19469	to	_	
92-56	19470-19473	the	_	
92-57	19474-19481	neutral	_	
92-58	19482-19488	object	_	
92-59	19489-19492	cue	_	
92-60	19493-19501	compared	_	
92-61	19502-19504	to	_	
92-62	19505-19508	the	_	
92-63	19509-19517	cannabis	_	
92-64	19518-19521	cue	_	
92-65	19522-19524	in	_	
92-66	19525-19528	the	_	
92-67	19529-19536	lateral	_	
92-68	19537-19546	occipital	_	
92-69	19547-19553	cortex	_	
92-70	19553-19554	,	_	
92-71	19555-19561	cuneus	_	
92-72	19561-19562	,	_	
92-73	19563-19572	precuneus	_	
92-74	19572-19573	,	_	
92-75	19574-19577	and	_	
92-76	19578-19581	the	_	
92-77	19582-19591	occipital	_	
92-78	19592-19596	pole	_	
92-79	19597-19598	(	_	
92-80	19598-19615	cluster‐threshold	_	
92-81	19616-19617	z	_	
92-82	19618-19619	=	_	
92-83	19620-19623	2.3	_	
92-84	19623-19624	,	_	
92-85	19625-19626	P	_	
92-86	19627-19628	<	_	
92-87	19629-19633	0.05	_	
92-88	19634-19647	FWE‐corrected	_	
92-89	19647-19648	)	_	
92-90	19648-19649	.	_	

#Text=The contrast between groups showed that the cannabis users had greater response than non‐users in several clusters of widespread activation encompassing frontal, cingulate, and midbrain (i.e., VTA) areas with peaks in the precuneus, caudate, anterior and posterior cingulate gyri in response to cannabis cues compared to the neutral object cue (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected).
93-1	19650-19653	The	_	
93-2	19654-19662	contrast	_	
93-3	19663-19670	between	_	
93-4	19671-19677	groups	_	
93-5	19678-19684	showed	_	
93-6	19685-19689	that	_	
93-7	19690-19693	the	_	
93-8	19694-19702	cannabis	_	
93-9	19703-19708	users	_	
93-10	19709-19712	had	_	
93-11	19713-19720	greater	_	
93-12	19721-19729	response	_	
93-13	19730-19734	than	_	
93-14	19735-19744	non‐users	_	
93-15	19745-19747	in	_	
93-16	19748-19755	several	_	
93-17	19756-19764	clusters	_	
93-18	19765-19767	of	_	
93-19	19768-19778	widespread	_	
93-20	19779-19789	activation	_	
93-21	19790-19802	encompassing	_	
93-22	19803-19810	frontal	_	
93-23	19810-19811	,	_	
93-24	19812-19821	cingulate	_	
93-25	19821-19822	,	_	
93-26	19823-19826	and	_	
93-27	19827-19835	midbrain	_	
93-28	19836-19837	(	_	
93-29	19837-19840	i.e	_	
93-30	19840-19841	.	_	
93-31	19841-19842	,	_	
93-32	19843-19846	VTA	_	
93-33	19846-19847	)	_	
93-34	19848-19853	areas	_	
93-35	19854-19858	with	_	
93-36	19859-19864	peaks	_	
93-37	19865-19867	in	_	
93-38	19868-19871	the	_	
93-39	19872-19881	precuneus	_	
93-40	19881-19882	,	_	
93-41	19883-19890	caudate	_	
93-42	19890-19891	,	_	
93-43	19892-19900	anterior	_	
93-44	19901-19904	and	_	
93-45	19905-19914	posterior	_	
93-46	19915-19924	cingulate	_	
93-47	19925-19929	gyri	_	
93-48	19930-19932	in	_	
93-49	19933-19941	response	_	
93-50	19942-19944	to	_	
93-51	19945-19953	cannabis	_	
93-52	19954-19958	cues	_	
93-53	19959-19967	compared	_	
93-54	19968-19970	to	_	
93-55	19971-19974	the	_	
93-56	19975-19982	neutral	_	
93-57	19983-19989	object	_	
93-58	19990-19993	cue	_	
93-59	19994-19995	(	_	
93-60	19995-20012	cluster‐threshold	_	
93-61	20013-20014	z	_	
93-62	20015-20016	=	_	
93-63	20017-20020	2.3	_	
93-64	20020-20021	,	_	
93-65	20022-20023	P	_	
93-66	20024-20025	<	_	
93-67	20026-20030	0.05	_	
93-68	20031-20044	FWE‐corrected	_	
93-69	20044-20045	)	_	
93-70	20045-20046	.	_	

#Text=In the reverse comparison, non‐users did not show a significant difference in response to cannabis cues compared to the neutral object cue when compared to the cannabis users (Table 3, Fig. 1).
94-1	20047-20049	In	_	
94-2	20050-20053	the	_	
94-3	20054-20061	reverse	_	
94-4	20062-20072	comparison	_	
94-5	20072-20073	,	_	
94-6	20074-20083	non‐users	_	
94-7	20084-20087	did	_	
94-8	20088-20091	not	_	
94-9	20092-20096	show	_	
94-10	20097-20098	a	_	
94-11	20099-20110	significant	_	
94-12	20111-20121	difference	_	
94-13	20122-20124	in	_	
94-14	20125-20133	response	_	
94-15	20134-20136	to	_	
94-16	20137-20145	cannabis	_	
94-17	20146-20150	cues	_	
94-18	20151-20159	compared	_	
94-19	20160-20162	to	_	
94-20	20163-20166	the	_	
94-21	20167-20174	neutral	_	
94-22	20175-20181	object	_	
94-23	20182-20185	cue	_	
94-24	20186-20190	when	_	
94-25	20191-20199	compared	_	
94-26	20200-20202	to	_	
94-27	20203-20206	the	_	
94-28	20207-20215	cannabis	_	
94-29	20216-20221	users	_	
94-30	20222-20223	(	_	
94-31	20223-20228	Table	_	
94-32	20229-20230	3	_	
94-33	20230-20231	,	_	
94-34	20232-20235	Fig	_	
94-35	20235-20236	.	_	
94-36	20237-20238	1	_	
94-37	20238-20239	)	_	
94-38	20239-20240	.	_	

#Text=Group interaction peaks for group and cue type
#Text=# Voxels\tPeak Z\tx\ty\tz\tLocalization\tBA\t \t(A) Users > non‐users for cannabis > pencil\t \tz = 2.3\t \t14434\t4.32\t13.8\t−52.54\t32.5\tR Precuneus\t31\t \t4.3\t30.97\t−34\t8.48\tR Caudate\t‐\t \t4.22\t−18.12\t−29.24\t−29.52\tL Cerebellum: Anterior Lobe\t‐\t \t4.22\t−0.99\t12.94\t−6.76\tL Anterior Cingulate Gyrus\t25\t \t4.21\t10.33\t−0.2\t−11.16\tR Subcallosal Gyrus\t34\t \t4.19\t2.51\t−38.93\t29.7\tR Posterior Cingulate Gyrus\t31\t \tz=3.2\t \t845\t4.14\t1.96\t−4.84\t6.9\tR Sub‐lobar Extra‐Nuclear White Matter\t—\t \t4.13\t1.83\t−40.79\t21.69\tR Posterior Cingulate Gyrus\t—\t \t207\t3.96\t−21.14\t−68.93\t−27.14\tL Cerebellum: Uvula\t—\t \t3.69\t−26.98\t−74.8\t−29.37\tL Cerebellum: Tuber\t—\t \t3.63\t−30.91\t−66.93\t−29.17\tL Cerebellum: Tuber\t—\t \t3.34\t−13.36\t−63.11\t−22.89\tL Cerebellum: Declive\t—\t \t3.28\t−40.68\t−63.04\t−29.15\tL Cerebellum: Tuber\t—\t \t3.75\t0.28\t−71.12\t−17.03\tR Cerebellum: Declive of Vermis\t—\t \t3.55\t−3.61\t−76.97\t−19.25\tL Cerebellum\t—\t \t3.53\t0.41\t−74.62\t−31.05\tL Cerebellum: Pyramis of Vermis\t—\t \t3.3\t−3.6\t−63.13\t−20.8\tL Cerebellum: Declive\t—\t \t167\t3.95\t0.12\t15.29\t−6.4\tL Anterior Cingulate Gyrus\t—\t \t(b) Users > non‐users for cannabis > fruit\t \tz = 2.3\t \t14256\t4.96\t4.8\t48.45\t2.82\tR Anterior Cingulate Gyrus\t32\t \t4.93\t−0.88\t41.5\t−6.71\tL Anterior Cingulate Gyrus\t32\t \t4.91\t−0.85\t49.19\t−8.02\tL Medial Frontal Gyrus\t10\t \t4.73\t−6.6\t45.84\t15.25\tL Medial Frontal Gyrus\t9\t \t4.67\t−1.28\t−38.9\t29.68\tL Posterior Cingulate Gyrus\t31\t \t4.61\t−6.59\t49.52\t17.3\tL Medial Frontal Gyrus\t10\t \tz = 3.2\t \t1532\t4.96\t5.91\t50.64\t−1.26\tR Medial Frontal Gyrus\t46\t \t4.73\t−5.95\t48.18\t12.44\tL Medial Frontal Gyrus\t10\t \t4.61\t−5.98\t52.05\t14.55\tL Medial Frontal Gyrus\t10\t \t4.44\t−9.8\t40.47\t6.2\tL Anterior Cingulate Gyrus\t32\t \t437\t4.67\t−0.22\t−39.13\t31.65\tL Posterior Cingulate Gyrus\t23\t \t3.62\t−13.92\t−47.13\t33.24\tL Precuneus\t31\t \t212\t3.85\t−3.7\t19.52\t−16.25\tL Medial Frontal Gyrus\t25\t \t3.72\t7.9\t17.16\t−2.29\tR Anterior Cingulate Gyrus\t24\t \t3.49\t−5.65\t5.73\t−16.69\tL Medial Frontal Gyrus\t45\t \t3.42\t6.08\t17.59\t−16.2\tR Medial Frontal Gyrus\t46\t \t3.93\t5.87\t−12.7\t6.71\tR Thalamus: Medial Dorsal Nucleus\t—\t \t3.86\t11.74\t−10.7\t6.84\tR Thalamus: Ventral Lateral Nucleus\t—\t \t210\t3.68\t−5.85\t−16.69\t6.45\tL Thalamus: Medial Dorsal Nucleus\t—\t \t3.56\t11.78\t−2.7\t3.1\tR Globus Pallidus\t—\t \t3.51\t−5.84\t−6.78\t4.77\tL Thalamus\t—\t \t3.25\t−9.81\t−12.89\t10.51\tL Thalamus\t—\t \t(C) Non‐users > users for cannabis > pencil\t \tNo significant results\t \t(D) Non‐users > users for cannabis > fruit\t \tNo significant results\t \t
#Text=Loci of significant activation for the contrast users > non‐users for cannabis cues versus (A) pencil (neutral control cue) and (B) fruit cues (appetitive control cue) and non‐users > users for cannabis cues versus (C) pencil (neutral control) and (D) fruit cues (appetitive control cue) at z‐value thresholds of 2.3 and 3.2, and GRF cluster‐corrected P‐value of exceeding 0.05.
95-1	20241-20246	Group	_	
95-2	20247-20258	interaction	_	
95-3	20259-20264	peaks	_	
95-4	20265-20268	for	_	
95-5	20269-20274	group	_	
95-6	20275-20278	and	_	
95-7	20279-20282	cue	_	
95-8	20283-20287	type	_	
95-9	20288-20289	#	_	
95-10	20290-20296	Voxels	_	
95-11	20297-20301	Peak	_	
95-12	20302-20303	Z	_	
95-13	20304-20305	x	_	
95-14	20306-20307	y	_	
95-15	20308-20309	z	_	
95-16	20310-20322	Localization	_	
95-17	20323-20325	BA	_	
95-18	20328-20329	(	_	
95-19	20329-20330	A	_	
95-20	20330-20331	)	_	
95-21	20332-20337	Users	_	
95-22	20338-20339	>	_	
95-23	20340-20349	non‐users	_	
95-24	20350-20353	for	_	
95-25	20354-20362	cannabis	_	
95-26	20363-20364	>	_	
95-27	20365-20371	pencil	_	
95-28	20374-20375	z	_	
95-29	20376-20377	=	_	
95-30	20378-20381	2.3	_	
95-31	20384-20389	14434	_	
95-32	20390-20394	4.32	_	
95-33	20395-20399	13.8	_	
95-34	20400-20401	−	_	
95-35	20401-20406	52.54	_	
95-36	20407-20411	32.5	_	
95-37	20412-20413	R	_	
95-38	20414-20423	Precuneus	_	
95-39	20424-20426	31	_	
95-40	20429-20432	4.3	_	
95-41	20433-20438	30.97	_	
95-42	20439-20440	−	_	
95-43	20440-20442	34	_	
95-44	20443-20447	8.48	_	
95-45	20448-20449	R	_	
95-46	20450-20457	Caudate	_	
95-47	20458-20459	‐	_	
95-48	20462-20466	4.22	_	
95-49	20467-20468	−	_	
95-50	20468-20473	18.12	_	
95-51	20474-20475	−	_	
95-52	20475-20480	29.24	_	
95-53	20481-20482	−	_	
95-54	20482-20487	29.52	_	
95-55	20488-20489	L	_	
95-56	20490-20500	Cerebellum	_	
95-57	20500-20501	:	_	
95-58	20502-20510	Anterior	_	
95-59	20511-20515	Lobe	_	
95-60	20516-20517	‐	_	
95-61	20520-20524	4.22	_	
95-62	20525-20526	−	_	
95-63	20526-20530	0.99	_	
95-64	20531-20536	12.94	_	
95-65	20537-20538	−	_	
95-66	20538-20542	6.76	_	
95-67	20543-20544	L	_	
95-68	20545-20553	Anterior	_	
95-69	20554-20563	Cingulate	_	
95-70	20564-20569	Gyrus	_	
95-71	20570-20572	25	_	
95-72	20575-20579	4.21	_	
95-73	20580-20585	10.33	_	
95-74	20586-20587	−	_	
95-75	20587-20590	0.2	_	
95-76	20591-20592	−	_	
95-77	20592-20597	11.16	_	
95-78	20598-20599	R	_	
95-79	20600-20611	Subcallosal	_	
95-80	20612-20617	Gyrus	_	
95-81	20618-20620	34	_	
95-82	20623-20627	4.19	_	
95-83	20628-20632	2.51	_	
95-84	20633-20634	−	_	
95-85	20634-20639	38.93	_	
95-86	20640-20644	29.7	_	
95-87	20645-20646	R	_	
95-88	20647-20656	Posterior	_	
95-89	20657-20666	Cingulate	_	
95-90	20667-20672	Gyrus	_	
95-91	20673-20675	31	_	
95-92	20678-20679	z	_	
95-93	20679-20680	=	_	
95-94	20680-20683	3.2	_	
95-95	20686-20689	845	_	
95-96	20690-20694	4.14	_	
95-97	20695-20699	1.96	_	
95-98	20700-20701	−	_	
95-99	20701-20705	4.84	_	
95-100	20706-20709	6.9	_	
95-101	20710-20711	R	_	
95-102	20712-20721	Sub‐lobar	_	
95-103	20722-20735	Extra‐Nuclear	_	
95-104	20736-20741	White	_	
95-105	20742-20748	Matter	_	
95-106	20749-20750	—	_	
95-107	20753-20757	4.13	_	
95-108	20758-20762	1.83	_	
95-109	20763-20764	−	_	
95-110	20764-20769	40.79	_	
95-111	20770-20775	21.69	_	
95-112	20776-20777	R	_	
95-113	20778-20787	Posterior	_	
95-114	20788-20797	Cingulate	_	
95-115	20798-20803	Gyrus	_	
95-116	20804-20805	—	_	
95-117	20808-20811	207	_	
95-118	20812-20816	3.96	_	
95-119	20817-20818	−	_	
95-120	20818-20823	21.14	_	
95-121	20824-20825	−	_	
95-122	20825-20830	68.93	_	
95-123	20831-20832	−	_	
95-124	20832-20837	27.14	_	
95-125	20838-20839	L	_	
95-126	20840-20850	Cerebellum	_	
95-127	20850-20851	:	_	
95-128	20852-20857	Uvula	_	
95-129	20858-20859	—	_	
95-130	20862-20866	3.69	_	
95-131	20867-20868	−	_	
95-132	20868-20873	26.98	_	
95-133	20874-20875	−	_	
95-134	20875-20879	74.8	_	
95-135	20880-20881	−	_	
95-136	20881-20886	29.37	_	
95-137	20887-20888	L	_	
95-138	20889-20899	Cerebellum	_	
95-139	20899-20900	:	_	
95-140	20901-20906	Tuber	_	
95-141	20907-20908	—	_	
95-142	20911-20915	3.63	_	
95-143	20916-20917	−	_	
95-144	20917-20922	30.91	_	
95-145	20923-20924	−	_	
95-146	20924-20929	66.93	_	
95-147	20930-20931	−	_	
95-148	20931-20936	29.17	_	
95-149	20937-20938	L	_	
95-150	20939-20949	Cerebellum	_	
95-151	20949-20950	:	_	
95-152	20951-20956	Tuber	_	
95-153	20957-20958	—	_	
95-154	20961-20965	3.34	_	
95-155	20966-20967	−	_	
95-156	20967-20972	13.36	_	
95-157	20973-20974	−	_	
95-158	20974-20979	63.11	_	
95-159	20980-20981	−	_	
95-160	20981-20986	22.89	_	
95-161	20987-20988	L	_	
95-162	20989-20999	Cerebellum	_	
95-163	20999-21000	:	_	
95-164	21001-21008	Declive	_	
95-165	21009-21010	—	_	
95-166	21013-21017	3.28	_	
95-167	21018-21019	−	_	
95-168	21019-21024	40.68	_	
95-169	21025-21026	−	_	
95-170	21026-21031	63.04	_	
95-171	21032-21033	−	_	
95-172	21033-21038	29.15	_	
95-173	21039-21040	L	_	
95-174	21041-21051	Cerebellum	_	
95-175	21051-21052	:	_	
95-176	21053-21058	Tuber	_	
95-177	21059-21060	—	_	
95-178	21063-21067	3.75	_	
95-179	21068-21072	0.28	_	
95-180	21073-21074	−	_	
95-181	21074-21079	71.12	_	
95-182	21080-21081	−	_	
95-183	21081-21086	17.03	_	
95-184	21087-21088	R	_	
95-185	21089-21099	Cerebellum	_	
95-186	21099-21100	:	_	
95-187	21101-21108	Declive	_	
95-188	21109-21111	of	_	
95-189	21112-21118	Vermis	_	
95-190	21119-21120	—	_	
95-191	21123-21127	3.55	_	
95-192	21128-21129	−	_	
95-193	21129-21133	3.61	_	
95-194	21134-21135	−	_	
95-195	21135-21140	76.97	_	
95-196	21141-21142	−	_	
95-197	21142-21147	19.25	_	
95-198	21148-21149	L	_	
95-199	21150-21160	Cerebellum	_	
95-200	21161-21162	—	_	
95-201	21165-21169	3.53	_	
95-202	21170-21174	0.41	_	
95-203	21175-21176	−	_	
95-204	21176-21181	74.62	_	
95-205	21182-21183	−	_	
95-206	21183-21188	31.05	_	
95-207	21189-21190	L	_	
95-208	21191-21201	Cerebellum	_	
95-209	21201-21202	:	_	
95-210	21203-21210	Pyramis	_	
95-211	21211-21213	of	_	
95-212	21214-21220	Vermis	_	
95-213	21221-21222	—	_	
95-214	21225-21228	3.3	_	
95-215	21229-21230	−	_	
95-216	21230-21233	3.6	_	
95-217	21234-21235	−	_	
95-218	21235-21240	63.13	_	
95-219	21241-21242	−	_	
95-220	21242-21246	20.8	_	
95-221	21247-21248	L	_	
95-222	21249-21259	Cerebellum	_	
95-223	21259-21260	:	_	
95-224	21261-21268	Declive	_	
95-225	21269-21270	—	_	
95-226	21273-21276	167	_	
95-227	21277-21281	3.95	_	
95-228	21282-21286	0.12	_	
95-229	21287-21292	15.29	_	
95-230	21293-21294	−	_	
95-231	21294-21297	6.4	_	
95-232	21298-21299	L	_	
95-233	21300-21308	Anterior	_	
95-234	21309-21318	Cingulate	_	
95-235	21319-21324	Gyrus	_	
95-236	21325-21326	—	_	
95-237	21329-21330	(	_	
95-238	21330-21331	b	_	
95-239	21331-21332	)	_	
95-240	21333-21338	Users	_	
95-241	21339-21340	>	_	
95-242	21341-21350	non‐users	_	
95-243	21351-21354	for	_	
95-244	21355-21363	cannabis	_	
95-245	21364-21365	>	_	
95-246	21366-21371	fruit	_	
95-247	21374-21375	z	_	
95-248	21376-21377	=	_	
95-249	21378-21381	2.3	_	
95-250	21384-21389	14256	_	
95-251	21390-21394	4.96	_	
95-252	21395-21398	4.8	_	
95-253	21399-21404	48.45	_	
95-254	21405-21409	2.82	_	
95-255	21410-21411	R	_	
95-256	21412-21420	Anterior	_	
95-257	21421-21430	Cingulate	_	
95-258	21431-21436	Gyrus	_	
95-259	21437-21439	32	_	
95-260	21442-21446	4.93	_	
95-261	21447-21448	−	_	
95-262	21448-21452	0.88	_	
95-263	21453-21457	41.5	_	
95-264	21458-21459	−	_	
95-265	21459-21463	6.71	_	
95-266	21464-21465	L	_	
95-267	21466-21474	Anterior	_	
95-268	21475-21484	Cingulate	_	
95-269	21485-21490	Gyrus	_	
95-270	21491-21493	32	_	
95-271	21496-21500	4.91	_	
95-272	21501-21502	−	_	
95-273	21502-21506	0.85	_	
95-274	21507-21512	49.19	_	
95-275	21513-21514	−	_	
95-276	21514-21518	8.02	_	
95-277	21519-21520	L	_	
95-278	21521-21527	Medial	_	
95-279	21528-21535	Frontal	_	
95-280	21536-21541	Gyrus	_	
95-281	21542-21544	10	_	
95-282	21547-21551	4.73	_	
95-283	21552-21553	−	_	
95-284	21553-21556	6.6	_	
95-285	21557-21562	45.84	_	
95-286	21563-21568	15.25	_	
95-287	21569-21570	L	_	
95-288	21571-21577	Medial	_	
95-289	21578-21585	Frontal	_	
95-290	21586-21591	Gyrus	_	
95-291	21592-21593	9	_	
95-292	21596-21600	4.67	_	
95-293	21601-21602	−	_	
95-294	21602-21606	1.28	_	
95-295	21607-21608	−	_	
95-296	21608-21612	38.9	_	
95-297	21613-21618	29.68	_	
95-298	21619-21620	L	_	
95-299	21621-21630	Posterior	_	
95-300	21631-21640	Cingulate	_	
95-301	21641-21646	Gyrus	_	
95-302	21647-21649	31	_	
95-303	21652-21656	4.61	_	
95-304	21657-21658	−	_	
95-305	21658-21662	6.59	_	
95-306	21663-21668	49.52	_	
95-307	21669-21673	17.3	_	
95-308	21674-21675	L	_	
95-309	21676-21682	Medial	_	
95-310	21683-21690	Frontal	_	
95-311	21691-21696	Gyrus	_	
95-312	21697-21699	10	_	
95-313	21702-21703	z	_	
95-314	21704-21705	=	_	
95-315	21706-21709	3.2	_	
95-316	21712-21716	1532	_	
95-317	21717-21721	4.96	_	
95-318	21722-21726	5.91	_	
95-319	21727-21732	50.64	_	
95-320	21733-21734	−	_	
95-321	21734-21738	1.26	_	
95-322	21739-21740	R	_	
95-323	21741-21747	Medial	_	
95-324	21748-21755	Frontal	_	
95-325	21756-21761	Gyrus	_	
95-326	21762-21764	46	_	
95-327	21767-21771	4.73	_	
95-328	21772-21773	−	_	
95-329	21773-21777	5.95	_	
95-330	21778-21783	48.18	_	
95-331	21784-21789	12.44	_	
95-332	21790-21791	L	_	
95-333	21792-21798	Medial	_	
95-334	21799-21806	Frontal	_	
95-335	21807-21812	Gyrus	_	
95-336	21813-21815	10	_	
95-337	21818-21822	4.61	_	
95-338	21823-21824	−	_	
95-339	21824-21828	5.98	_	
95-340	21829-21834	52.05	_	
95-341	21835-21840	14.55	_	
95-342	21841-21842	L	_	
95-343	21843-21849	Medial	_	
95-344	21850-21857	Frontal	_	
95-345	21858-21863	Gyrus	_	
95-346	21864-21866	10	_	
95-347	21869-21873	4.44	_	
95-348	21874-21875	−	_	
95-349	21875-21878	9.8	_	
95-350	21879-21884	40.47	_	
95-351	21885-21888	6.2	_	
95-352	21889-21890	L	_	
95-353	21891-21899	Anterior	_	
95-354	21900-21909	Cingulate	_	
95-355	21910-21915	Gyrus	_	
95-356	21916-21918	32	_	
95-357	21921-21924	437	_	
95-358	21925-21929	4.67	_	
95-359	21930-21931	−	_	
95-360	21931-21935	0.22	_	
95-361	21936-21937	−	_	
95-362	21937-21942	39.13	_	
95-363	21943-21948	31.65	_	
95-364	21949-21950	L	_	
95-365	21951-21960	Posterior	_	
95-366	21961-21970	Cingulate	_	
95-367	21971-21976	Gyrus	_	
95-368	21977-21979	23	_	
95-369	21982-21986	3.62	_	
95-370	21987-21988	−	_	
95-371	21988-21993	13.92	_	
95-372	21994-21995	−	_	
95-373	21995-22000	47.13	_	
95-374	22001-22006	33.24	_	
95-375	22007-22008	L	_	
95-376	22009-22018	Precuneus	_	
95-377	22019-22021	31	_	
95-378	22024-22027	212	_	
95-379	22028-22032	3.85	_	
95-380	22033-22034	−	_	
95-381	22034-22037	3.7	_	
95-382	22038-22043	19.52	_	
95-383	22044-22045	−	_	
95-384	22045-22050	16.25	_	
95-385	22051-22052	L	_	
95-386	22053-22059	Medial	_	
95-387	22060-22067	Frontal	_	
95-388	22068-22073	Gyrus	_	
95-389	22074-22076	25	_	
95-390	22079-22083	3.72	_	
95-391	22084-22087	7.9	_	
95-392	22088-22093	17.16	_	
95-393	22094-22095	−	_	
95-394	22095-22099	2.29	_	
95-395	22100-22101	R	_	
95-396	22102-22110	Anterior	_	
95-397	22111-22120	Cingulate	_	
95-398	22121-22126	Gyrus	_	
95-399	22127-22129	24	_	
95-400	22132-22136	3.49	_	
95-401	22137-22138	−	_	
95-402	22138-22142	5.65	_	
95-403	22143-22147	5.73	_	
95-404	22148-22149	−	_	
95-405	22149-22154	16.69	_	
95-406	22155-22156	L	_	
95-407	22157-22163	Medial	_	
95-408	22164-22171	Frontal	_	
95-409	22172-22177	Gyrus	_	
95-410	22178-22180	45	_	
95-411	22183-22187	3.42	_	
95-412	22188-22192	6.08	_	
95-413	22193-22198	17.59	_	
95-414	22199-22200	−	_	
95-415	22200-22204	16.2	_	
95-416	22205-22206	R	_	
95-417	22207-22213	Medial	_	
95-418	22214-22221	Frontal	_	
95-419	22222-22227	Gyrus	_	
95-420	22228-22230	46	_	
95-421	22233-22237	3.93	_	
95-422	22238-22242	5.87	_	
95-423	22243-22244	−	_	
95-424	22244-22248	12.7	_	
95-425	22249-22253	6.71	_	
95-426	22254-22255	R	_	
95-427	22256-22264	Thalamus	_	
95-428	22264-22265	:	_	
95-429	22266-22272	Medial	_	
95-430	22273-22279	Dorsal	_	
95-431	22280-22287	Nucleus	_	
95-432	22288-22289	—	_	
95-433	22292-22296	3.86	_	
95-434	22297-22302	11.74	_	
95-435	22303-22304	−	_	
95-436	22304-22308	10.7	_	
95-437	22309-22313	6.84	_	
95-438	22314-22315	R	_	
95-439	22316-22324	Thalamus	_	
95-440	22324-22325	:	_	
95-441	22326-22333	Ventral	_	
95-442	22334-22341	Lateral	_	
95-443	22342-22349	Nucleus	_	
95-444	22350-22351	—	_	
95-445	22354-22357	210	_	
95-446	22358-22362	3.68	_	
95-447	22363-22364	−	_	
95-448	22364-22368	5.85	_	
95-449	22369-22370	−	_	
95-450	22370-22375	16.69	_	
95-451	22376-22380	6.45	_	
95-452	22381-22382	L	_	
95-453	22383-22391	Thalamus	_	
95-454	22391-22392	:	_	
95-455	22393-22399	Medial	_	
95-456	22400-22406	Dorsal	_	
95-457	22407-22414	Nucleus	_	
95-458	22415-22416	—	_	
95-459	22419-22423	3.56	_	
95-460	22424-22429	11.78	_	
95-461	22430-22431	−	_	
95-462	22431-22434	2.7	_	
95-463	22435-22438	3.1	_	
95-464	22439-22440	R	_	
95-465	22441-22447	Globus	_	
95-466	22448-22456	Pallidus	_	
95-467	22457-22458	—	_	
95-468	22461-22465	3.51	_	
95-469	22466-22467	−	_	
95-470	22467-22471	5.84	_	
95-471	22472-22473	−	_	
95-472	22473-22477	6.78	_	
95-473	22478-22482	4.77	_	
95-474	22483-22484	L	_	
95-475	22485-22493	Thalamus	_	
95-476	22494-22495	—	_	
95-477	22498-22502	3.25	_	
95-478	22503-22504	−	_	
95-479	22504-22508	9.81	_	
95-480	22509-22510	−	_	
95-481	22510-22515	12.89	_	
95-482	22516-22521	10.51	_	
95-483	22522-22523	L	_	
95-484	22524-22532	Thalamus	_	
95-485	22533-22534	—	_	
95-486	22537-22538	(	_	
95-487	22538-22539	C	_	
95-488	22539-22540	)	_	
95-489	22541-22550	Non‐users	_	
95-490	22551-22552	>	_	
95-491	22553-22558	users	_	
95-492	22559-22562	for	_	
95-493	22563-22571	cannabis	_	
95-494	22572-22573	>	_	
95-495	22574-22580	pencil	_	
95-496	22583-22585	No	_	
95-497	22586-22597	significant	_	
95-498	22598-22605	results	_	
95-499	22608-22609	(	_	
95-500	22609-22610	D	_	
95-501	22610-22611	)	_	
95-502	22612-22621	Non‐users	_	
95-503	22622-22623	>	_	
95-504	22624-22629	users	_	
95-505	22630-22633	for	_	
95-506	22634-22642	cannabis	_	
95-507	22643-22644	>	_	
95-508	22645-22650	fruit	_	
95-509	22653-22655	No	_	
95-510	22656-22667	significant	_	
95-511	22668-22675	results	_	
95-512	22679-22683	Loci	_	
95-513	22684-22686	of	_	
95-514	22687-22698	significant	_	
95-515	22699-22709	activation	_	
95-516	22710-22713	for	_	
95-517	22714-22717	the	_	
95-518	22718-22726	contrast	_	
95-519	22727-22732	users	_	
95-520	22733-22734	>	_	
95-521	22735-22744	non‐users	_	
95-522	22745-22748	for	_	
95-523	22749-22757	cannabis	_	
95-524	22758-22762	cues	_	
95-525	22763-22769	versus	_	
95-526	22770-22771	(	_	
95-527	22771-22772	A	_	
95-528	22772-22773	)	_	
95-529	22774-22780	pencil	_	
95-530	22781-22782	(	_	
95-531	22782-22789	neutral	_	
95-532	22790-22797	control	_	
95-533	22798-22801	cue	_	
95-534	22801-22802	)	_	
95-535	22803-22806	and	_	
95-536	22807-22808	(	_	
95-537	22808-22809	B	_	
95-538	22809-22810	)	_	
95-539	22811-22816	fruit	_	
95-540	22817-22821	cues	_	
95-541	22822-22823	(	_	
95-542	22823-22833	appetitive	_	
95-543	22834-22841	control	_	
95-544	22842-22845	cue	_	
95-545	22845-22846	)	_	
95-546	22847-22850	and	_	
95-547	22851-22860	non‐users	_	
95-548	22861-22862	>	_	
95-549	22863-22868	users	_	
95-550	22869-22872	for	_	
95-551	22873-22881	cannabis	_	
95-552	22882-22886	cues	_	
95-553	22887-22893	versus	_	
95-554	22894-22895	(	_	
95-555	22895-22896	C	_	
95-556	22896-22897	)	_	
95-557	22898-22904	pencil	_	
95-558	22905-22906	(	_	
95-559	22906-22913	neutral	_	
95-560	22914-22921	control	_	
95-561	22921-22922	)	_	
95-562	22923-22926	and	_	
95-563	22927-22928	(	_	
95-564	22928-22929	D	_	
95-565	22929-22930	)	_	
95-566	22931-22936	fruit	_	
95-567	22937-22941	cues	_	
95-568	22942-22943	(	_	
95-569	22943-22953	appetitive	_	
95-570	22954-22961	control	_	
95-571	22962-22965	cue	_	
95-572	22965-22966	)	_	
95-573	22967-22969	at	_	
95-574	22970-22977	z‐value	_	
95-575	22978-22988	thresholds	_	
95-576	22989-22991	of	_	
95-577	22992-22995	2.3	_	
95-578	22996-22999	and	_	
95-579	23000-23003	3.2	_	
95-580	23003-23004	,	_	
95-581	23005-23008	and	_	
95-582	23009-23012	GRF	_	
95-583	23013-23030	cluster‐corrected	_	
95-584	23031-23038	P‐value	_	
95-585	23039-23041	of	_	
95-586	23042-23051	exceeding	_	
95-587	23052-23056	0.05	_	
95-588	23056-23057	.	_	

#Text=Cluster size in terms of number of voxels, Z values for peak voxels along with corresponding MNI coordinates, anatomical localization, and Brodmann areas are provided.
96-1	23058-23065	Cluster	_	
96-2	23066-23070	size	_	
96-3	23071-23073	in	_	
96-4	23074-23079	terms	_	
96-5	23080-23082	of	_	
96-6	23083-23089	number	_	
96-7	23090-23092	of	_	
96-8	23093-23099	voxels	_	
96-9	23099-23100	,	_	
96-10	23101-23102	Z	_	
96-11	23103-23109	values	_	
96-12	23110-23113	for	_	
96-13	23114-23118	peak	_	
96-14	23119-23125	voxels	_	
96-15	23126-23131	along	_	
96-16	23132-23136	with	_	
96-17	23137-23150	corresponding	_	
96-18	23151-23154	MNI	_	
96-19	23155-23166	coordinates	_	
96-20	23166-23167	,	_	
96-21	23168-23178	anatomical	_	
96-22	23179-23191	localization	_	
96-23	23191-23192	,	_	
96-24	23193-23196	and	_	
96-25	23197-23205	Brodmann	_	
96-26	23206-23211	areas	_	
96-27	23212-23215	are	_	
96-28	23216-23224	provided	_	
96-29	23224-23225	.	_	

#Text=Effect between cues (cannabis cues, fruit cues, and neutral cues) and group (users, non‐users).
97-1	23226-23232	Effect	_	
97-2	23233-23240	between	_	
97-3	23241-23245	cues	_	
97-4	23246-23247	(	_	
97-5	23247-23255	cannabis	_	
97-6	23256-23260	cues	_	
97-7	23260-23261	,	_	
97-8	23262-23267	fruit	_	
97-9	23268-23272	cues	_	
97-10	23272-23273	,	_	
97-11	23274-23277	and	_	
97-12	23278-23285	neutral	_	
97-13	23286-23290	cues	_	
97-14	23290-23291	)	_	
97-15	23292-23295	and	_	
97-16	23296-23301	group	_	
97-17	23302-23303	(	_	
97-18	23303-23308	users	_	
97-19	23308-23309	,	_	
97-20	23310-23319	non‐users	_	
97-21	23319-23320	)	_	
97-22	23320-23321	.	_	

#Text=Cannabis cues relative to (A) fruit cues and (B) neutral cues in the users compared to non‐users.
98-1	23322-23330	Cannabis	_	
98-2	23331-23335	cues	_	
98-3	23336-23344	relative	_	
98-4	23345-23347	to	_	
98-5	23348-23349	(	_	
98-6	23349-23350	A	_	
98-7	23350-23351	)	_	
98-8	23352-23357	fruit	_	
98-9	23358-23362	cues	_	
98-10	23363-23366	and	_	
98-11	23367-23368	(	_	
98-12	23368-23369	B	_	
98-13	23369-23370	)	_	
98-14	23371-23378	neutral	_	
98-15	23379-23383	cues	_	
98-16	23384-23386	in	_	
98-17	23387-23390	the	_	
98-18	23391-23396	users	_	
98-19	23397-23405	compared	_	
98-20	23406-23408	to	_	
98-21	23409-23418	non‐users	_	
98-22	23418-23419	.	_	

#Text=The box and whisker plots show the range of Gaussianized t‐scores in the overlapping anterior cingulate gyrus peaks for both groups.
99-1	23420-23423	The	_	
99-2	23424-23427	box	_	
99-3	23428-23431	and	_	
99-4	23432-23439	whisker	_	
99-5	23440-23445	plots	_	
99-6	23446-23450	show	_	
99-7	23451-23454	the	_	
99-8	23455-23460	range	_	
99-9	23461-23463	of	_	
99-10	23464-23476	Gaussianized	_	
99-11	23477-23485	t‐scores	_	
99-12	23486-23488	in	_	
99-13	23489-23492	the	_	
99-14	23493-23504	overlapping	_	
99-15	23505-23513	anterior	_	
99-16	23514-23523	cingulate	_	
99-17	23524-23529	gyrus	_	
99-18	23530-23535	peaks	_	
99-19	23536-23539	for	_	
99-20	23540-23544	both	_	
99-21	23545-23551	groups	_	
99-22	23551-23552	.	_	

#Text=Boxes represent the middle quartiles (Q1–Q3) with the bar at the median.
100-1	23553-23558	Boxes	_	
100-2	23559-23568	represent	_	
100-3	23569-23572	the	_	
100-4	23573-23579	middle	_	
100-5	23580-23589	quartiles	_	
100-6	23590-23591	(	_	
100-7	23591-23593	Q1	_	
100-8	23593-23594	–	_	
100-9	23594-23596	Q3	_	
100-10	23596-23597	)	_	
100-11	23598-23602	with	_	
100-12	23603-23606	the	_	
100-13	23607-23610	bar	_	
100-14	23611-23613	at	_	
100-15	23614-23617	the	_	
100-16	23618-23624	median	_	
100-17	23624-23625	.	_	

#Text=Whiskers show the full range of values, with circles representing “outlier” scores for this peak (i.e., more than 3 SD from the median value) (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected).
101-1	23626-23634	Whiskers	_	
101-2	23635-23639	show	_	
101-3	23640-23643	the	_	
101-4	23644-23648	full	_	
101-5	23649-23654	range	_	
101-6	23655-23657	of	_	
101-7	23658-23664	values	_	
101-8	23664-23665	,	_	
101-9	23666-23670	with	_	
101-10	23671-23678	circles	_	
101-11	23679-23691	representing	_	
101-12	23692-23693	“	_	
101-13	23693-23700	outlier	_	
101-14	23700-23701	”	_	
101-15	23702-23708	scores	_	
101-16	23709-23712	for	_	
101-17	23713-23717	this	_	
101-18	23718-23722	peak	_	
101-19	23723-23724	(	_	
101-20	23724-23727	i.e	_	
101-21	23727-23728	.	_	
101-22	23728-23729	,	_	
101-23	23730-23734	more	_	
101-24	23735-23739	than	_	
101-25	23740-23741	3	_	
101-26	23742-23744	SD	_	
101-27	23745-23749	from	_	
101-28	23750-23753	the	_	
101-29	23754-23760	median	_	
101-30	23761-23766	value	_	
101-31	23766-23767	)	_	
101-32	23768-23769	(	_	
101-33	23769-23786	cluster‐threshold	_	
101-34	23787-23788	z	_	
101-35	23789-23790	=	_	
101-36	23791-23794	2.3	_	
101-37	23794-23795	,	_	
101-38	23796-23797	P	_	
101-39	23798-23799	<	_	
101-40	23800-23804	0.05	_	
101-41	23805-23818	FWE‐corrected	_	
101-42	23818-23819	)	_	
101-43	23819-23820	.	_	

#Text=Cannabis cues versus natural reward cues
#Text=In the users, exposure to cannabis cues showed greater activation than exposure to the fruit cue in the anterior cingulate gyrus, posterior cingulate gyrus, medial frontal gyrus, inferior occipital gyrus, fusiform gyrus, and lingual gyrus (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected).
102-1	23821-23829	Cannabis	_	
102-2	23830-23834	cues	_	
102-3	23835-23841	versus	_	
102-4	23842-23849	natural	_	
102-5	23850-23856	reward	_	
102-6	23857-23861	cues	_	
102-7	23862-23864	In	_	
102-8	23865-23868	the	_	
102-9	23869-23874	users	_	
102-10	23874-23875	,	_	
102-11	23876-23884	exposure	_	
102-12	23885-23887	to	_	
102-13	23888-23896	cannabis	_	
102-14	23897-23901	cues	_	
102-15	23902-23908	showed	_	
102-16	23909-23916	greater	_	
102-17	23917-23927	activation	_	
102-18	23928-23932	than	_	
102-19	23933-23941	exposure	_	
102-20	23942-23944	to	_	
102-21	23945-23948	the	_	
102-22	23949-23954	fruit	_	
102-23	23955-23958	cue	_	
102-24	23959-23961	in	_	
102-25	23962-23965	the	_	
102-26	23966-23974	anterior	_	
102-27	23975-23984	cingulate	_	
102-28	23985-23990	gyrus	_	
102-29	23990-23991	,	_	
102-30	23992-24001	posterior	_	
102-31	24002-24011	cingulate	_	
102-32	24012-24017	gyrus	_	
102-33	24017-24018	,	_	
102-34	24019-24025	medial	_	
102-35	24026-24033	frontal	_	
102-36	24034-24039	gyrus	_	
102-37	24039-24040	,	_	
102-38	24041-24049	inferior	_	
102-39	24050-24059	occipital	_	
102-40	24060-24065	gyrus	_	
102-41	24065-24066	,	_	
102-42	24067-24075	fusiform	_	
102-43	24076-24081	gyrus	_	
102-44	24081-24082	,	_	
102-45	24083-24086	and	_	
102-46	24087-24094	lingual	_	
102-47	24095-24100	gyrus	_	
102-48	24101-24102	(	_	
102-49	24102-24119	cluster‐threshold	_	
102-50	24120-24121	z	_	
102-51	24122-24123	=	_	
102-52	24124-24127	2.3	_	
102-53	24127-24128	,	_	
102-54	24129-24130	P	_	
102-55	24131-24132	<	_	
102-56	24133-24137	0.05	_	
102-57	24138-24151	FWE‐corrected	_	
102-58	24151-24152	)	_	
102-59	24152-24153	.	_	

#Text=Response to fruit cue was also greater than cannabis cue in the cuneus, precuneus, and middle occipital gyrus (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected) (Supporting Information).
103-1	24154-24162	Response	_	
103-2	24163-24165	to	_	
103-3	24166-24171	fruit	_	
103-4	24172-24175	cue	_	
103-5	24176-24179	was	_	
103-6	24180-24184	also	_	
103-7	24185-24192	greater	_	
103-8	24193-24197	than	_	
103-9	24198-24206	cannabis	_	
103-10	24207-24210	cue	_	
103-11	24211-24213	in	_	
103-12	24214-24217	the	_	
103-13	24218-24224	cuneus	_	
103-14	24224-24225	,	_	
103-15	24226-24235	precuneus	_	
103-16	24235-24236	,	_	
103-17	24237-24240	and	_	
103-18	24241-24247	middle	_	
103-19	24248-24257	occipital	_	
103-20	24258-24263	gyrus	_	
103-21	24264-24265	(	_	
103-22	24265-24282	cluster‐threshold	_	
103-23	24283-24284	z	_	
103-24	24285-24286	=	_	
103-25	24287-24290	2.3	_	
103-26	24290-24291	,	_	
103-27	24292-24293	P	_	
103-28	24294-24295	<	_	
103-29	24296-24300	0.05	_	
103-30	24301-24314	FWE‐corrected	_	
103-31	24314-24315	)	_	
103-32	24316-24317	(	_	
103-33	24317-24327	Supporting	_	
103-34	24328-24339	Information	_	
103-35	24339-24340	)	_	
103-36	24340-24341	.	_	

#Text=In the non‐users, greater response was found for the fruit cue compared to the cannabis cue in the lingual gyrus and precuneus (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected), but not in the reverse comparison (Supporting Information).
104-1	24342-24344	In	_	
104-2	24345-24348	the	_	
104-3	24349-24358	non‐users	_	
104-4	24358-24359	,	_	
104-5	24360-24367	greater	_	
104-6	24368-24376	response	_	
104-7	24377-24380	was	_	
104-8	24381-24386	found	_	
104-9	24387-24390	for	_	
104-10	24391-24394	the	_	
104-11	24395-24400	fruit	_	
104-12	24401-24404	cue	_	
104-13	24405-24413	compared	_	
104-14	24414-24416	to	_	
104-15	24417-24420	the	_	
104-16	24421-24429	cannabis	_	
104-17	24430-24433	cue	_	
104-18	24434-24436	in	_	
104-19	24437-24440	the	_	
104-20	24441-24448	lingual	_	
104-21	24449-24454	gyrus	_	
104-22	24455-24458	and	_	
104-23	24459-24468	precuneus	_	
104-24	24469-24470	(	_	
104-25	24470-24487	cluster‐threshold	_	
104-26	24488-24489	z	_	
104-27	24490-24491	=	_	
104-28	24492-24495	2.3	_	
104-29	24495-24496	,	_	
104-30	24497-24498	P	_	
104-31	24499-24500	<	_	
104-32	24501-24505	0.05	_	
104-33	24506-24519	FWE‐corrected	_	
104-34	24519-24520	)	_	
104-35	24520-24521	,	_	
104-36	24522-24525	but	_	
104-37	24526-24529	not	_	
104-38	24530-24532	in	_	
104-39	24533-24536	the	_	
104-40	24537-24544	reverse	_	
104-41	24545-24555	comparison	_	
104-42	24556-24557	(	_	
104-43	24557-24567	Supporting	_	
104-44	24568-24579	Information	_	
104-45	24579-24580	)	_	
104-46	24580-24581	.	_	

#Text=The contrast between the groups showed that the cannabis users showed greater response to cannabis cues compared to the fruit cues in several clusters of widespread activation encompassing frontal, cingulate, and midbrain (i.e., VTA) areas with peaks in the posterior cingulate gyrus and medial frontal gyrus (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected), whereas the non‐users did not have significantly greater response to cannabis cues versus fruit cues.
105-1	24582-24585	The	_	
105-2	24586-24594	contrast	_	
105-3	24595-24602	between	_	
105-4	24603-24606	the	_	
105-5	24607-24613	groups	_	
105-6	24614-24620	showed	_	
105-7	24621-24625	that	_	
105-8	24626-24629	the	_	
105-9	24630-24638	cannabis	_	
105-10	24639-24644	users	_	
105-11	24645-24651	showed	_	
105-12	24652-24659	greater	_	
105-13	24660-24668	response	_	
105-14	24669-24671	to	_	
105-15	24672-24680	cannabis	_	
105-16	24681-24685	cues	_	
105-17	24686-24694	compared	_	
105-18	24695-24697	to	_	
105-19	24698-24701	the	_	
105-20	24702-24707	fruit	_	
105-21	24708-24712	cues	_	
105-22	24713-24715	in	_	
105-23	24716-24723	several	_	
105-24	24724-24732	clusters	_	
105-25	24733-24735	of	_	
105-26	24736-24746	widespread	_	
105-27	24747-24757	activation	_	
105-28	24758-24770	encompassing	_	
105-29	24771-24778	frontal	_	
105-30	24778-24779	,	_	
105-31	24780-24789	cingulate	_	
105-32	24789-24790	,	_	
105-33	24791-24794	and	_	
105-34	24795-24803	midbrain	_	
105-35	24804-24805	(	_	
105-36	24805-24808	i.e	_	
105-37	24808-24809	.	_	
105-38	24809-24810	,	_	
105-39	24811-24814	VTA	_	
105-40	24814-24815	)	_	
105-41	24816-24821	areas	_	
105-42	24822-24826	with	_	
105-43	24827-24832	peaks	_	
105-44	24833-24835	in	_	
105-45	24836-24839	the	_	
105-46	24840-24849	posterior	_	
105-47	24850-24859	cingulate	_	
105-48	24860-24865	gyrus	_	
105-49	24866-24869	and	_	
105-50	24870-24876	medial	_	
105-51	24877-24884	frontal	_	
105-52	24885-24890	gyrus	_	
105-53	24891-24892	(	_	
105-54	24892-24909	cluster‐threshold	_	
105-55	24910-24911	z	_	
105-56	24912-24913	=	_	
105-57	24914-24917	2.3	_	
105-58	24917-24918	,	_	
105-59	24919-24920	P	_	
105-60	24921-24922	<	_	
105-61	24923-24927	0.05	_	
105-62	24928-24941	FWE‐corrected	_	
105-63	24941-24942	)	_	
105-64	24942-24943	,	_	
105-65	24944-24951	whereas	_	
105-66	24952-24955	the	_	
105-67	24956-24965	non‐users	_	
105-68	24966-24969	did	_	
105-69	24970-24973	not	_	
105-70	24974-24978	have	_	
105-71	24979-24992	significantly	_	
105-72	24993-25000	greater	_	
105-73	25001-25009	response	_	
105-74	25010-25012	to	_	
105-75	25013-25021	cannabis	_	
105-76	25022-25026	cues	_	
105-77	25027-25033	versus	_	
105-78	25034-25039	fruit	_	
105-79	25040-25044	cues	_	
105-80	25044-25045	.	_	

#Text=These differences are attributable to greater estimated activation during the cannabis cue exposure rather than reductions in activation during the fruit cue exposure (Table 3, Fig. 1).
106-1	25046-25051	These	_	
106-2	25052-25063	differences	_	
106-3	25064-25067	are	_	
106-4	25068-25080	attributable	_	
106-5	25081-25083	to	_	
106-6	25084-25091	greater	_	
106-7	25092-25101	estimated	_	
106-8	25102-25112	activation	_	
106-9	25113-25119	during	_	
106-10	25120-25123	the	_	
106-11	25124-25132	cannabis	_	
106-12	25133-25136	cue	_	
106-13	25137-25145	exposure	_	
106-14	25146-25152	rather	_	
106-15	25153-25157	than	_	
106-16	25158-25168	reductions	_	
106-17	25169-25171	in	_	
106-18	25172-25182	activation	_	
106-19	25183-25189	during	_	
106-20	25190-25193	the	_	
106-21	25194-25199	fruit	_	
106-22	25200-25203	cue	_	
106-23	25204-25212	exposure	_	
106-24	25213-25214	(	_	
106-25	25214-25219	Table	_	
106-26	25220-25221	3	_	
106-27	25221-25222	,	_	
106-28	25223-25226	Fig	_	
106-29	25226-25227	.	_	
106-30	25228-25229	1	_	
106-31	25229-25230	)	_	
106-32	25230-25231	.	_	

#Text=Fruit cues versus neutral object cues
#Text=In users, there was greater response to the fruit cue compared to the neutral object cue in the thalamus, claustrum, and cerebellum (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected), and, in lateral occipital cortex, cuneus and precuneus for the reverse contrast (i.e., neutral object cue compared to fruit cue) (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected).
107-1	25232-25237	Fruit	_	
107-2	25238-25242	cues	_	
107-3	25243-25249	versus	_	
107-4	25250-25257	neutral	_	
107-5	25258-25264	object	_	
107-6	25265-25269	cues	_	
107-7	25270-25272	In	_	
107-8	25273-25278	users	_	
107-9	25278-25279	,	_	
107-10	25280-25285	there	_	
107-11	25286-25289	was	_	
107-12	25290-25297	greater	_	
107-13	25298-25306	response	_	
107-14	25307-25309	to	_	
107-15	25310-25313	the	_	
107-16	25314-25319	fruit	_	
107-17	25320-25323	cue	_	
107-18	25324-25332	compared	_	
107-19	25333-25335	to	_	
107-20	25336-25339	the	_	
107-21	25340-25347	neutral	_	
107-22	25348-25354	object	_	
107-23	25355-25358	cue	_	
107-24	25359-25361	in	_	
107-25	25362-25365	the	_	
107-26	25366-25374	thalamus	_	
107-27	25374-25375	,	_	
107-28	25376-25385	claustrum	_	
107-29	25385-25386	,	_	
107-30	25387-25390	and	_	
107-31	25391-25401	cerebellum	_	
107-32	25402-25403	(	_	
107-33	25403-25420	cluster‐threshold	_	
107-34	25421-25422	z	_	
107-35	25423-25424	=	_	
107-36	25425-25428	2.3	_	
107-37	25428-25429	,	_	
107-38	25430-25431	P	_	
107-39	25432-25433	<	_	
107-40	25434-25438	0.05	_	
107-41	25439-25452	FWE‐corrected	_	
107-42	25452-25453	)	_	
107-43	25453-25454	,	_	
107-44	25455-25458	and	_	
107-45	25458-25459	,	_	
107-46	25460-25462	in	_	
107-47	25463-25470	lateral	_	
107-48	25471-25480	occipital	_	
107-49	25481-25487	cortex	_	
107-50	25487-25488	,	_	
107-51	25489-25495	cuneus	_	
107-52	25496-25499	and	_	
107-53	25500-25509	precuneus	_	
107-54	25510-25513	for	_	
107-55	25514-25517	the	_	
107-56	25518-25525	reverse	_	
107-57	25526-25534	contrast	_	
107-58	25535-25536	(	_	
107-59	25536-25539	i.e	_	
107-60	25539-25540	.	_	
107-61	25540-25541	,	_	
107-62	25542-25549	neutral	_	
107-63	25550-25556	object	_	
107-64	25557-25560	cue	_	
107-65	25561-25569	compared	_	
107-66	25570-25572	to	_	
107-67	25573-25578	fruit	_	
107-68	25579-25582	cue	_	
107-69	25582-25583	)	_	
107-70	25584-25585	(	_	
107-71	25585-25602	cluster‐threshold	_	
107-72	25603-25604	z	_	
107-73	25605-25606	=	_	
107-74	25607-25610	2.3	_	
107-75	25610-25611	,	_	
107-76	25612-25613	P	_	
107-77	25614-25615	<	_	
107-78	25616-25620	0.05	_	
107-79	25621-25634	FWE‐corrected	_	
107-80	25634-25635	)	_	
107-81	25635-25636	.	_	

#Text=In non‐users, robust response was found for the fruit cue compared to the neutral object cue in the posterior cingulate gyrus, superior temporal gyrus, thalamus, and cerebellum (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected), and a smaller response in the occipital cortex, centered on the cuneus at cluster‐threshold z = 2.3, P < 0.05 (FWE‐corrected), for the neutral object cue compared to the fruit cue.
108-1	25637-25639	In	_	
108-2	25640-25649	non‐users	_	
108-3	25649-25650	,	_	
108-4	25651-25657	robust	_	
108-5	25658-25666	response	_	
108-6	25667-25670	was	_	
108-7	25671-25676	found	_	
108-8	25677-25680	for	_	
108-9	25681-25684	the	_	
108-10	25685-25690	fruit	_	
108-11	25691-25694	cue	_	
108-12	25695-25703	compared	_	
108-13	25704-25706	to	_	
108-14	25707-25710	the	_	
108-15	25711-25718	neutral	_	
108-16	25719-25725	object	_	
108-17	25726-25729	cue	_	
108-18	25730-25732	in	_	
108-19	25733-25736	the	_	
108-20	25737-25746	posterior	_	
108-21	25747-25756	cingulate	_	
108-22	25757-25762	gyrus	_	
108-23	25762-25763	,	_	
108-24	25764-25772	superior	_	
108-25	25773-25781	temporal	_	
108-26	25782-25787	gyrus	_	
108-27	25787-25788	,	_	
108-28	25789-25797	thalamus	_	
108-29	25797-25798	,	_	
108-30	25799-25802	and	_	
108-31	25803-25813	cerebellum	_	
108-32	25814-25815	(	_	
108-33	25815-25832	cluster‐threshold	_	
108-34	25833-25834	z	_	
108-35	25835-25836	=	_	
108-36	25837-25840	2.3	_	
108-37	25840-25841	,	_	
108-38	25842-25843	P	_	
108-39	25844-25845	<	_	
108-40	25846-25850	0.05	_	
108-41	25851-25864	FWE‐corrected	_	
108-42	25864-25865	)	_	
108-43	25865-25866	,	_	
108-44	25867-25870	and	_	
108-45	25871-25872	a	_	
108-46	25873-25880	smaller	_	
108-47	25881-25889	response	_	
108-48	25890-25892	in	_	
108-49	25893-25896	the	_	
108-50	25897-25906	occipital	_	
108-51	25907-25913	cortex	_	
108-52	25913-25914	,	_	
108-53	25915-25923	centered	_	
108-54	25924-25926	on	_	
108-55	25927-25930	the	_	
108-56	25931-25937	cuneus	_	
108-57	25938-25940	at	_	
108-58	25941-25958	cluster‐threshold	_	
108-59	25959-25960	z	_	
108-60	25961-25962	=	_	
108-61	25963-25966	2.3	_	
108-62	25966-25967	,	_	
108-63	25968-25969	P	_	
108-64	25970-25971	<	_	
108-65	25972-25976	0.05	_	
108-66	25977-25978	(	_	
108-67	25978-25991	FWE‐corrected	_	
108-68	25991-25992	)	_	
108-69	25992-25993	,	_	
108-70	25994-25997	for	_	
108-71	25998-26001	the	_	
108-72	26002-26009	neutral	_	
108-73	26010-26016	object	_	
108-74	26017-26020	cue	_	
108-75	26021-26029	compared	_	
108-76	26030-26032	to	_	
108-77	26033-26036	the	_	
108-78	26037-26042	fruit	_	
108-79	26043-26046	cue	_	
108-80	26046-26047	.	_	

#Text=No significant difference was detected between cannabis users and non‐users when comparing fruit cue and neutral object cues at the selected threshold.
109-1	26048-26050	No	_	
109-2	26051-26062	significant	_	
109-3	26063-26073	difference	_	
109-4	26074-26077	was	_	
109-5	26078-26086	detected	_	
109-6	26087-26094	between	_	
109-7	26095-26103	cannabis	_	
109-8	26104-26109	users	_	
109-9	26110-26113	and	_	
109-10	26114-26123	non‐users	_	
109-11	26124-26128	when	_	
109-12	26129-26138	comparing	_	
109-13	26139-26144	fruit	_	
109-14	26145-26148	cue	_	
109-15	26149-26152	and	_	
109-16	26153-26160	neutral	_	
109-17	26161-26167	object	_	
109-18	26168-26172	cues	_	
109-19	26173-26175	at	_	
109-20	26176-26179	the	_	
109-21	26180-26188	selected	_	
109-22	26189-26198	threshold	_	
109-23	26198-26199	.	_	

#Text=Brain‐Behavior Correlations
#Text=Subjective craving
#Text=Because the cannabis users reported more craving after all of the cue types compared to the non‐users, we correlated the BOLD response to cues with net in‐scanner craving ratings (craving ratings for cannabis cues minus ratings during appetitive or neutral control cues) to normalize the subjective craving ratings.
110-1	26200-26214	Brain‐Behavior	_	
110-2	26215-26227	Correlations	_	
110-3	26228-26238	Subjective	_	
110-4	26239-26246	craving	_	
110-5	26247-26254	Because	_	
110-6	26255-26258	the	_	
110-7	26259-26267	cannabis	_	
110-8	26268-26273	users	_	
110-9	26274-26282	reported	_	
110-10	26283-26287	more	_	
110-11	26288-26295	craving	_	
110-12	26296-26301	after	_	
110-13	26302-26305	all	_	
110-14	26306-26308	of	_	
110-15	26309-26312	the	_	
110-16	26313-26316	cue	_	
110-17	26317-26322	types	_	
110-18	26323-26331	compared	_	
110-19	26332-26334	to	_	
110-20	26335-26338	the	_	
110-21	26339-26348	non‐users	_	
110-22	26348-26349	,	_	
110-23	26350-26352	we	_	
110-24	26353-26363	correlated	_	
110-25	26364-26367	the	_	
110-26	26368-26372	BOLD	_	
110-27	26373-26381	response	_	
110-28	26382-26384	to	_	
110-29	26385-26389	cues	_	
110-30	26390-26394	with	_	
110-31	26395-26398	net	_	
110-32	26399-26409	in‐scanner	_	
110-33	26410-26417	craving	_	
110-34	26418-26425	ratings	_	
110-35	26426-26427	(	_	
110-36	26427-26434	craving	_	
110-37	26435-26442	ratings	_	
110-38	26443-26446	for	_	
110-39	26447-26455	cannabis	_	
110-40	26456-26460	cues	_	
110-41	26461-26466	minus	_	
110-42	26467-26474	ratings	_	
110-43	26475-26481	during	_	
110-44	26482-26492	appetitive	_	
110-45	26493-26495	or	_	
110-46	26496-26503	neutral	_	
110-47	26504-26511	control	_	
110-48	26512-26516	cues	_	
110-49	26516-26517	)	_	
110-50	26518-26520	to	_	
110-51	26521-26530	normalize	_	
110-52	26531-26534	the	_	
110-53	26535-26545	subjective	_	
110-54	26546-26553	craving	_	
110-55	26554-26561	ratings	_	
110-56	26561-26562	.	_	

#Text=The results showed that in the cannabis users, there were significant positive correlations between in‐scanner cue‐induced craving ratings for cannabis cues (minus ratings during appetitive or neutral control cues) in amygdala and striatum (cannabis > neutral), frontal and insula regions (fruit > cannabis) and regions in frontal, temporal, striatum, and insula (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected) (Table 4).
111-1	26563-26566	The	_	
111-2	26567-26574	results	_	
111-3	26575-26581	showed	_	
111-4	26582-26586	that	_	
111-5	26587-26589	in	_	
111-6	26590-26593	the	_	
111-7	26594-26602	cannabis	_	
111-8	26603-26608	users	_	
111-9	26608-26609	,	_	
111-10	26610-26615	there	_	
111-11	26616-26620	were	_	
111-12	26621-26632	significant	_	
111-13	26633-26641	positive	_	
111-14	26642-26654	correlations	_	
111-15	26655-26662	between	_	
111-16	26663-26673	in‐scanner	_	
111-17	26674-26685	cue‐induced	_	
111-18	26686-26693	craving	_	
111-19	26694-26701	ratings	_	
111-20	26702-26705	for	_	
111-21	26706-26714	cannabis	_	
111-22	26715-26719	cues	_	
111-23	26720-26721	(	_	
111-24	26721-26726	minus	_	
111-25	26727-26734	ratings	_	
111-26	26735-26741	during	_	
111-27	26742-26752	appetitive	_	
111-28	26753-26755	or	_	
111-29	26756-26763	neutral	_	
111-30	26764-26771	control	_	
111-31	26772-26776	cues	_	
111-32	26776-26777	)	_	
111-33	26778-26780	in	_	
111-34	26781-26789	amygdala	_	
111-35	26790-26793	and	_	
111-36	26794-26802	striatum	_	
111-37	26803-26804	(	_	
111-38	26804-26812	cannabis	_	
111-39	26813-26814	>	_	
111-40	26815-26822	neutral	_	
111-41	26822-26823	)	_	
111-42	26823-26824	,	_	
111-43	26825-26832	frontal	_	
111-44	26833-26836	and	_	
111-45	26837-26843	insula	_	
111-46	26844-26851	regions	_	
111-47	26852-26853	(	_	
111-48	26853-26858	fruit	_	
111-49	26859-26860	>	_	
111-50	26861-26869	cannabis	_	
111-51	26869-26870	)	_	
111-52	26871-26874	and	_	
111-53	26875-26882	regions	_	
111-54	26883-26885	in	_	
111-55	26886-26893	frontal	_	
111-56	26893-26894	,	_	
111-57	26895-26903	temporal	_	
111-58	26903-26904	,	_	
111-59	26905-26913	striatum	_	
111-60	26913-26914	,	_	
111-61	26915-26918	and	_	
111-62	26919-26925	insula	_	
111-63	26926-26927	(	_	
111-64	26927-26944	cluster‐threshold	_	
111-65	26945-26946	z	_	
111-66	26947-26948	=	_	
111-67	26949-26952	2.3	_	
111-68	26952-26953	,	_	
111-69	26954-26955	P	_	
111-70	26956-26957	<	_	
111-71	26958-26962	0.05	_	
111-72	26963-26976	FWE‐corrected	_	
111-73	26976-26977	)	_	
111-74	26978-26979	(	_	
111-75	26979-26984	Table	_	
111-76	26985-26986	4	_	
111-77	26986-26987	)	_	
111-78	26987-26988	.	_	

#Text=MCQ scores was positively correlated with response to cannabis cues (vs. fruit cue) in the right superior temporal gyrus, pre/post central gyrus and insula (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected) (Table 5) and with response to cannabis cues (vs. neutral cue) in the right superior temporal gyrus, postcentral gyrus and insula (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected) (See Supporting Information).
112-1	26989-26992	MCQ	_	
112-2	26993-26999	scores	_	
112-3	27000-27003	was	_	
112-4	27004-27014	positively	_	
112-5	27015-27025	correlated	_	
112-6	27026-27030	with	_	
112-7	27031-27039	response	_	
112-8	27040-27042	to	_	
112-9	27043-27051	cannabis	_	
112-10	27052-27056	cues	_	
112-11	27057-27058	(	_	
112-12	27058-27060	vs	_	
112-13	27060-27061	.	_	
112-14	27062-27067	fruit	_	
112-15	27068-27071	cue	_	
112-16	27071-27072	)	_	
112-17	27073-27075	in	_	
112-18	27076-27079	the	_	
112-19	27080-27085	right	_	
112-20	27086-27094	superior	_	
112-21	27095-27103	temporal	_	
112-22	27104-27109	gyrus	_	
112-23	27109-27110	,	_	
112-24	27111-27114	pre	_	
112-25	27114-27115	/	_	
112-26	27115-27119	post	_	
112-27	27120-27127	central	_	
112-28	27128-27133	gyrus	_	
112-29	27134-27137	and	_	
112-30	27138-27144	insula	_	
112-31	27145-27146	(	_	
112-32	27146-27163	cluster‐threshold	_	
112-33	27164-27165	z	_	
112-34	27166-27167	=	_	
112-35	27168-27171	2.3	_	
112-36	27171-27172	,	_	
112-37	27173-27174	P	_	
112-38	27175-27176	<	_	
112-39	27177-27181	0.05	_	
112-40	27182-27195	FWE‐corrected	_	
112-41	27195-27196	)	_	
112-42	27197-27198	(	_	
112-43	27198-27203	Table	_	
112-44	27204-27205	5	_	
112-45	27205-27206	)	_	
112-46	27207-27210	and	_	
112-47	27211-27215	with	_	
112-48	27216-27224	response	_	
112-49	27225-27227	to	_	
112-50	27228-27236	cannabis	_	
112-51	27237-27241	cues	_	
112-52	27242-27243	(	_	
112-53	27243-27245	vs	_	
112-54	27245-27246	.	_	
112-55	27247-27254	neutral	_	
112-56	27255-27258	cue	_	
112-57	27258-27259	)	_	
112-58	27260-27262	in	_	
112-59	27263-27266	the	_	
112-60	27267-27272	right	_	
112-61	27273-27281	superior	_	
112-62	27282-27290	temporal	_	
112-63	27291-27296	gyrus	_	
112-64	27296-27297	,	_	
112-65	27298-27309	postcentral	_	
112-66	27310-27315	gyrus	_	
112-67	27316-27319	and	_	
112-68	27320-27326	insula	_	
112-69	27327-27328	(	_	
112-70	27328-27345	cluster‐threshold	_	
112-71	27346-27347	z	_	
112-72	27348-27349	=	_	
112-73	27350-27353	2.3	_	
112-74	27353-27354	,	_	
112-75	27355-27356	P	_	
112-76	27357-27358	<	_	
112-77	27359-27363	0.05	_	
112-78	27364-27377	FWE‐corrected	_	
112-79	27377-27378	)	_	
112-80	27379-27380	(	_	
112-81	27380-27383	See	_	
112-82	27384-27394	Supporting	_	
112-83	27395-27406	Information	_	
112-84	27406-27407	)	_	
112-85	27407-27408	.	_	

#Text=Relationship between subjective and neural response to cannabis cues
#Text=# Voxels\tPeak Z\tx\ty\tz\tLocalization\tBA\t \t(a) Cannabis > pencil\t \tz = 2.3\t \t12195\t4.56\t18\t−6\t−14\tR Amygdala\t—\t \t4.41\t−16\t−16\t22\tL Caudate Body\t—\t \t4.41\t16\t−4\t6\tR Lateral Globus Pallidus\t—\t \t4.41\t−10\t−18\t26\tL Caudate Body\t—\t \t4.41\t−16\t8\t−20\tL Inferior Frontal Gyrus\t47\t \t4.29\t−14\t−14\t4\tL Ventral Lateral Nucleus\t—\t \t1312\t3.84\t6\t−62\t−36\tR Inferior Semi‐Lunar Lobule\t—\t \t3.68\t−32\t−54\t−36\tL Cerebellar Tonsil\t—\t \t3.57\t−26\t−64\t−28\tL Pyramis\t—\t \t3.56\t−28\t−68\t−28\tL Pyramis\t—\t \t3.45\t−20\t−68\t−28\tL Pyramis\t—\t \t3.36\t−22\t−74\t−26\tL Uvula\t—\t \tz = 3.2\t \t10888\t5.49\t14\t0\t−16\tR Parahippocampal Gyrus\t—\t \t5.48\t4\t−22\t2\tR Thalamus\t50\t \t5.48\t6\t−6\t2\tR Thalamus\t50\t \t5.16\t2\t−38\t26\tR Posterior Cingulate Gyrus\t23\t \t2366\t4.36\t−4\t46\t4\tL Anterior Cingulate Gyrus\t32\t \t4.32\t−6\t50\t10\tL Medial Frontal Gyrus\t10\t \t886\t4.58\t34\t−76\t−28\tR Cerebellum: Tuber\t—\t \t4.54\t34\t−54\t−34\tR Cerebellar Tonsil\t—\t \t4.29\t32\t−46\t−30\tR Cerebellum: Anterior Lobe\t—\t \t4.05\t44\t−74\t−32\tR Cerebellum: Pyramis\t—\t \t3.99\t42\t−62\t−38\tR Cerebellum: Inferior Semi‐Lunar Lobule\t—\t \t3.92\t48\t−70\t−28\tR Cerebellum: Tuber\t—\t \t226\t4.41\t34\t26\t−20\tOrbital Frontal Cortex\t47\t \t4.36\t48\t26\t−16\tOrbital Frontal Cortex\t47\t \t3.86\t52\t18\t−10\tR Inferior Frontal Gyrus\t47\t \t3.73\t48\t16\t−14\tR Superior Temporal Gyrus\t38\t \t3.54\t56\t14\t−6\tR Superior Temporal Gyrus\t38\t \t(b) Fruit > cannabis\t \tz = 2.3\t \t1771\t3.9\t−6\t54\t−14\tL Medial Frontal Gyrus\t11\t \t3.88\t8\t58\t16\tR Medial Frontal Gyrus\t10\t \t3.7\t8\t52\t−6\tR Medial Frontal Gyrus\t10\t \t3.68\t10\t56\t−12\tR Superior Frontal Gyrus\t10\t \t3.38\t−2\t38\t−8\tL Anterior Cingulate Gyrus\t32\t \t3.32\t−8\t50\t10\tL Medial Frontal Gyrus\t10\t \t821\t3.66\t26\t30\t26\tR Middle Frontal Gyrus\t9\t \t3.66\t20\t14\t34\tR Cingulate Gyrus\t32\t \t3.12\t28\t26\t8\tR Insula\t13\t \t3.08\t32\t26\t12\tR Insula\t13\t \t2.93\t34\t14\t8\tR Insula\t13\t \tz = 3.2\t \t395\t4.54\t12\t−94\t20\tR Cuneus\t18\t \t3.88\t2\t−82\t18\tR Cuneus\t18\t \t3.61\t−10\t−90\t12\tL Cuneus\t17\t \t3.55\t−8\t−78\t20\tL Cuneus\t18\t \t(c) Pencil > fruit\t \tz = 2.3\t \t1136\t3.85\t46\t−60\t26\tR Middle Temporal Gyrus\t39\t \t3.78\t54\t−48\t18\tR Supramarginal Gyrus\t40\t \t3.76\t56\t−58\t26\tR Superior Temporal Gyrus\t39\t \t3.73\t46\t−66\t34\tR Angular Gyrus\t39\t \t3.38\t50\t−48\t26\tR Supramarginal Gyrus\t40\t \t3.33\t60\t−46\t36\tR Supramarginal Gyrus\t40\t \t1074\t4.6\t10\t18\t64\tR Superior Frontal Gyrus\t6\t \t3.83\t4\t8\t64\tR Superior Frontal Gyrus\t6\t \t3.82\t0\t12\t64\tL Superior Frontal Gyrus\t6\t \t3.62\t4\t18\t54\tR Superior Frontal Gyrus\t6\t \t3.29\t8\t30\t28\tR Mid‐cingulate Gyrus\t32\t \t3.22\t−2\t16\t46\tL Medial Frontal Gyrus\t6\t \t891\t3.56\t40\t−14\t18\tR Insula\t13\t \t3.47\t44\t−24\t10\tR Transverse Temporal Gyrus\t41\t \t3.47\t40\t−20\t8\tR Insula\t13\t \t3.36\t32\t−28\t−2\tR Caudate\t—\t \t3.33\t40\t−16\t4\tR Insula\t13\t \t3.29\t30\t−32\t0\tR Hippocampus\t—\t \tz = 3.2\t \t4864\t5.87\t24\t−60\t−26\tR Cerebellum: Culmen\t—\t \t5.42\t−32\t−64\t−28\tL Cerebellum: Tuber\t—\t \t5.23\t−14\t−48\t−20\tL Cerebellum: Dentate\t—\t \t4.91\t10\t−64\t−20\tR Cerebellum: Declive\t—\t \t4.75\t34\t−46\t−30\tR Cerebellum: Culmen\t—\t \t
#Text=Loci of significant correlations in the cannabis users between in‐scanner net cannabis craving score (urge ratings during cannabis cues minus urge ratings during respective control cues for the different contrasts at a z‐value threshold of 2.3 and GRF cluster‐corrected P‐value of exceeding 0.05.
113-1	27409-27421	Relationship	_	
113-2	27422-27429	between	_	
113-3	27430-27440	subjective	_	
113-4	27441-27444	and	_	
113-5	27445-27451	neural	_	
113-6	27452-27460	response	_	
113-7	27461-27463	to	_	
113-8	27464-27472	cannabis	_	
113-9	27473-27477	cues	_	
113-10	27478-27479	#	_	
113-11	27480-27486	Voxels	_	
113-12	27487-27491	Peak	_	
113-13	27492-27493	Z	_	
113-14	27494-27495	x	_	
113-15	27496-27497	y	_	
113-16	27498-27499	z	_	
113-17	27500-27512	Localization	_	
113-18	27513-27515	BA	_	
113-19	27518-27519	(	_	
113-20	27519-27520	a	_	
113-21	27520-27521	)	_	
113-22	27522-27530	Cannabis	_	
113-23	27531-27532	>	_	
113-24	27533-27539	pencil	_	
113-25	27542-27543	z	_	
113-26	27544-27545	=	_	
113-27	27546-27549	2.3	_	
113-28	27552-27557	12195	_	
113-29	27558-27562	4.56	_	
113-30	27563-27565	18	_	
113-31	27566-27567	−	_	
113-32	27567-27568	6	_	
113-33	27569-27570	−	_	
113-34	27570-27572	14	_	
113-35	27573-27574	R	_	
113-36	27575-27583	Amygdala	_	
113-37	27584-27585	—	_	
113-38	27588-27592	4.41	_	
113-39	27593-27594	−	_	
113-40	27594-27596	16	_	
113-41	27597-27598	−	_	
113-42	27598-27600	16	_	
113-43	27601-27603	22	_	
113-44	27604-27605	L	_	
113-45	27606-27613	Caudate	_	
113-46	27614-27618	Body	_	
113-47	27619-27620	—	_	
113-48	27623-27627	4.41	_	
113-49	27628-27630	16	_	
113-50	27631-27632	−	_	
113-51	27632-27633	4	_	
113-52	27634-27635	6	_	
113-53	27636-27637	R	_	
113-54	27638-27645	Lateral	_	
113-55	27646-27652	Globus	_	
113-56	27653-27661	Pallidus	_	
113-57	27662-27663	—	_	
113-58	27666-27670	4.41	_	
113-59	27671-27672	−	_	
113-60	27672-27674	10	_	
113-61	27675-27676	−	_	
113-62	27676-27678	18	_	
113-63	27679-27681	26	_	
113-64	27682-27683	L	_	
113-65	27684-27691	Caudate	_	
113-66	27692-27696	Body	_	
113-67	27697-27698	—	_	
113-68	27701-27705	4.41	_	
113-69	27706-27707	−	_	
113-70	27707-27709	16	_	
113-71	27710-27711	8	_	
113-72	27712-27713	−	_	
113-73	27713-27715	20	_	
113-74	27716-27717	L	_	
113-75	27718-27726	Inferior	_	
113-76	27727-27734	Frontal	_	
113-77	27735-27740	Gyrus	_	
113-78	27741-27743	47	_	
113-79	27746-27750	4.29	_	
113-80	27751-27752	−	_	
113-81	27752-27754	14	_	
113-82	27755-27756	−	_	
113-83	27756-27758	14	_	
113-84	27759-27760	4	_	
113-85	27761-27762	L	_	
113-86	27763-27770	Ventral	_	
113-87	27771-27778	Lateral	_	
113-88	27779-27786	Nucleus	_	
113-89	27787-27788	—	_	
113-90	27791-27795	1312	_	
113-91	27796-27800	3.84	_	
113-92	27801-27802	6	_	
113-93	27803-27804	−	_	
113-94	27804-27806	62	_	
113-95	27807-27808	−	_	
113-96	27808-27810	36	_	
113-97	27811-27812	R	_	
113-98	27813-27821	Inferior	_	
113-99	27822-27832	Semi‐Lunar	_	
113-100	27833-27839	Lobule	_	
113-101	27840-27841	—	_	
113-102	27844-27848	3.68	_	
113-103	27849-27850	−	_	
113-104	27850-27852	32	_	
113-105	27853-27854	−	_	
113-106	27854-27856	54	_	
113-107	27857-27858	−	_	
113-108	27858-27860	36	_	
113-109	27861-27862	L	_	
113-110	27863-27873	Cerebellar	_	
113-111	27874-27880	Tonsil	_	
113-112	27881-27882	—	_	
113-113	27885-27889	3.57	_	
113-114	27890-27891	−	_	
113-115	27891-27893	26	_	
113-116	27894-27895	−	_	
113-117	27895-27897	64	_	
113-118	27898-27899	−	_	
113-119	27899-27901	28	_	
113-120	27902-27903	L	_	
113-121	27904-27911	Pyramis	_	
113-122	27912-27913	—	_	
113-123	27916-27920	3.56	_	
113-124	27921-27922	−	_	
113-125	27922-27924	28	_	
113-126	27925-27926	−	_	
113-127	27926-27928	68	_	
113-128	27929-27930	−	_	
113-129	27930-27932	28	_	
113-130	27933-27934	L	_	
113-131	27935-27942	Pyramis	_	
113-132	27943-27944	—	_	
113-133	27947-27951	3.45	_	
113-134	27952-27953	−	_	
113-135	27953-27955	20	_	
113-136	27956-27957	−	_	
113-137	27957-27959	68	_	
113-138	27960-27961	−	_	
113-139	27961-27963	28	_	
113-140	27964-27965	L	_	
113-141	27966-27973	Pyramis	_	
113-142	27974-27975	—	_	
113-143	27978-27982	3.36	_	
113-144	27983-27984	−	_	
113-145	27984-27986	22	_	
113-146	27987-27988	−	_	
113-147	27988-27990	74	_	
113-148	27991-27992	−	_	
113-149	27992-27994	26	_	
113-150	27995-27996	L	_	
113-151	27997-28002	Uvula	_	
113-152	28003-28004	—	_	
113-153	28007-28008	z	_	
113-154	28009-28010	=	_	
113-155	28011-28014	3.2	_	
113-156	28017-28022	10888	_	
113-157	28023-28027	5.49	_	
113-158	28028-28030	14	_	
113-159	28031-28032	0	_	
113-160	28033-28034	−	_	
113-161	28034-28036	16	_	
113-162	28037-28038	R	_	
113-163	28039-28054	Parahippocampal	_	
113-164	28055-28060	Gyrus	_	
113-165	28061-28062	—	_	
113-166	28065-28069	5.48	_	
113-167	28070-28071	4	_	
113-168	28072-28073	−	_	
113-169	28073-28075	22	_	
113-170	28076-28077	2	_	
113-171	28078-28079	R	_	
113-172	28080-28088	Thalamus	_	
113-173	28089-28091	50	_	
113-174	28094-28098	5.48	_	
113-175	28099-28100	6	_	
113-176	28101-28102	−	_	
113-177	28102-28103	6	_	
113-178	28104-28105	2	_	
113-179	28106-28107	R	_	
113-180	28108-28116	Thalamus	_	
113-181	28117-28119	50	_	
113-182	28122-28126	5.16	_	
113-183	28127-28128	2	_	
113-184	28129-28130	−	_	
113-185	28130-28132	38	_	
113-186	28133-28135	26	_	
113-187	28136-28137	R	_	
113-188	28138-28147	Posterior	_	
113-189	28148-28157	Cingulate	_	
113-190	28158-28163	Gyrus	_	
113-191	28164-28166	23	_	
113-192	28169-28173	2366	_	
113-193	28174-28178	4.36	_	
113-194	28179-28180	−	_	
113-195	28180-28181	4	_	
113-196	28182-28184	46	_	
113-197	28185-28186	4	_	
113-198	28187-28188	L	_	
113-199	28189-28197	Anterior	_	
113-200	28198-28207	Cingulate	_	
113-201	28208-28213	Gyrus	_	
113-202	28214-28216	32	_	
113-203	28219-28223	4.32	_	
113-204	28224-28225	−	_	
113-205	28225-28226	6	_	
113-206	28227-28229	50	_	
113-207	28230-28232	10	_	
113-208	28233-28234	L	_	
113-209	28235-28241	Medial	_	
113-210	28242-28249	Frontal	_	
113-211	28250-28255	Gyrus	_	
113-212	28256-28258	10	_	
113-213	28261-28264	886	_	
113-214	28265-28269	4.58	_	
113-215	28270-28272	34	_	
113-216	28273-28274	−	_	
113-217	28274-28276	76	_	
113-218	28277-28278	−	_	
113-219	28278-28280	28	_	
113-220	28281-28282	R	_	
113-221	28283-28293	Cerebellum	_	
113-222	28293-28294	:	_	
113-223	28295-28300	Tuber	_	
113-224	28301-28302	—	_	
113-225	28305-28309	4.54	_	
113-226	28310-28312	34	_	
113-227	28313-28314	−	_	
113-228	28314-28316	54	_	
113-229	28317-28318	−	_	
113-230	28318-28320	34	_	
113-231	28321-28322	R	_	
113-232	28323-28333	Cerebellar	_	
113-233	28334-28340	Tonsil	_	
113-234	28341-28342	—	_	
113-235	28345-28349	4.29	_	
113-236	28350-28352	32	_	
113-237	28353-28354	−	_	
113-238	28354-28356	46	_	
113-239	28357-28358	−	_	
113-240	28358-28360	30	_	
113-241	28361-28362	R	_	
113-242	28363-28373	Cerebellum	_	
113-243	28373-28374	:	_	
113-244	28375-28383	Anterior	_	
113-245	28384-28388	Lobe	_	
113-246	28389-28390	—	_	
113-247	28393-28397	4.05	_	
113-248	28398-28400	44	_	
113-249	28401-28402	−	_	
113-250	28402-28404	74	_	
113-251	28405-28406	−	_	
113-252	28406-28408	32	_	
113-253	28409-28410	R	_	
113-254	28411-28421	Cerebellum	_	
113-255	28421-28422	:	_	
113-256	28423-28430	Pyramis	_	
113-257	28431-28432	—	_	
113-258	28435-28439	3.99	_	
113-259	28440-28442	42	_	
113-260	28443-28444	−	_	
113-261	28444-28446	62	_	
113-262	28447-28448	−	_	
113-263	28448-28450	38	_	
113-264	28451-28452	R	_	
113-265	28453-28463	Cerebellum	_	
113-266	28463-28464	:	_	
113-267	28465-28473	Inferior	_	
113-268	28474-28484	Semi‐Lunar	_	
113-269	28485-28491	Lobule	_	
113-270	28492-28493	—	_	
113-271	28496-28500	3.92	_	
113-272	28501-28503	48	_	
113-273	28504-28505	−	_	
113-274	28505-28507	70	_	
113-275	28508-28509	−	_	
113-276	28509-28511	28	_	
113-277	28512-28513	R	_	
113-278	28514-28524	Cerebellum	_	
113-279	28524-28525	:	_	
113-280	28526-28531	Tuber	_	
113-281	28532-28533	—	_	
113-282	28536-28539	226	_	
113-283	28540-28544	4.41	_	
113-284	28545-28547	34	_	
113-285	28548-28550	26	_	
113-286	28551-28552	−	_	
113-287	28552-28554	20	_	
113-288	28555-28562	Orbital	_	
113-289	28563-28570	Frontal	_	
113-290	28571-28577	Cortex	_	
113-291	28578-28580	47	_	
113-292	28583-28587	4.36	_	
113-293	28588-28590	48	_	
113-294	28591-28593	26	_	
113-295	28594-28595	−	_	
113-296	28595-28597	16	_	
113-297	28598-28605	Orbital	_	
113-298	28606-28613	Frontal	_	
113-299	28614-28620	Cortex	_	
113-300	28621-28623	47	_	
113-301	28626-28630	3.86	_	
113-302	28631-28633	52	_	
113-303	28634-28636	18	_	
113-304	28637-28638	−	_	
113-305	28638-28640	10	_	
113-306	28641-28642	R	_	
113-307	28643-28651	Inferior	_	
113-308	28652-28659	Frontal	_	
113-309	28660-28665	Gyrus	_	
113-310	28666-28668	47	_	
113-311	28671-28675	3.73	_	
113-312	28676-28678	48	_	
113-313	28679-28681	16	_	
113-314	28682-28683	−	_	
113-315	28683-28685	14	_	
113-316	28686-28687	R	_	
113-317	28688-28696	Superior	_	
113-318	28697-28705	Temporal	_	
113-319	28706-28711	Gyrus	_	
113-320	28712-28714	38	_	
113-321	28717-28721	3.54	_	
113-322	28722-28724	56	_	
113-323	28725-28727	14	_	
113-324	28728-28729	−	_	
113-325	28729-28730	6	_	
113-326	28731-28732	R	_	
113-327	28733-28741	Superior	_	
113-328	28742-28750	Temporal	_	
113-329	28751-28756	Gyrus	_	
113-330	28757-28759	38	_	
113-331	28762-28763	(	_	
113-332	28763-28764	b	_	
113-333	28764-28765	)	_	
113-334	28766-28771	Fruit	_	
113-335	28772-28773	>	_	
113-336	28774-28782	cannabis	_	
113-337	28785-28786	z	_	
113-338	28787-28788	=	_	
113-339	28789-28792	2.3	_	
113-340	28795-28799	1771	_	
113-341	28800-28803	3.9	_	
113-342	28804-28805	−	_	
113-343	28805-28806	6	_	
113-344	28807-28809	54	_	
113-345	28810-28811	−	_	
113-346	28811-28813	14	_	
113-347	28814-28815	L	_	
113-348	28816-28822	Medial	_	
113-349	28823-28830	Frontal	_	
113-350	28831-28836	Gyrus	_	
113-351	28837-28839	11	_	
113-352	28842-28846	3.88	_	
113-353	28847-28848	8	_	
113-354	28849-28851	58	_	
113-355	28852-28854	16	_	
113-356	28855-28856	R	_	
113-357	28857-28863	Medial	_	
113-358	28864-28871	Frontal	_	
113-359	28872-28877	Gyrus	_	
113-360	28878-28880	10	_	
113-361	28883-28886	3.7	_	
113-362	28887-28888	8	_	
113-363	28889-28891	52	_	
113-364	28892-28893	−	_	
113-365	28893-28894	6	_	
113-366	28895-28896	R	_	
113-367	28897-28903	Medial	_	
113-368	28904-28911	Frontal	_	
113-369	28912-28917	Gyrus	_	
113-370	28918-28920	10	_	
113-371	28923-28927	3.68	_	
113-372	28928-28930	10	_	
113-373	28931-28933	56	_	
113-374	28934-28935	−	_	
113-375	28935-28937	12	_	
113-376	28938-28939	R	_	
113-377	28940-28948	Superior	_	
113-378	28949-28956	Frontal	_	
113-379	28957-28962	Gyrus	_	
113-380	28963-28965	10	_	
113-381	28968-28972	3.38	_	
113-382	28973-28974	−	_	
113-383	28974-28975	2	_	
113-384	28976-28978	38	_	
113-385	28979-28980	−	_	
113-386	28980-28981	8	_	
113-387	28982-28983	L	_	
113-388	28984-28992	Anterior	_	
113-389	28993-29002	Cingulate	_	
113-390	29003-29008	Gyrus	_	
113-391	29009-29011	32	_	
113-392	29014-29018	3.32	_	
113-393	29019-29020	−	_	
113-394	29020-29021	8	_	
113-395	29022-29024	50	_	
113-396	29025-29027	10	_	
113-397	29028-29029	L	_	
113-398	29030-29036	Medial	_	
113-399	29037-29044	Frontal	_	
113-400	29045-29050	Gyrus	_	
113-401	29051-29053	10	_	
113-402	29056-29059	821	_	
113-403	29060-29064	3.66	_	
113-404	29065-29067	26	_	
113-405	29068-29070	30	_	
113-406	29071-29073	26	_	
113-407	29074-29075	R	_	
113-408	29076-29082	Middle	_	
113-409	29083-29090	Frontal	_	
113-410	29091-29096	Gyrus	_	
113-411	29097-29098	9	_	
113-412	29101-29105	3.66	_	
113-413	29106-29108	20	_	
113-414	29109-29111	14	_	
113-415	29112-29114	34	_	
113-416	29115-29116	R	_	
113-417	29117-29126	Cingulate	_	
113-418	29127-29132	Gyrus	_	
113-419	29133-29135	32	_	
113-420	29138-29142	3.12	_	
113-421	29143-29145	28	_	
113-422	29146-29148	26	_	
113-423	29149-29150	8	_	
113-424	29151-29152	R	_	
113-425	29153-29159	Insula	_	
113-426	29160-29162	13	_	
113-427	29165-29169	3.08	_	
113-428	29170-29172	32	_	
113-429	29173-29175	26	_	
113-430	29176-29178	12	_	
113-431	29179-29180	R	_	
113-432	29181-29187	Insula	_	
113-433	29188-29190	13	_	
113-434	29193-29197	2.93	_	
113-435	29198-29200	34	_	
113-436	29201-29203	14	_	
113-437	29204-29205	8	_	
113-438	29206-29207	R	_	
113-439	29208-29214	Insula	_	
113-440	29215-29217	13	_	
113-441	29220-29221	z	_	
113-442	29222-29223	=	_	
113-443	29224-29227	3.2	_	
113-444	29230-29233	395	_	
113-445	29234-29238	4.54	_	
113-446	29239-29241	12	_	
113-447	29242-29243	−	_	
113-448	29243-29245	94	_	
113-449	29246-29248	20	_	
113-450	29249-29250	R	_	
113-451	29251-29257	Cuneus	_	
113-452	29258-29260	18	_	
113-453	29263-29267	3.88	_	
113-454	29268-29269	2	_	
113-455	29270-29271	−	_	
113-456	29271-29273	82	_	
113-457	29274-29276	18	_	
113-458	29277-29278	R	_	
113-459	29279-29285	Cuneus	_	
113-460	29286-29288	18	_	
113-461	29291-29295	3.61	_	
113-462	29296-29297	−	_	
113-463	29297-29299	10	_	
113-464	29300-29301	−	_	
113-465	29301-29303	90	_	
113-466	29304-29306	12	_	
113-467	29307-29308	L	_	
113-468	29309-29315	Cuneus	_	
113-469	29316-29318	17	_	
113-470	29321-29325	3.55	_	
113-471	29326-29327	−	_	
113-472	29327-29328	8	_	
113-473	29329-29330	−	_	
113-474	29330-29332	78	_	
113-475	29333-29335	20	_	
113-476	29336-29337	L	_	
113-477	29338-29344	Cuneus	_	
113-478	29345-29347	18	_	
113-479	29350-29351	(	_	
113-480	29351-29352	c	_	
113-481	29352-29353	)	_	
113-482	29354-29360	Pencil	_	
113-483	29361-29362	>	_	
113-484	29363-29368	fruit	_	
113-485	29371-29372	z	_	
113-486	29373-29374	=	_	
113-487	29375-29378	2.3	_	
113-488	29381-29385	1136	_	
113-489	29386-29390	3.85	_	
113-490	29391-29393	46	_	
113-491	29394-29395	−	_	
113-492	29395-29397	60	_	
113-493	29398-29400	26	_	
113-494	29401-29402	R	_	
113-495	29403-29409	Middle	_	
113-496	29410-29418	Temporal	_	
113-497	29419-29424	Gyrus	_	
113-498	29425-29427	39	_	
113-499	29430-29434	3.78	_	
113-500	29435-29437	54	_	
113-501	29438-29439	−	_	
113-502	29439-29441	48	_	
113-503	29442-29444	18	_	
113-504	29445-29446	R	_	
113-505	29447-29460	Supramarginal	_	
113-506	29461-29466	Gyrus	_	
113-507	29467-29469	40	_	
113-508	29472-29476	3.76	_	
113-509	29477-29479	56	_	
113-510	29480-29481	−	_	
113-511	29481-29483	58	_	
113-512	29484-29486	26	_	
113-513	29487-29488	R	_	
113-514	29489-29497	Superior	_	
113-515	29498-29506	Temporal	_	
113-516	29507-29512	Gyrus	_	
113-517	29513-29515	39	_	
113-518	29518-29522	3.73	_	
113-519	29523-29525	46	_	
113-520	29526-29527	−	_	
113-521	29527-29529	66	_	
113-522	29530-29532	34	_	
113-523	29533-29534	R	_	
113-524	29535-29542	Angular	_	
113-525	29543-29548	Gyrus	_	
113-526	29549-29551	39	_	
113-527	29554-29558	3.38	_	
113-528	29559-29561	50	_	
113-529	29562-29563	−	_	
113-530	29563-29565	48	_	
113-531	29566-29568	26	_	
113-532	29569-29570	R	_	
113-533	29571-29584	Supramarginal	_	
113-534	29585-29590	Gyrus	_	
113-535	29591-29593	40	_	
113-536	29596-29600	3.33	_	
113-537	29601-29603	60	_	
113-538	29604-29605	−	_	
113-539	29605-29607	46	_	
113-540	29608-29610	36	_	
113-541	29611-29612	R	_	
113-542	29613-29626	Supramarginal	_	
113-543	29627-29632	Gyrus	_	
113-544	29633-29635	40	_	
113-545	29638-29642	1074	_	
113-546	29643-29646	4.6	_	
113-547	29647-29649	10	_	
113-548	29650-29652	18	_	
113-549	29653-29655	64	_	
113-550	29656-29657	R	_	
113-551	29658-29666	Superior	_	
113-552	29667-29674	Frontal	_	
113-553	29675-29680	Gyrus	_	
113-554	29681-29682	6	_	
113-555	29685-29689	3.83	_	
113-556	29690-29691	4	_	
113-557	29692-29693	8	_	
113-558	29694-29696	64	_	
113-559	29697-29698	R	_	
113-560	29699-29707	Superior	_	
113-561	29708-29715	Frontal	_	
113-562	29716-29721	Gyrus	_	
113-563	29722-29723	6	_	
113-564	29726-29730	3.82	_	
113-565	29731-29732	0	_	
113-566	29733-29735	12	_	
113-567	29736-29738	64	_	
113-568	29739-29740	L	_	
113-569	29741-29749	Superior	_	
113-570	29750-29757	Frontal	_	
113-571	29758-29763	Gyrus	_	
113-572	29764-29765	6	_	
113-573	29768-29772	3.62	_	
113-574	29773-29774	4	_	
113-575	29775-29777	18	_	
113-576	29778-29780	54	_	
113-577	29781-29782	R	_	
113-578	29783-29791	Superior	_	
113-579	29792-29799	Frontal	_	
113-580	29800-29805	Gyrus	_	
113-581	29806-29807	6	_	
113-582	29810-29814	3.29	_	
113-583	29815-29816	8	_	
113-584	29817-29819	30	_	
113-585	29820-29822	28	_	
113-586	29823-29824	R	_	
113-587	29825-29838	Mid‐cingulate	_	
113-588	29839-29844	Gyrus	_	
113-589	29845-29847	32	_	
113-590	29850-29854	3.22	_	
113-591	29855-29856	−	_	
113-592	29856-29857	2	_	
113-593	29858-29860	16	_	
113-594	29861-29863	46	_	
113-595	29864-29865	L	_	
113-596	29866-29872	Medial	_	
113-597	29873-29880	Frontal	_	
113-598	29881-29886	Gyrus	_	
113-599	29887-29888	6	_	
113-600	29891-29894	891	_	
113-601	29895-29899	3.56	_	
113-602	29900-29902	40	_	
113-603	29903-29904	−	_	
113-604	29904-29906	14	_	
113-605	29907-29909	18	_	
113-606	29910-29911	R	_	
113-607	29912-29918	Insula	_	
113-608	29919-29921	13	_	
113-609	29924-29928	3.47	_	
113-610	29929-29931	44	_	
113-611	29932-29933	−	_	
113-612	29933-29935	24	_	
113-613	29936-29938	10	_	
113-614	29939-29940	R	_	
113-615	29941-29951	Transverse	_	
113-616	29952-29960	Temporal	_	
113-617	29961-29966	Gyrus	_	
113-618	29967-29969	41	_	
113-619	29972-29976	3.47	_	
113-620	29977-29979	40	_	
113-621	29980-29981	−	_	
113-622	29981-29983	20	_	
113-623	29984-29985	8	_	
113-624	29986-29987	R	_	
113-625	29988-29994	Insula	_	
113-626	29995-29997	13	_	
113-627	30000-30004	3.36	_	
113-628	30005-30007	32	_	
113-629	30008-30009	−	_	
113-630	30009-30011	28	_	
113-631	30012-30013	−	_	
113-632	30013-30014	2	_	
113-633	30015-30016	R	_	
113-634	30017-30024	Caudate	_	
113-635	30025-30026	—	_	
113-636	30029-30033	3.33	_	
113-637	30034-30036	40	_	
113-638	30037-30038	−	_	
113-639	30038-30040	16	_	
113-640	30041-30042	4	_	
113-641	30043-30044	R	_	
113-642	30045-30051	Insula	_	
113-643	30052-30054	13	_	
113-644	30057-30061	3.29	_	
113-645	30062-30064	30	_	
113-646	30065-30066	−	_	
113-647	30066-30068	32	_	
113-648	30069-30070	0	_	
113-649	30071-30072	R	_	
113-650	30073-30084	Hippocampus	_	
113-651	30085-30086	—	_	
113-652	30089-30090	z	_	
113-653	30091-30092	=	_	
113-654	30093-30096	3.2	_	
113-655	30099-30103	4864	_	
113-656	30104-30108	5.87	_	
113-657	30109-30111	24	_	
113-658	30112-30113	−	_	
113-659	30113-30115	60	_	
113-660	30116-30117	−	_	
113-661	30117-30119	26	_	
113-662	30120-30121	R	_	
113-663	30122-30132	Cerebellum	_	
113-664	30132-30133	:	_	
113-665	30134-30140	Culmen	_	
113-666	30141-30142	—	_	
113-667	30145-30149	5.42	_	
113-668	30150-30151	−	_	
113-669	30151-30153	32	_	
113-670	30154-30155	−	_	
113-671	30155-30157	64	_	
113-672	30158-30159	−	_	
113-673	30159-30161	28	_	
113-674	30162-30163	L	_	
113-675	30164-30174	Cerebellum	_	
113-676	30174-30175	:	_	
113-677	30176-30181	Tuber	_	
113-678	30182-30183	—	_	
113-679	30186-30190	5.23	_	
113-680	30191-30192	−	_	
113-681	30192-30194	14	_	
113-682	30195-30196	−	_	
113-683	30196-30198	48	_	
113-684	30199-30200	−	_	
113-685	30200-30202	20	_	
113-686	30203-30204	L	_	
113-687	30205-30215	Cerebellum	_	
113-688	30215-30216	:	_	
113-689	30217-30224	Dentate	_	
113-690	30225-30226	—	_	
113-691	30229-30233	4.91	_	
113-692	30234-30236	10	_	
113-693	30237-30238	−	_	
113-694	30238-30240	64	_	
113-695	30241-30242	−	_	
113-696	30242-30244	20	_	
113-697	30245-30246	R	_	
113-698	30247-30257	Cerebellum	_	
113-699	30257-30258	:	_	
113-700	30259-30266	Declive	_	
113-701	30267-30268	—	_	
113-702	30271-30275	4.75	_	
113-703	30276-30278	34	_	
113-704	30279-30280	−	_	
113-705	30280-30282	46	_	
113-706	30283-30284	−	_	
113-707	30284-30286	30	_	
113-708	30287-30288	R	_	
113-709	30289-30299	Cerebellum	_	
113-710	30299-30300	:	_	
113-711	30301-30307	Culmen	_	
113-712	30308-30309	—	_	
113-713	30313-30317	Loci	_	
113-714	30318-30320	of	_	
113-715	30321-30332	significant	_	
113-716	30333-30345	correlations	_	
113-717	30346-30348	in	_	
113-718	30349-30352	the	_	
113-719	30353-30361	cannabis	_	
113-720	30362-30367	users	_	
113-721	30368-30375	between	_	
113-722	30376-30386	in‐scanner	_	
113-723	30387-30390	net	_	
113-724	30391-30399	cannabis	_	
113-725	30400-30407	craving	_	
113-726	30408-30413	score	_	
113-727	30414-30415	(	_	
113-728	30415-30419	urge	_	
113-729	30420-30427	ratings	_	
113-730	30428-30434	during	_	
113-731	30435-30443	cannabis	_	
113-732	30444-30448	cues	_	
113-733	30449-30454	minus	_	
113-734	30455-30459	urge	_	
113-735	30460-30467	ratings	_	
113-736	30468-30474	during	_	
113-737	30475-30485	respective	_	
113-738	30486-30493	control	_	
113-739	30494-30498	cues	_	
113-740	30499-30502	for	_	
113-741	30503-30506	the	_	
113-742	30507-30516	different	_	
113-743	30517-30526	contrasts	_	
113-744	30527-30529	at	_	
113-745	30530-30531	a	_	
113-746	30532-30539	z‐value	_	
113-747	30540-30549	threshold	_	
113-748	30550-30552	of	_	
113-749	30553-30556	2.3	_	
113-750	30557-30560	and	_	
113-751	30561-30564	GRF	_	
113-752	30565-30582	cluster‐corrected	_	
113-753	30583-30590	P‐value	_	
113-754	30591-30593	of	_	
113-755	30594-30603	exceeding	_	
113-756	30604-30608	0.05	_	
113-757	30608-30609	.	_	

#Text=Cluster size in terms of number of voxels, Z values for peak voxels along with corresponding MNI coordinates, anatomical localization, and Brodmann areas are provided.
114-1	30610-30617	Cluster	_	
114-2	30618-30622	size	_	
114-3	30623-30625	in	_	
114-4	30626-30631	terms	_	
114-5	30632-30634	of	_	
114-6	30635-30641	number	_	
114-7	30642-30644	of	_	
114-8	30645-30651	voxels	_	
114-9	30651-30652	,	_	
114-10	30653-30654	Z	_	
114-11	30655-30661	values	_	
114-12	30662-30665	for	_	
114-13	30666-30670	peak	_	
114-14	30671-30677	voxels	_	
114-15	30678-30683	along	_	
114-16	30684-30688	with	_	
114-17	30689-30702	corresponding	_	
114-18	30703-30706	MNI	_	
114-19	30707-30718	coordinates	_	
114-20	30718-30719	,	_	
114-21	30720-30730	anatomical	_	
114-22	30731-30743	localization	_	
114-23	30743-30744	,	_	
114-24	30745-30748	and	_	
114-25	30749-30757	Brodmann	_	
114-26	30758-30763	areas	_	
114-27	30764-30767	are	_	
114-28	30768-30776	provided	_	
114-29	30776-30777	.	_	

#Text=Brain‐behavior correlations for cannabis cues versus fruit cues
#Text=# Voxels\tPeak Z\tx\ty\tz\tLocalization\tBA\t \t(a) MCQ: cannabis > fruit\t \tz = 2.3\t \t923\t4.71\t55.6\t−23.19\t14.76\tR Postcentral Gyrus\t40\t \t3.33\t40.43\t−28.97\t17.91\tR Insula\t13\t \t3.28\t53.67\t−32.88\t17.74\tR Superior Temporal Gyrus\t13\t \t3.19\t49.88\t−32.85\t17.72\tR Superior Temporal Gyrus\t41\t \t3.08\t57.44\t−28.04\t30.74\tR Inferior Parietal Lobule\t40\t \t3.04\t59.36\t−15.13\t37.03\tR Precentral Gyrus\t4\t \tz = 3.2\t \t332\t4.35\t12\t−94\t20\tR Cuneus\t18\t \t3.68\t2\t−84\t20\tR Cuneus\t18\t \t3.6\t−6\t−78\t18\tL Cuneus\t18\t \t3.57\t−10\t−90\t12\tL Cuneus\t17\t \t3.49\t0\t−88\t16\tL Cuneus\t18\t \t3.35\t0\t−76\t12\tL Cuneus\t17\t \t(b) MWC: Cannabis > Fruit\t \tz = 2.3\t \t1998\t4.49\t40.39\t−63.14\t−13.26\tR Fusiform Gyrus\t37\t \t4.03\t51.67\t−68.42\t8.18\tR Middle Occipital Gyrus\t19\t \t3.44\t38.36\t−76.58\t18.42\tR Middle Temporal Gyrus\t19\t \t3.42\t30.81\t−65.61\t26.33\tR Middle Temporal Gyrus\t39\t \t3.41\t42.14\t−75.07\t23.97\tR Superior Occipital Gyrus\t19\t \t1158\t3.64\t−57.83\t5.16\t3.24\tL Superior Temporal Gyrus\t22\t \t3.53\t−59.68\t7.89\t−9.26\tL Superior Temporal Gyrus\t38\t \t3.46\t−38.88\t3.8\t−7.59\tL Extra‐Nuclear Gray\t13\t \t3.28\t−46.49\t4.83\t6.91\tL Insula\t13\t \t3.22\t−44.49\t17.58\t−13.96\tL Superior Temporal Gyrus\t38\t \t3.21\t−48.42\t−6.53\t6.16\tL Precentral Gyrus\t6\t \t938\t3.75\t−40.96\t−47.49\t−9.13\tL Fusiform Gyrus\t37\t \t3.66\t−46.68\t−50.15\t3.33\tL Middle Temporal Gyrus\t37\t \t3.39\t−54.26\t−53.76\t1.24\tL Middle Temporal Gyrus\t37\t \t3.38\t−59.96\t−62.84\t−4.82\tL Inferior Temporal Gyrus\t37\t \t3.05\t−67.45\t−34.8\t4.2\tL Middle Temporal Gyrus\t22\t \t3\t−59.9\t−51.0\t−11.28\tL Inferior Temporal Gyrus\t20\t \t926\t3.65\t0.78\t5.03\t27.12\tR Mid‐Cingulate Gyrus\t24\t \t3.5\t−3.0\t8.51\t32.75\tL Mid‐Cingulate Gyrus\t24\t \t3.25\t12.08\t1.76\t36.88\tR Mid‐Cingulate Gyrus\t24\t \t3.19\t8.35\t8.41\t32.81\tR Mid‐Cingulate Gyrus\t24\t \t2.99\t19.7\t11.64\t40.33\tR Medial Frontal Gyrus\t32\t \t2.98\t0.71\t−3.59\t42.84\tR Mid‐Cingulate Gyrus\t24\t \t687\t3.49\t61.29\t−23.12\t12.99\tR Superior Temporal Gyrus\t42\t \t3.33\t57.41\t−28.62\t39.75\tR Postcentral Gyrus\t2\t \t3.06\t53.67\t−22.44\t32.9\tR Postcentral Gyrus\t2\t \t3\t57.41\t−32.06\t34.1\tR Inferior Parietal\t40\t \t2.92\t65.02\t−29.54\t23.46\tR Inferior Parietal\t40\t \t2.79\t61.02\t−26.29\t32.69\tR Inferior Parietal\t40\t \tz = 3.2\t \t429\t4.48\t16\t−90\t20\tR Cuneus\t18\t \t3.77\t2\t−84\t20\tR Cuneus\t18\t \t3.69\t−8\t−78\t20\tL Cuneus\t18\t \t3.67\t−10\t−90\t12\tL Cuneus\t17\t \t3.65\t0\t−88\t16\tL Cuneus\t18\t \t3.5\t0\t−78\t12\tL Cuneus\t17\t \t(c) THC ng/ml: cannabis > fruit\t \tz = 2.3\t \t677\t4.51\t8.11\t−77.29\t3.71\tR Lingual Gyrus\t18\t \t3.23\t6.12\t−86.36\t26.63\tR Cuneus\t19\t \t3.14\t−18.37\t−73.15\t2.01\tL Lingual Gyrus\t18\t \t2.95\t−6.98\t−65.55\t0.76\tL Lingual Gyrus\t19\t \t2.78\t−1.4\t−85.14\t8.57\tL Cuneus\t17\t \tz = 3.2\t \t338\t4.33\t12\t−92\t20\tR Cuneus\t18\t \t3.78\t2\t−84\t20\tR Cuneus\t18\t \t3.67\t0\t−88\t16\tL Cuneus\t18\t \t3.64\t−10\t−90\t12\tL Cuneus\t17\t \t3.6\t10\t−94\t10\tR Cuneus\t18\t \t3.58\t−8\t−78\t20\tL Cuneus\t18\t \t
#Text=Loci of significant correlations in the cannabis users between total scores on the (a) Marijuana Craving Questionnaire (MCQ), (b) Withdrawal Checklist (MWC), and (c) THC ng/mL (over creatinine) for the cannabis cues versus fruit cues contrast at a z‐value threshold of 2.3 and GRF cluster‐corrected P‐value of exceeding 0.05.
115-1	30778-30792	Brain‐behavior	_	
115-2	30793-30805	correlations	_	
115-3	30806-30809	for	_	
115-4	30810-30818	cannabis	_	
115-5	30819-30823	cues	_	
115-6	30824-30830	versus	_	
115-7	30831-30836	fruit	_	
115-8	30837-30841	cues	_	
115-9	30842-30843	#	_	
115-10	30844-30850	Voxels	_	
115-11	30851-30855	Peak	_	
115-12	30856-30857	Z	_	
115-13	30858-30859	x	_	
115-14	30860-30861	y	_	
115-15	30862-30863	z	_	
115-16	30864-30876	Localization	_	
115-17	30877-30879	BA	_	
115-18	30882-30883	(	_	
115-19	30883-30884	a	_	
115-20	30884-30885	)	_	
115-21	30886-30889	MCQ	_	
115-22	30889-30890	:	_	
115-23	30891-30899	cannabis	_	
115-24	30900-30901	>	_	
115-25	30902-30907	fruit	_	
115-26	30910-30911	z	_	
115-27	30912-30913	=	_	
115-28	30914-30917	2.3	_	
115-29	30920-30923	923	_	
115-30	30924-30928	4.71	_	
115-31	30929-30933	55.6	_	
115-32	30934-30935	−	_	
115-33	30935-30940	23.19	_	
115-34	30941-30946	14.76	_	
115-35	30947-30948	R	_	
115-36	30949-30960	Postcentral	_	
115-37	30961-30966	Gyrus	_	
115-38	30967-30969	40	_	
115-39	30972-30976	3.33	_	
115-40	30977-30982	40.43	_	
115-41	30983-30984	−	_	
115-42	30984-30989	28.97	_	
115-43	30990-30995	17.91	_	
115-44	30996-30997	R	_	
115-45	30998-31004	Insula	_	
115-46	31005-31007	13	_	
115-47	31010-31014	3.28	_	
115-48	31015-31020	53.67	_	
115-49	31021-31022	−	_	
115-50	31022-31027	32.88	_	
115-51	31028-31033	17.74	_	
115-52	31034-31035	R	_	
115-53	31036-31044	Superior	_	
115-54	31045-31053	Temporal	_	
115-55	31054-31059	Gyrus	_	
115-56	31060-31062	13	_	
115-57	31065-31069	3.19	_	
115-58	31070-31075	49.88	_	
115-59	31076-31077	−	_	
115-60	31077-31082	32.85	_	
115-61	31083-31088	17.72	_	
115-62	31089-31090	R	_	
115-63	31091-31099	Superior	_	
115-64	31100-31108	Temporal	_	
115-65	31109-31114	Gyrus	_	
115-66	31115-31117	41	_	
115-67	31120-31124	3.08	_	
115-68	31125-31130	57.44	_	
115-69	31131-31132	−	_	
115-70	31132-31137	28.04	_	
115-71	31138-31143	30.74	_	
115-72	31144-31145	R	_	
115-73	31146-31154	Inferior	_	
115-74	31155-31163	Parietal	_	
115-75	31164-31170	Lobule	_	
115-76	31171-31173	40	_	
115-77	31176-31180	3.04	_	
115-78	31181-31186	59.36	_	
115-79	31187-31188	−	_	
115-80	31188-31193	15.13	_	
115-81	31194-31199	37.03	_	
115-82	31200-31201	R	_	
115-83	31202-31212	Precentral	_	
115-84	31213-31218	Gyrus	_	
115-85	31219-31220	4	_	
115-86	31223-31224	z	_	
115-87	31225-31226	=	_	
115-88	31227-31230	3.2	_	
115-89	31233-31236	332	_	
115-90	31237-31241	4.35	_	
115-91	31242-31244	12	_	
115-92	31245-31246	−	_	
115-93	31246-31248	94	_	
115-94	31249-31251	20	_	
115-95	31252-31253	R	_	
115-96	31254-31260	Cuneus	_	
115-97	31261-31263	18	_	
115-98	31266-31270	3.68	_	
115-99	31271-31272	2	_	
115-100	31273-31274	−	_	
115-101	31274-31276	84	_	
115-102	31277-31279	20	_	
115-103	31280-31281	R	_	
115-104	31282-31288	Cuneus	_	
115-105	31289-31291	18	_	
115-106	31294-31297	3.6	_	
115-107	31298-31299	−	_	
115-108	31299-31300	6	_	
115-109	31301-31302	−	_	
115-110	31302-31304	78	_	
115-111	31305-31307	18	_	
115-112	31308-31309	L	_	
115-113	31310-31316	Cuneus	_	
115-114	31317-31319	18	_	
115-115	31322-31326	3.57	_	
115-116	31327-31328	−	_	
115-117	31328-31330	10	_	
115-118	31331-31332	−	_	
115-119	31332-31334	90	_	
115-120	31335-31337	12	_	
115-121	31338-31339	L	_	
115-122	31340-31346	Cuneus	_	
115-123	31347-31349	17	_	
115-124	31352-31356	3.49	_	
115-125	31357-31358	0	_	
115-126	31359-31360	−	_	
115-127	31360-31362	88	_	
115-128	31363-31365	16	_	
115-129	31366-31367	L	_	
115-130	31368-31374	Cuneus	_	
115-131	31375-31377	18	_	
115-132	31380-31384	3.35	_	
115-133	31385-31386	0	_	
115-134	31387-31388	−	_	
115-135	31388-31390	76	_	
115-136	31391-31393	12	_	
115-137	31394-31395	L	_	
115-138	31396-31402	Cuneus	_	
115-139	31403-31405	17	_	
115-140	31408-31409	(	_	
115-141	31409-31410	b	_	
115-142	31410-31411	)	_	
115-143	31412-31415	MWC	_	
115-144	31415-31416	:	_	
115-145	31417-31425	Cannabis	_	
115-146	31426-31427	>	_	
115-147	31428-31433	Fruit	_	
115-148	31436-31437	z	_	
115-149	31438-31439	=	_	
115-150	31440-31443	2.3	_	
115-151	31446-31450	1998	_	
115-152	31451-31455	4.49	_	
115-153	31456-31461	40.39	_	
115-154	31462-31463	−	_	
115-155	31463-31468	63.14	_	
115-156	31469-31470	−	_	
115-157	31470-31475	13.26	_	
115-158	31476-31477	R	_	
115-159	31478-31486	Fusiform	_	
115-160	31487-31492	Gyrus	_	
115-161	31493-31495	37	_	
115-162	31498-31502	4.03	_	
115-163	31503-31508	51.67	_	
115-164	31509-31510	−	_	
115-165	31510-31515	68.42	_	
115-166	31516-31520	8.18	_	
115-167	31521-31522	R	_	
115-168	31523-31529	Middle	_	
115-169	31530-31539	Occipital	_	
115-170	31540-31545	Gyrus	_	
115-171	31546-31548	19	_	
115-172	31551-31555	3.44	_	
115-173	31556-31561	38.36	_	
115-174	31562-31563	−	_	
115-175	31563-31568	76.58	_	
115-176	31569-31574	18.42	_	
115-177	31575-31576	R	_	
115-178	31577-31583	Middle	_	
115-179	31584-31592	Temporal	_	
115-180	31593-31598	Gyrus	_	
115-181	31599-31601	19	_	
115-182	31604-31608	3.42	_	
115-183	31609-31614	30.81	_	
115-184	31615-31616	−	_	
115-185	31616-31621	65.61	_	
115-186	31622-31627	26.33	_	
115-187	31628-31629	R	_	
115-188	31630-31636	Middle	_	
115-189	31637-31645	Temporal	_	
115-190	31646-31651	Gyrus	_	
115-191	31652-31654	39	_	
115-192	31657-31661	3.41	_	
115-193	31662-31667	42.14	_	
115-194	31668-31669	−	_	
115-195	31669-31674	75.07	_	
115-196	31675-31680	23.97	_	
115-197	31681-31682	R	_	
115-198	31683-31691	Superior	_	
115-199	31692-31701	Occipital	_	
115-200	31702-31707	Gyrus	_	
115-201	31708-31710	19	_	
115-202	31713-31717	1158	_	
115-203	31718-31722	3.64	_	
115-204	31723-31724	−	_	
115-205	31724-31729	57.83	_	
115-206	31730-31734	5.16	_	
115-207	31735-31739	3.24	_	
115-208	31740-31741	L	_	
115-209	31742-31750	Superior	_	
115-210	31751-31759	Temporal	_	
115-211	31760-31765	Gyrus	_	
115-212	31766-31768	22	_	
115-213	31771-31775	3.53	_	
115-214	31776-31777	−	_	
115-215	31777-31782	59.68	_	
115-216	31783-31787	7.89	_	
115-217	31788-31789	−	_	
115-218	31789-31793	9.26	_	
115-219	31794-31795	L	_	
115-220	31796-31804	Superior	_	
115-221	31805-31813	Temporal	_	
115-222	31814-31819	Gyrus	_	
115-223	31820-31822	38	_	
115-224	31825-31829	3.46	_	
115-225	31830-31831	−	_	
115-226	31831-31836	38.88	_	
115-227	31837-31840	3.8	_	
115-228	31841-31842	−	_	
115-229	31842-31846	7.59	_	
115-230	31847-31848	L	_	
115-231	31849-31862	Extra‐Nuclear	_	
115-232	31863-31867	Gray	_	
115-233	31868-31870	13	_	
115-234	31873-31877	3.28	_	
115-235	31878-31879	−	_	
115-236	31879-31884	46.49	_	
115-237	31885-31889	4.83	_	
115-238	31890-31894	6.91	_	
115-239	31895-31896	L	_	
115-240	31897-31903	Insula	_	
115-241	31904-31906	13	_	
115-242	31909-31913	3.22	_	
115-243	31914-31915	−	_	
115-244	31915-31920	44.49	_	
115-245	31921-31926	17.58	_	
115-246	31927-31928	−	_	
115-247	31928-31933	13.96	_	
115-248	31934-31935	L	_	
115-249	31936-31944	Superior	_	
115-250	31945-31953	Temporal	_	
115-251	31954-31959	Gyrus	_	
115-252	31960-31962	38	_	
115-253	31965-31969	3.21	_	
115-254	31970-31971	−	_	
115-255	31971-31976	48.42	_	
115-256	31977-31978	−	_	
115-257	31978-31982	6.53	_	
115-258	31983-31987	6.16	_	
115-259	31988-31989	L	_	
115-260	31990-32000	Precentral	_	
115-261	32001-32006	Gyrus	_	
115-262	32007-32008	6	_	
115-263	32011-32014	938	_	
115-264	32015-32019	3.75	_	
115-265	32020-32021	−	_	
115-266	32021-32026	40.96	_	
115-267	32027-32028	−	_	
115-268	32028-32033	47.49	_	
115-269	32034-32035	−	_	
115-270	32035-32039	9.13	_	
115-271	32040-32041	L	_	
115-272	32042-32050	Fusiform	_	
115-273	32051-32056	Gyrus	_	
115-274	32057-32059	37	_	
115-275	32062-32066	3.66	_	
115-276	32067-32068	−	_	
115-277	32068-32073	46.68	_	
115-278	32074-32075	−	_	
115-279	32075-32080	50.15	_	
115-280	32081-32085	3.33	_	
115-281	32086-32087	L	_	
115-282	32088-32094	Middle	_	
115-283	32095-32103	Temporal	_	
115-284	32104-32109	Gyrus	_	
115-285	32110-32112	37	_	
115-286	32115-32119	3.39	_	
115-287	32120-32121	−	_	
115-288	32121-32126	54.26	_	
115-289	32127-32128	−	_	
115-290	32128-32133	53.76	_	
115-291	32134-32138	1.24	_	
115-292	32139-32140	L	_	
115-293	32141-32147	Middle	_	
115-294	32148-32156	Temporal	_	
115-295	32157-32162	Gyrus	_	
115-296	32163-32165	37	_	
115-297	32168-32172	3.38	_	
115-298	32173-32174	−	_	
115-299	32174-32179	59.96	_	
115-300	32180-32181	−	_	
115-301	32181-32186	62.84	_	
115-302	32187-32188	−	_	
115-303	32188-32192	4.82	_	
115-304	32193-32194	L	_	
115-305	32195-32203	Inferior	_	
115-306	32204-32212	Temporal	_	
115-307	32213-32218	Gyrus	_	
115-308	32219-32221	37	_	
115-309	32224-32228	3.05	_	
115-310	32229-32230	−	_	
115-311	32230-32235	67.45	_	
115-312	32236-32237	−	_	
115-313	32237-32241	34.8	_	
115-314	32242-32245	4.2	_	
115-315	32246-32247	L	_	
115-316	32248-32254	Middle	_	
115-317	32255-32263	Temporal	_	
115-318	32264-32269	Gyrus	_	
115-319	32270-32272	22	_	
115-320	32275-32276	3	_	
115-321	32277-32278	−	_	
115-322	32278-32282	59.9	_	
115-323	32283-32284	−	_	
115-324	32284-32288	51.0	_	
115-325	32289-32290	−	_	
115-326	32290-32295	11.28	_	
115-327	32296-32297	L	_	
115-328	32298-32306	Inferior	_	
115-329	32307-32315	Temporal	_	
115-330	32316-32321	Gyrus	_	
115-331	32322-32324	20	_	
115-332	32327-32330	926	_	
115-333	32331-32335	3.65	_	
115-334	32336-32340	0.78	_	
115-335	32341-32345	5.03	_	
115-336	32346-32351	27.12	_	
115-337	32352-32353	R	_	
115-338	32354-32367	Mid‐Cingulate	_	
115-339	32368-32373	Gyrus	_	
115-340	32374-32376	24	_	
115-341	32379-32382	3.5	_	
115-342	32383-32384	−	_	
115-343	32384-32387	3.0	_	
115-344	32388-32392	8.51	_	
115-345	32393-32398	32.75	_	
115-346	32399-32400	L	_	
115-347	32401-32414	Mid‐Cingulate	_	
115-348	32415-32420	Gyrus	_	
115-349	32421-32423	24	_	
115-350	32426-32430	3.25	_	
115-351	32431-32436	12.08	_	
115-352	32437-32441	1.76	_	
115-353	32442-32447	36.88	_	
115-354	32448-32449	R	_	
115-355	32450-32463	Mid‐Cingulate	_	
115-356	32464-32469	Gyrus	_	
115-357	32470-32472	24	_	
115-358	32475-32479	3.19	_	
115-359	32480-32484	8.35	_	
115-360	32485-32489	8.41	_	
115-361	32490-32495	32.81	_	
115-362	32496-32497	R	_	
115-363	32498-32511	Mid‐Cingulate	_	
115-364	32512-32517	Gyrus	_	
115-365	32518-32520	24	_	
115-366	32523-32527	2.99	_	
115-367	32528-32532	19.7	_	
115-368	32533-32538	11.64	_	
115-369	32539-32544	40.33	_	
115-370	32545-32546	R	_	
115-371	32547-32553	Medial	_	
115-372	32554-32561	Frontal	_	
115-373	32562-32567	Gyrus	_	
115-374	32568-32570	32	_	
115-375	32573-32577	2.98	_	
115-376	32578-32582	0.71	_	
115-377	32583-32584	−	_	
115-378	32584-32588	3.59	_	
115-379	32589-32594	42.84	_	
115-380	32595-32596	R	_	
115-381	32597-32610	Mid‐Cingulate	_	
115-382	32611-32616	Gyrus	_	
115-383	32617-32619	24	_	
115-384	32622-32625	687	_	
115-385	32626-32630	3.49	_	
115-386	32631-32636	61.29	_	
115-387	32637-32638	−	_	
115-388	32638-32643	23.12	_	
115-389	32644-32649	12.99	_	
115-390	32650-32651	R	_	
115-391	32652-32660	Superior	_	
115-392	32661-32669	Temporal	_	
115-393	32670-32675	Gyrus	_	
115-394	32676-32678	42	_	
115-395	32681-32685	3.33	_	
115-396	32686-32691	57.41	_	
115-397	32692-32693	−	_	
115-398	32693-32698	28.62	_	
115-399	32699-32704	39.75	_	
115-400	32705-32706	R	_	
115-401	32707-32718	Postcentral	_	
115-402	32719-32724	Gyrus	_	
115-403	32725-32726	2	_	
115-404	32729-32733	3.06	_	
115-405	32734-32739	53.67	_	
115-406	32740-32741	−	_	
115-407	32741-32746	22.44	_	
115-408	32747-32751	32.9	_	
115-409	32752-32753	R	_	
115-410	32754-32765	Postcentral	_	
115-411	32766-32771	Gyrus	_	
115-412	32772-32773	2	_	
115-413	32776-32777	3	_	
115-414	32778-32783	57.41	_	
115-415	32784-32785	−	_	
115-416	32785-32790	32.06	_	
115-417	32791-32795	34.1	_	
115-418	32796-32797	R	_	
115-419	32798-32806	Inferior	_	
115-420	32807-32815	Parietal	_	
115-421	32816-32818	40	_	
115-422	32821-32825	2.92	_	
115-423	32826-32831	65.02	_	
115-424	32832-32833	−	_	
115-425	32833-32838	29.54	_	
115-426	32839-32844	23.46	_	
115-427	32845-32846	R	_	
115-428	32847-32855	Inferior	_	
115-429	32856-32864	Parietal	_	
115-430	32865-32867	40	_	
115-431	32870-32874	2.79	_	
115-432	32875-32880	61.02	_	
115-433	32881-32882	−	_	
115-434	32882-32887	26.29	_	
115-435	32888-32893	32.69	_	
115-436	32894-32895	R	_	
115-437	32896-32904	Inferior	_	
115-438	32905-32913	Parietal	_	
115-439	32914-32916	40	_	
115-440	32919-32920	z	_	
115-441	32921-32922	=	_	
115-442	32923-32926	3.2	_	
115-443	32929-32932	429	_	
115-444	32933-32937	4.48	_	
115-445	32938-32940	16	_	
115-446	32941-32942	−	_	
115-447	32942-32944	90	_	
115-448	32945-32947	20	_	
115-449	32948-32949	R	_	
115-450	32950-32956	Cuneus	_	
115-451	32957-32959	18	_	
115-452	32962-32966	3.77	_	
115-453	32967-32968	2	_	
115-454	32969-32970	−	_	
115-455	32970-32972	84	_	
115-456	32973-32975	20	_	
115-457	32976-32977	R	_	
115-458	32978-32984	Cuneus	_	
115-459	32985-32987	18	_	
115-460	32990-32994	3.69	_	
115-461	32995-32996	−	_	
115-462	32996-32997	8	_	
115-463	32998-32999	−	_	
115-464	32999-33001	78	_	
115-465	33002-33004	20	_	
115-466	33005-33006	L	_	
115-467	33007-33013	Cuneus	_	
115-468	33014-33016	18	_	
115-469	33019-33023	3.67	_	
115-470	33024-33025	−	_	
115-471	33025-33027	10	_	
115-472	33028-33029	−	_	
115-473	33029-33031	90	_	
115-474	33032-33034	12	_	
115-475	33035-33036	L	_	
115-476	33037-33043	Cuneus	_	
115-477	33044-33046	17	_	
115-478	33049-33053	3.65	_	
115-479	33054-33055	0	_	
115-480	33056-33057	−	_	
115-481	33057-33059	88	_	
115-482	33060-33062	16	_	
115-483	33063-33064	L	_	
115-484	33065-33071	Cuneus	_	
115-485	33072-33074	18	_	
115-486	33077-33080	3.5	_	
115-487	33081-33082	0	_	
115-488	33083-33084	−	_	
115-489	33084-33086	78	_	
115-490	33087-33089	12	_	
115-491	33090-33091	L	_	
115-492	33092-33098	Cuneus	_	
115-493	33099-33101	17	_	
115-494	33104-33105	(	_	
115-495	33105-33106	c	_	
115-496	33106-33107	)	_	
115-497	33108-33111	THC	_	
115-498	33112-33114	ng	_	
115-499	33114-33115	/	_	
115-500	33115-33117	ml	_	
115-501	33117-33118	:	_	
115-502	33119-33127	cannabis	_	
115-503	33128-33129	>	_	
115-504	33130-33135	fruit	_	
115-505	33138-33139	z	_	
115-506	33140-33141	=	_	
115-507	33142-33145	2.3	_	
115-508	33148-33151	677	_	
115-509	33152-33156	4.51	_	
115-510	33157-33161	8.11	_	
115-511	33162-33163	−	_	
115-512	33163-33168	77.29	_	
115-513	33169-33173	3.71	_	
115-514	33174-33175	R	_	
115-515	33176-33183	Lingual	_	
115-516	33184-33189	Gyrus	_	
115-517	33190-33192	18	_	
115-518	33195-33199	3.23	_	
115-519	33200-33204	6.12	_	
115-520	33205-33206	−	_	
115-521	33206-33211	86.36	_	
115-522	33212-33217	26.63	_	
115-523	33218-33219	R	_	
115-524	33220-33226	Cuneus	_	
115-525	33227-33229	19	_	
115-526	33232-33236	3.14	_	
115-527	33237-33238	−	_	
115-528	33238-33243	18.37	_	
115-529	33244-33245	−	_	
115-530	33245-33250	73.15	_	
115-531	33251-33255	2.01	_	
115-532	33256-33257	L	_	
115-533	33258-33265	Lingual	_	
115-534	33266-33271	Gyrus	_	
115-535	33272-33274	18	_	
115-536	33277-33281	2.95	_	
115-537	33282-33283	−	_	
115-538	33283-33287	6.98	_	
115-539	33288-33289	−	_	
115-540	33289-33294	65.55	_	
115-541	33295-33299	0.76	_	
115-542	33300-33301	L	_	
115-543	33302-33309	Lingual	_	
115-544	33310-33315	Gyrus	_	
115-545	33316-33318	19	_	
115-546	33321-33325	2.78	_	
115-547	33326-33327	−	_	
115-548	33327-33330	1.4	_	
115-549	33331-33332	−	_	
115-550	33332-33337	85.14	_	
115-551	33338-33342	8.57	_	
115-552	33343-33344	L	_	
115-553	33345-33351	Cuneus	_	
115-554	33352-33354	17	_	
115-555	33357-33358	z	_	
115-556	33359-33360	=	_	
115-557	33361-33364	3.2	_	
115-558	33367-33370	338	_	
115-559	33371-33375	4.33	_	
115-560	33376-33378	12	_	
115-561	33379-33380	−	_	
115-562	33380-33382	92	_	
115-563	33383-33385	20	_	
115-564	33386-33387	R	_	
115-565	33388-33394	Cuneus	_	
115-566	33395-33397	18	_	
115-567	33400-33404	3.78	_	
115-568	33405-33406	2	_	
115-569	33407-33408	−	_	
115-570	33408-33410	84	_	
115-571	33411-33413	20	_	
115-572	33414-33415	R	_	
115-573	33416-33422	Cuneus	_	
115-574	33423-33425	18	_	
115-575	33428-33432	3.67	_	
115-576	33433-33434	0	_	
115-577	33435-33436	−	_	
115-578	33436-33438	88	_	
115-579	33439-33441	16	_	
115-580	33442-33443	L	_	
115-581	33444-33450	Cuneus	_	
115-582	33451-33453	18	_	
115-583	33456-33460	3.64	_	
115-584	33461-33462	−	_	
115-585	33462-33464	10	_	
115-586	33465-33466	−	_	
115-587	33466-33468	90	_	
115-588	33469-33471	12	_	
115-589	33472-33473	L	_	
115-590	33474-33480	Cuneus	_	
115-591	33481-33483	17	_	
115-592	33486-33489	3.6	_	
115-593	33490-33492	10	_	
115-594	33493-33494	−	_	
115-595	33494-33496	94	_	
115-596	33497-33499	10	_	
115-597	33500-33501	R	_	
115-598	33502-33508	Cuneus	_	
115-599	33509-33511	18	_	
115-600	33514-33518	3.58	_	
115-601	33519-33520	−	_	
115-602	33520-33521	8	_	
115-603	33522-33523	−	_	
115-604	33523-33525	78	_	
115-605	33526-33528	20	_	
115-606	33529-33530	L	_	
115-607	33531-33537	Cuneus	_	
115-608	33538-33540	18	_	
115-609	33544-33548	Loci	_	
115-610	33549-33551	of	_	
115-611	33552-33563	significant	_	
115-612	33564-33576	correlations	_	
115-613	33577-33579	in	_	
115-614	33580-33583	the	_	
115-615	33584-33592	cannabis	_	
115-616	33593-33598	users	_	
115-617	33599-33606	between	_	
115-618	33607-33612	total	_	
115-619	33613-33619	scores	_	
115-620	33620-33622	on	_	
115-621	33623-33626	the	_	
115-622	33627-33628	(	_	
115-623	33628-33629	a	_	
115-624	33629-33630	)	_	
115-625	33631-33640	Marijuana	_	
115-626	33641-33648	Craving	_	
115-627	33649-33662	Questionnaire	_	
115-628	33663-33664	(	_	
115-629	33664-33667	MCQ	_	
115-630	33667-33668	)	_	
115-631	33668-33669	,	_	
115-632	33670-33671	(	_	
115-633	33671-33672	b	_	
115-634	33672-33673	)	_	
115-635	33674-33684	Withdrawal	_	
115-636	33685-33694	Checklist	_	
115-637	33695-33696	(	_	
115-638	33696-33699	MWC	_	
115-639	33699-33700	)	_	
115-640	33700-33701	,	_	
115-641	33702-33705	and	_	
115-642	33706-33707	(	_	
115-643	33707-33708	c	_	
115-644	33708-33709	)	_	
115-645	33710-33713	THC	_	
115-646	33714-33716	ng	_	
115-647	33716-33717	/	_	
115-648	33717-33719	mL	_	
115-649	33720-33721	(	_	
115-650	33721-33725	over	_	
115-651	33726-33736	creatinine	_	
115-652	33736-33737	)	_	
115-653	33738-33741	for	_	
115-654	33742-33745	the	_	
115-655	33746-33754	cannabis	_	
115-656	33755-33759	cues	_	
115-657	33760-33766	versus	_	
115-658	33767-33772	fruit	_	
115-659	33773-33777	cues	_	
115-660	33778-33786	contrast	_	
115-661	33787-33789	at	_	
115-662	33790-33791	a	_	
115-663	33792-33799	z‐value	_	
115-664	33800-33809	threshold	_	
115-665	33810-33812	of	_	
115-666	33813-33816	2.3	_	
115-667	33817-33820	and	_	
115-668	33821-33824	GRF	_	
115-669	33825-33842	cluster‐corrected	_	
115-670	33843-33850	P‐value	_	
115-671	33851-33853	of	_	
115-672	33854-33863	exceeding	_	
115-673	33864-33868	0.05	_	
115-674	33868-33869	.	_	

#Text=Cluster size in terms of number of voxels, Z values for peak voxels along with corresponding MNI coordinates, anatomical localization, and Brodmann areas are provided.
116-1	33870-33877	Cluster	_	
116-2	33878-33882	size	_	
116-3	33883-33885	in	_	
116-4	33886-33891	terms	_	
116-5	33892-33894	of	_	
116-6	33895-33901	number	_	
116-7	33902-33904	of	_	
116-8	33905-33911	voxels	_	
116-9	33911-33912	,	_	
116-10	33913-33914	Z	_	
116-11	33915-33921	values	_	
116-12	33922-33925	for	_	
116-13	33926-33930	peak	_	
116-14	33931-33937	voxels	_	
116-15	33938-33943	along	_	
116-16	33944-33948	with	_	
116-17	33949-33962	corresponding	_	
116-18	33963-33966	MNI	_	
116-19	33967-33978	coordinates	_	
116-20	33978-33979	,	_	
116-21	33980-33990	anatomical	_	
116-22	33991-34003	localization	_	
116-23	34003-34004	,	_	
116-24	34005-34008	and	_	
116-25	34009-34017	Brodmann	_	
116-26	34018-34023	areas	_	
116-27	34024-34027	are	_	
116-28	34028-34036	provided	_	
116-29	34036-34037	.	_	

#Text=Patterns of cannabis use
#Text=For the contrast of cannabis cues versus fruit cue, we found significant correlations between THC/creatinine levels and response in the bilateral lingual gyrus and cuneus (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected) (Table 5 and Fig. 2).
117-1	34038-34046	Patterns	_	
117-2	34047-34049	of	_	
117-3	34050-34058	cannabis	_	
117-4	34059-34062	use	_	
117-5	34063-34066	For	_	
117-6	34067-34070	the	_	
117-7	34071-34079	contrast	_	
117-8	34080-34082	of	_	
117-9	34083-34091	cannabis	_	
117-10	34092-34096	cues	_	
117-11	34097-34103	versus	_	
117-12	34104-34109	fruit	_	
117-13	34110-34113	cue	_	
117-14	34113-34114	,	_	
117-15	34115-34117	we	_	
117-16	34118-34123	found	_	
117-17	34124-34135	significant	_	
117-18	34136-34148	correlations	_	
117-19	34149-34156	between	_	
117-20	34157-34160	THC	_	
117-21	34160-34161	/	_	
117-22	34161-34171	creatinine	_	
117-23	34172-34178	levels	_	
117-24	34179-34182	and	_	
117-25	34183-34191	response	_	
117-26	34192-34194	in	_	
117-27	34195-34198	the	_	
117-28	34199-34208	bilateral	_	
117-29	34209-34216	lingual	_	
117-30	34217-34222	gyrus	_	
117-31	34223-34226	and	_	
117-32	34227-34233	cuneus	_	
117-33	34234-34235	(	_	
117-34	34235-34252	cluster‐threshold	_	
117-35	34253-34254	z	_	
117-36	34255-34256	=	_	
117-37	34257-34260	2.3	_	
117-38	34260-34261	,	_	
117-39	34262-34263	P	_	
117-40	34264-34265	<	_	
117-41	34266-34270	0.05	_	
117-42	34271-34284	FWE‐corrected	_	
117-43	34284-34285	)	_	
117-44	34286-34287	(	_	
117-45	34287-34292	Table	_	
117-46	34293-34294	5	_	
117-47	34295-34298	and	_	
117-48	34299-34302	Fig	_	
117-49	34302-34303	.	_	
117-50	34304-34305	2	_	
117-51	34305-34306	)	_	
117-52	34306-34307	.	_	

#Text=Grams used per day was not significantly related to task‐related activation for cannabis cues (vs. neutral object).
118-1	34308-34313	Grams	_	
118-2	34314-34318	used	_	
118-3	34319-34322	per	_	
118-4	34323-34326	day	_	
118-5	34327-34330	was	_	
118-6	34331-34334	not	_	
118-7	34335-34348	significantly	_	
118-8	34349-34356	related	_	
118-9	34357-34359	to	_	
118-10	34360-34372	task‐related	_	
118-11	34373-34383	activation	_	
118-12	34384-34387	for	_	
118-13	34388-34396	cannabis	_	
118-14	34397-34401	cues	_	
118-15	34402-34403	(	_	
118-16	34403-34405	vs	_	
118-17	34405-34406	.	_	
118-18	34407-34414	neutral	_	
118-19	34415-34421	object	_	
118-20	34421-34422	)	_	
118-21	34422-34423	.	_	

#Text=Correlations between cannabis cue (vs. fruit cue) and Marijuana Craving Questionnaire (MCQ), Marijuana Withdrawal Checklist (MWC), creatinine‐weighted THC ng/ml in cannabis users.
119-1	34424-34436	Correlations	_	
119-2	34437-34444	between	_	
119-3	34445-34453	cannabis	_	
119-4	34454-34457	cue	_	
119-5	34458-34459	(	_	
119-6	34459-34461	vs	_	
119-7	34461-34462	.	_	
119-8	34463-34468	fruit	_	
119-9	34469-34472	cue	_	
119-10	34472-34473	)	_	
119-11	34474-34477	and	_	
119-12	34478-34487	Marijuana	_	
119-13	34488-34495	Craving	_	
119-14	34496-34509	Questionnaire	_	
119-15	34510-34511	(	_	
119-16	34511-34514	MCQ	_	
119-17	34514-34515	)	_	
119-18	34515-34516	,	_	
119-19	34517-34526	Marijuana	_	
119-20	34527-34537	Withdrawal	_	
119-21	34538-34547	Checklist	_	
119-22	34548-34549	(	_	
119-23	34549-34552	MWC	_	
119-24	34552-34553	)	_	
119-25	34553-34554	,	_	
119-26	34555-34574	creatinine‐weighted	_	
119-27	34575-34578	THC	_	
119-28	34579-34581	ng	_	
119-29	34581-34582	/	_	
119-30	34582-34584	ml	_	
119-31	34585-34587	in	_	
119-32	34588-34596	cannabis	_	
119-33	34597-34602	users	_	
119-34	34602-34603	.	_	

#Text=Crosshairs depict the peaks in users for the correlation with (A) right post‐central gyrus and MCQ scores (B) right fusiform gyrus and MWC scores, (C) right lingual gyrus and THC levels (over creatinine).
120-1	34604-34614	Crosshairs	_	
120-2	34615-34621	depict	_	
120-3	34622-34625	the	_	
120-4	34626-34631	peaks	_	
120-5	34632-34634	in	_	
120-6	34635-34640	users	_	
120-7	34641-34644	for	_	
120-8	34645-34648	the	_	
120-9	34649-34660	correlation	_	
120-10	34661-34665	with	_	
120-11	34666-34667	(	_	
120-12	34667-34668	A	_	
120-13	34668-34669	)	_	
120-14	34670-34675	right	_	
120-15	34676-34688	post‐central	_	
120-16	34689-34694	gyrus	_	
120-17	34695-34698	and	_	
120-18	34699-34702	MCQ	_	
120-19	34703-34709	scores	_	
120-20	34710-34711	(	_	
120-21	34711-34712	B	_	
120-22	34712-34713	)	_	
120-23	34714-34719	right	_	
120-24	34720-34728	fusiform	_	
120-25	34729-34734	gyrus	_	
120-26	34735-34738	and	_	
120-27	34739-34742	MWC	_	
120-28	34743-34749	scores	_	
120-29	34749-34750	,	_	
120-30	34751-34752	(	_	
120-31	34752-34753	C	_	
120-32	34753-34754	)	_	
120-33	34755-34760	right	_	
120-34	34761-34768	lingual	_	
120-35	34769-34774	gyrus	_	
120-36	34775-34778	and	_	
120-37	34779-34782	THC	_	
120-38	34783-34789	levels	_	
120-39	34790-34791	(	_	
120-40	34791-34795	over	_	
120-41	34796-34806	creatinine	_	
120-42	34806-34807	)	_	
120-43	34807-34808	.	_	

#Text=The scatterplots show the relationship of Gaussianized t‐scores at the peak with each behavioral measure (cluster‐threshold z = 2.3, FWE P < 0.05).
121-1	34809-34812	The	_	
121-2	34813-34825	scatterplots	_	
121-3	34826-34830	show	_	
121-4	34831-34834	the	_	
121-5	34835-34847	relationship	_	
121-6	34848-34850	of	_	
121-7	34851-34863	Gaussianized	_	
121-8	34864-34872	t‐scores	_	
121-9	34873-34875	at	_	
121-10	34876-34879	the	_	
121-11	34880-34884	peak	_	
121-12	34885-34889	with	_	
121-13	34890-34894	each	_	
121-14	34895-34905	behavioral	_	
121-15	34906-34913	measure	_	
121-16	34914-34915	(	_	
121-17	34915-34932	cluster‐threshold	_	
121-18	34933-34934	z	_	
121-19	34935-34936	=	_	
121-20	34937-34940	2.3	_	
121-21	34940-34941	,	_	
121-22	34942-34945	FWE	_	
121-23	34946-34947	P	_	
121-24	34948-34949	<	_	
121-25	34950-34954	0.05	_	
121-26	34954-34955	)	_	
121-27	34955-34956	.	_	

#Text=Clinical symptoms of cannabis use
#Text=In the cannabis users, response to cannabis cues (vs. neutral cue) positively correlated with MPS scores in the superior temporal gyrus, Heschl's gyrus, and planum temporale (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected) (See Supporting Information).
122-1	34957-34965	Clinical	_	
122-2	34966-34974	symptoms	_	
122-3	34975-34977	of	_	
122-4	34978-34986	cannabis	_	
122-5	34987-34990	use	_	
122-6	34991-34993	In	_	
122-7	34994-34997	the	_	
122-8	34998-35006	cannabis	_	
122-9	35007-35012	users	_	
122-10	35012-35013	,	_	
122-11	35014-35022	response	_	
122-12	35023-35025	to	_	
122-13	35026-35034	cannabis	_	
122-14	35035-35039	cues	_	
122-15	35040-35041	(	_	
122-16	35041-35043	vs	_	
122-17	35043-35044	.	_	
122-18	35045-35052	neutral	_	
122-19	35053-35056	cue	_	
122-20	35056-35057	)	_	
122-21	35058-35068	positively	_	
122-22	35069-35079	correlated	_	
122-23	35080-35084	with	_	
122-24	35085-35088	MPS	_	
122-25	35089-35095	scores	_	
122-26	35096-35098	in	_	
122-27	35099-35102	the	_	
122-28	35103-35111	superior	_	
122-29	35112-35120	temporal	_	
122-30	35121-35126	gyrus	_	
122-31	35126-35127	,	_	
122-32	35128-35136	Heschl's	_	
122-33	35137-35142	gyrus	_	
122-34	35142-35143	,	_	
122-35	35144-35147	and	_	
122-36	35148-35154	planum	_	
122-37	35155-35164	temporale	_	
122-38	35165-35166	(	_	
122-39	35166-35183	cluster‐threshold	_	
122-40	35184-35185	z	_	
122-41	35186-35187	=	_	
122-42	35188-35191	2.3	_	
122-43	35191-35192	,	_	
122-44	35193-35194	P	_	
122-45	35195-35196	<	_	
122-46	35197-35201	0.05	_	
122-47	35202-35215	FWE‐corrected	_	
122-48	35215-35216	)	_	
122-49	35217-35218	(	_	
122-50	35218-35221	See	_	
122-51	35222-35232	Supporting	_	
122-52	35233-35244	Information	_	
122-53	35244-35245	)	_	
122-54	35245-35246	.	_	

#Text=For the contrast of cannabis cues versus fruit cue, we found significant correlations between MWC and response in the bilateral fusiform, middle and superior temporal gyus, mid‐cingulate gyrus, and right inferior parietal, but not SCID IV CUD symptom count (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected) (Table 5 and Fig. 2).
123-1	35247-35250	For	_	
123-2	35251-35254	the	_	
123-3	35255-35263	contrast	_	
123-4	35264-35266	of	_	
123-5	35267-35275	cannabis	_	
123-6	35276-35280	cues	_	
123-7	35281-35287	versus	_	
123-8	35288-35293	fruit	_	
123-9	35294-35297	cue	_	
123-10	35297-35298	,	_	
123-11	35299-35301	we	_	
123-12	35302-35307	found	_	
123-13	35308-35319	significant	_	
123-14	35320-35332	correlations	_	
123-15	35333-35340	between	_	
123-16	35341-35344	MWC	_	
123-17	35345-35348	and	_	
123-18	35349-35357	response	_	
123-19	35358-35360	in	_	
123-20	35361-35364	the	_	
123-21	35365-35374	bilateral	_	
123-22	35375-35383	fusiform	_	
123-23	35383-35384	,	_	
123-24	35385-35391	middle	_	
123-25	35392-35395	and	_	
123-26	35396-35404	superior	_	
123-27	35405-35413	temporal	_	
123-28	35414-35418	gyus	_	
123-29	35418-35419	,	_	
123-30	35420-35433	mid‐cingulate	_	
123-31	35434-35439	gyrus	_	
123-32	35439-35440	,	_	
123-33	35441-35444	and	_	
123-34	35445-35450	right	_	
123-35	35451-35459	inferior	_	
123-36	35460-35468	parietal	_	
123-37	35468-35469	,	_	
123-38	35470-35473	but	_	
123-39	35474-35477	not	_	
123-40	35478-35482	SCID	_	
123-41	35483-35485	IV	_	
123-42	35486-35489	CUD	_	
123-43	35490-35497	symptom	_	
123-44	35498-35503	count	_	
123-45	35504-35505	(	_	
123-46	35505-35522	cluster‐threshold	_	
123-47	35523-35524	z	_	
123-48	35525-35526	=	_	
123-49	35527-35530	2.3	_	
123-50	35530-35531	,	_	
123-51	35532-35533	P	_	
123-52	35534-35535	<	_	
123-53	35536-35540	0.05	_	
123-54	35541-35554	FWE‐corrected	_	
123-55	35554-35555	)	_	
123-56	35556-35557	(	_	
123-57	35557-35562	Table	_	
123-58	35563-35564	5	_	
123-59	35565-35568	and	_	
123-60	35569-35572	Fig	_	
123-61	35572-35573	.	_	
123-62	35574-35575	2	_	
123-63	35575-35576	)	_	
123-64	35576-35577	.	_	

#Text=Post Hoc Analyses
#Text=To interrogate the relationship between BOLD response to cues and subjective craving, we tested the neural response to cues while taking subjective craving related differences into account.
124-1	35578-35582	Post	_	
124-2	35583-35586	Hoc	_	
124-3	35587-35595	Analyses	_	
124-4	35596-35598	To	_	
124-5	35599-35610	interrogate	_	
124-6	35611-35614	the	_	
124-7	35615-35627	relationship	_	
124-8	35628-35635	between	_	
124-9	35636-35640	BOLD	_	
124-10	35641-35649	response	_	
124-11	35650-35652	to	_	
124-12	35653-35657	cues	_	
124-13	35658-35661	and	_	
124-14	35662-35672	subjective	_	
124-15	35673-35680	craving	_	
124-16	35680-35681	,	_	
124-17	35682-35684	we	_	
124-18	35685-35691	tested	_	
124-19	35692-35695	the	_	
124-20	35696-35702	neural	_	
124-21	35703-35711	response	_	
124-22	35712-35714	to	_	
124-23	35715-35719	cues	_	
124-24	35720-35725	while	_	
124-25	35726-35732	taking	_	
124-26	35733-35743	subjective	_	
124-27	35744-35751	craving	_	
124-28	35752-35759	related	_	
124-29	35760-35771	differences	_	
124-30	35772-35776	into	_	
124-31	35777-35784	account	_	
124-32	35784-35785	.	_	

#Text=In other words, we analyzed between group differences in response to cues while controlling for in‐scanner craving score.
125-1	35786-35788	In	_	
125-2	35789-35794	other	_	
125-3	35795-35800	words	_	
125-4	35800-35801	,	_	
125-5	35802-35804	we	_	
125-6	35805-35813	analyzed	_	
125-7	35814-35821	between	_	
125-8	35822-35827	group	_	
125-9	35828-35839	differences	_	
125-10	35840-35842	in	_	
125-11	35843-35851	response	_	
125-12	35852-35854	to	_	
125-13	35855-35859	cues	_	
125-14	35860-35865	while	_	
125-15	35866-35877	controlling	_	
125-16	35878-35881	for	_	
125-17	35882-35892	in‐scanner	_	
125-18	35893-35900	craving	_	
125-19	35901-35906	score	_	
125-20	35906-35907	.	_	

#Text=The results showed that, users had greater response during cannabis (vs. neutral cue) than non‐users in the precuneus and posterior cingulate gyrus (cluster‐threshold z = 2.3, P ≤ 0.05 FWE‐corrected).
126-1	35908-35911	The	_	
126-2	35912-35919	results	_	
126-3	35920-35926	showed	_	
126-4	35927-35931	that	_	
126-5	35931-35932	,	_	
126-6	35933-35938	users	_	
126-7	35939-35942	had	_	
126-8	35943-35950	greater	_	
126-9	35951-35959	response	_	
126-10	35960-35966	during	_	
126-11	35967-35975	cannabis	_	
126-12	35976-35977	(	_	
126-13	35977-35979	vs	_	
126-14	35979-35980	.	_	
126-15	35981-35988	neutral	_	
126-16	35989-35992	cue	_	
126-17	35992-35993	)	_	
126-18	35994-35998	than	_	
126-19	35999-36008	non‐users	_	
126-20	36009-36011	in	_	
126-21	36012-36015	the	_	
126-22	36016-36025	precuneus	_	
126-23	36026-36029	and	_	
126-24	36030-36039	posterior	_	
126-25	36040-36049	cingulate	_	
126-26	36050-36055	gyrus	_	
126-27	36056-36057	(	_	
126-28	36057-36074	cluster‐threshold	_	
126-29	36075-36076	z	_	
126-30	36077-36078	=	_	
126-31	36079-36082	2.3	_	
126-32	36082-36083	,	_	
126-33	36084-36085	P	_	
126-34	36086-36087	≤	_	
126-35	36088-36092	0.05	_	
126-36	36093-36106	FWE‐corrected	_	
126-37	36106-36107	)	_	
126-38	36107-36108	.	_	

#Text=Users were also greater than non‐users during cannabis ≥ fruit cue in the anterior cingulate gyrus (cluster‐threshold z = 2.3, P ≤ 0.05 FWE‐corrected).
127-1	36109-36114	Users	_	
127-2	36115-36119	were	_	
127-3	36120-36124	also	_	
127-4	36125-36132	greater	_	
127-5	36133-36137	than	_	
127-6	36138-36147	non‐users	_	
127-7	36148-36154	during	_	
127-8	36155-36163	cannabis	_	
127-9	36164-36165	≥	_	
127-10	36166-36171	fruit	_	
127-11	36172-36175	cue	_	
127-12	36176-36178	in	_	
127-13	36179-36182	the	_	
127-14	36183-36191	anterior	_	
127-15	36192-36201	cingulate	_	
127-16	36202-36207	gyrus	_	
127-17	36208-36209	(	_	
127-18	36209-36226	cluster‐threshold	_	
127-19	36227-36228	z	_	
127-20	36229-36230	=	_	
127-21	36231-36234	2.3	_	
127-22	36234-36235	,	_	
127-23	36236-36237	P	_	
127-24	36238-36239	≤	_	
127-25	36240-36244	0.05	_	
127-26	36245-36258	FWE‐corrected	_	
127-27	36258-36259	)	_	
127-28	36259-36260	.	_	

#Text=Last, we tested potential confounding effects of individual factors.
128-1	36261-36265	Last	_	
128-2	36265-36266	,	_	
128-3	36267-36269	we	_	
128-4	36270-36276	tested	_	
128-5	36277-36286	potential	_	
128-6	36287-36298	confounding	_	
128-7	36299-36306	effects	_	
128-8	36307-36309	of	_	
128-9	36310-36320	individual	_	
128-10	36321-36328	factors	_	
128-11	36328-36329	.	_	

#Text=Since there was a large degree of variability in alcohol use, we examined the effects of alcohol on the responses by adding alcohol drinks per drinking day as a covariate of no interest.
129-1	36330-36335	Since	_	
129-2	36336-36341	there	_	
129-3	36342-36345	was	_	
129-4	36346-36347	a	_	
129-5	36348-36353	large	_	
129-6	36354-36360	degree	_	
129-7	36361-36363	of	_	
129-8	36364-36375	variability	_	
129-9	36376-36378	in	_	
129-10	36379-36386	alcohol	_	
129-11	36387-36390	use	_	
129-12	36390-36391	,	_	
129-13	36392-36394	we	_	
129-14	36395-36403	examined	_	
129-15	36404-36407	the	_	
129-16	36408-36415	effects	_	
129-17	36416-36418	of	_	
129-18	36419-36426	alcohol	_	
129-19	36427-36429	on	_	
129-20	36430-36433	the	_	
129-21	36434-36443	responses	_	
129-22	36444-36446	by	_	
129-23	36447-36453	adding	_	
129-24	36454-36461	alcohol	_	
129-25	36462-36468	drinks	_	
129-26	36469-36472	per	_	
129-27	36473-36481	drinking	_	
129-28	36482-36485	day	_	
129-29	36486-36488	as	_	
129-30	36489-36490	a	_	
129-31	36491-36500	covariate	_	
129-32	36501-36503	of	_	
129-33	36504-36506	no	_	
129-34	36507-36515	interest	_	
129-35	36515-36516	.	_	

#Text=The findings of greater activation in users versus non‐users in the cannabis versus neutral cue and cannabis versus fruit comparisons remained despite controlling for alcohol use suggesting that these effects are specific to cannabis (see Supporting Information).
130-1	36517-36520	The	_	
130-2	36521-36529	findings	_	
130-3	36530-36532	of	_	
130-4	36533-36540	greater	_	
130-5	36541-36551	activation	_	
130-6	36552-36554	in	_	
130-7	36555-36560	users	_	
130-8	36561-36567	versus	_	
130-9	36568-36577	non‐users	_	
130-10	36578-36580	in	_	
130-11	36581-36584	the	_	
130-12	36585-36593	cannabis	_	
130-13	36594-36600	versus	_	
130-14	36601-36608	neutral	_	
130-15	36609-36612	cue	_	
130-16	36613-36616	and	_	
130-17	36617-36625	cannabis	_	
130-18	36626-36632	versus	_	
130-19	36633-36638	fruit	_	
130-20	36639-36650	comparisons	_	
130-21	36651-36659	remained	_	
130-22	36660-36667	despite	_	
130-23	36668-36679	controlling	_	
130-24	36680-36683	for	_	
130-25	36684-36691	alcohol	_	
130-26	36692-36695	use	_	
130-27	36696-36706	suggesting	_	
130-28	36707-36711	that	_	
130-29	36712-36717	these	_	
130-30	36718-36725	effects	_	
130-31	36726-36729	are	_	
130-32	36730-36738	specific	_	
130-33	36739-36741	to	_	
130-34	36742-36750	cannabis	_	
130-35	36751-36752	(	_	
130-36	36752-36755	see	_	
130-37	36756-36766	Supporting	_	
130-38	36767-36778	Information	_	
130-39	36778-36779	)	_	
130-40	36779-36780	.	_	

#Text=The groups also differed in education; therefore, we also performed analyses to determine potential effects of education in response to cannabis cues.
131-1	36781-36784	The	_	
131-2	36785-36791	groups	_	
131-3	36792-36796	also	_	
131-4	36797-36805	differed	_	
131-5	36806-36808	in	_	
131-6	36809-36818	education	_	
131-7	36818-36819	;	_	
131-8	36820-36829	therefore	_	
131-9	36829-36830	,	_	
131-10	36831-36833	we	_	
131-11	36834-36838	also	_	
131-12	36839-36848	performed	_	
131-13	36849-36857	analyses	_	
131-14	36858-36860	to	_	
131-15	36861-36870	determine	_	
131-16	36871-36880	potential	_	
131-17	36881-36888	effects	_	
131-18	36889-36891	of	_	
131-19	36892-36901	education	_	
131-20	36902-36904	in	_	
131-21	36905-36913	response	_	
131-22	36914-36916	to	_	
131-23	36917-36925	cannabis	_	
131-24	36926-36930	cues	_	
131-25	36930-36931	.	_	

#Text=We found no confounding effect of education in the cannabis versus neutral cue and cannabis versus fruit comparisons (See Supporting Information).
132-1	36932-36934	We	_	
132-2	36935-36940	found	_	
132-3	36941-36943	no	_	
132-4	36944-36955	confounding	_	
132-5	36956-36962	effect	_	
132-6	36963-36965	of	_	
132-7	36966-36975	education	_	
132-8	36976-36978	in	_	
132-9	36979-36982	the	_	
132-10	36983-36991	cannabis	_	
132-11	36992-36998	versus	_	
132-12	36999-37006	neutral	_	
132-13	37007-37010	cue	_	
132-14	37011-37014	and	_	
132-15	37015-37023	cannabis	_	
132-16	37024-37030	versus	_	
132-17	37031-37036	fruit	_	
132-18	37037-37048	comparisons	_	
132-19	37049-37050	(	_	
132-20	37050-37053	See	_	
132-21	37054-37064	Supporting	_	
132-22	37065-37076	Information	_	
132-23	37076-37077	)	_	
132-24	37077-37078	.	_	

#Text=DISCUSSION
#Text=To address the question of whether cannabis sensitizes and disrupts mesocorticolimbic reward processes, we compared the neural response to cannabis cues to that of natural reward cues (i.e., fruit cues), which are inherently salient and represented in the brain's reward system.
133-1	37079-37089	DISCUSSION	_	
133-2	37090-37092	To	_	
133-3	37093-37100	address	_	
133-4	37101-37104	the	_	
133-5	37105-37113	question	_	
133-6	37114-37116	of	_	
133-7	37117-37124	whether	_	
133-8	37125-37133	cannabis	_	
133-9	37134-37144	sensitizes	_	
133-10	37145-37148	and	_	
133-11	37149-37157	disrupts	_	
133-12	37158-37175	mesocorticolimbic	_	
133-13	37176-37182	reward	_	
133-14	37183-37192	processes	_	
133-15	37192-37193	,	_	
133-16	37194-37196	we	_	
133-17	37197-37205	compared	_	
133-18	37206-37209	the	_	
133-19	37210-37216	neural	_	
133-20	37217-37225	response	_	
133-21	37226-37228	to	_	
133-22	37229-37237	cannabis	_	
133-23	37238-37242	cues	_	
133-24	37243-37245	to	_	
133-25	37246-37250	that	_	
133-26	37251-37253	of	_	
133-27	37254-37261	natural	_	
133-28	37262-37268	reward	_	
133-29	37269-37273	cues	_	
133-30	37274-37275	(	_	
133-31	37275-37278	i.e	_	
133-32	37278-37279	.	_	
133-33	37279-37280	,	_	
133-34	37281-37286	fruit	_	
133-35	37287-37291	cues	_	
133-36	37291-37292	)	_	
133-37	37292-37293	,	_	
133-38	37294-37299	which	_	
133-39	37300-37303	are	_	
133-40	37304-37314	inherently	_	
133-41	37315-37322	salient	_	
133-42	37323-37326	and	_	
133-43	37327-37338	represented	_	
133-44	37339-37341	in	_	
133-45	37342-37345	the	_	
133-46	37346-37353	brain's	_	
133-47	37354-37360	reward	_	
133-48	37361-37367	system	_	
133-49	37367-37368	.	_	

#Text=Our findings showed enhanced response in the mesocorticolimbic‐reward system in cannabis users that is specific to cannabis, rather than a generalized hyper‐responsivity to all rewarding stimuli.
134-1	37369-37372	Our	_	
134-2	37373-37381	findings	_	
134-3	37382-37388	showed	_	
134-4	37389-37397	enhanced	_	
134-5	37398-37406	response	_	
134-6	37407-37409	in	_	
134-7	37410-37413	the	_	
134-8	37414-37438	mesocorticolimbic‐reward	_	
134-9	37439-37445	system	_	
134-10	37446-37448	in	_	
134-11	37449-37457	cannabis	_	
134-12	37458-37463	users	_	
134-13	37464-37468	that	_	
134-14	37469-37471	is	_	
134-15	37472-37480	specific	_	
134-16	37481-37483	to	_	
134-17	37484-37492	cannabis	_	
134-18	37492-37493	,	_	
134-19	37494-37500	rather	_	
134-20	37501-37505	than	_	
134-21	37506-37507	a	_	
134-22	37508-37519	generalized	_	
134-23	37520-37538	hyper‐responsivity	_	
134-24	37539-37541	to	_	
134-25	37542-37545	all	_	
134-26	37546-37555	rewarding	_	
134-27	37556-37563	stimuli	_	
134-28	37563-37564	.	_	

#Text=This response was also associated with subjective craving (basal and cue‐induced), THC metabolite levels as well as clinical symptoms of CUD (withdrawal and problems related to cannabis use).
135-1	37565-37569	This	_	
135-2	37570-37578	response	_	
135-3	37579-37582	was	_	
135-4	37583-37587	also	_	
135-5	37588-37598	associated	_	
135-6	37599-37603	with	_	
135-7	37604-37614	subjective	_	
135-8	37615-37622	craving	_	
135-9	37623-37624	(	_	
135-10	37624-37629	basal	_	
135-11	37630-37633	and	_	
135-12	37634-37645	cue‐induced	_	
135-13	37645-37646	)	_	
135-14	37646-37647	,	_	
135-15	37648-37651	THC	_	
135-16	37652-37662	metabolite	_	
135-17	37663-37669	levels	_	
135-18	37670-37672	as	_	
135-19	37673-37677	well	_	
135-20	37678-37680	as	_	
135-21	37681-37689	clinical	_	
135-22	37690-37698	symptoms	_	
135-23	37699-37701	of	_	
135-24	37702-37705	CUD	_	
135-25	37706-37707	(	_	
135-26	37707-37717	withdrawal	_	
135-27	37718-37721	and	_	
135-28	37722-37730	problems	_	
135-29	37731-37738	related	_	
135-30	37739-37741	to	_	
135-31	37742-37750	cannabis	_	
135-32	37751-37754	use	_	
135-33	37754-37755	)	_	
135-34	37755-37756	.	_	

#Text=The critical tension in the literature surrounds whether cannabis use may be due to a general reward‐centricity in individuals or whether neural plasticity following substance abuse enhances this reward response that thereby promotes continued cannabis use.
136-1	37757-37760	The	_	
136-2	37761-37769	critical	_	
136-3	37770-37777	tension	_	
136-4	37778-37780	in	_	
136-5	37781-37784	the	_	
136-6	37785-37795	literature	_	
136-7	37796-37805	surrounds	_	
136-8	37806-37813	whether	_	
136-9	37814-37822	cannabis	_	
136-10	37823-37826	use	_	
136-11	37827-37830	may	_	
136-12	37831-37833	be	_	
136-13	37834-37837	due	_	
136-14	37838-37840	to	_	
136-15	37841-37842	a	_	
136-16	37843-37850	general	_	
136-17	37851-37868	reward‐centricity	_	
136-18	37869-37871	in	_	
136-19	37872-37883	individuals	_	
136-20	37884-37886	or	_	
136-21	37887-37894	whether	_	
136-22	37895-37901	neural	_	
136-23	37902-37912	plasticity	_	
136-24	37913-37922	following	_	
136-25	37923-37932	substance	_	
136-26	37933-37938	abuse	_	
136-27	37939-37947	enhances	_	
136-28	37948-37952	this	_	
136-29	37953-37959	reward	_	
136-30	37960-37968	response	_	
136-31	37969-37973	that	_	
136-32	37974-37981	thereby	_	
136-33	37982-37990	promotes	_	
136-34	37991-38000	continued	_	
136-35	38001-38009	cannabis	_	
136-36	38010-38013	use	_	
136-37	38013-38014	.	_	

#Text=Incentive sensitization theories posit that drugs of abuse sensitize the brain's natural reward pathway [Robinson and Berridge, 2000].
137-1	38015-38024	Incentive	_	
137-2	38025-38038	sensitization	_	
137-3	38039-38047	theories	_	
137-4	38048-38053	posit	_	
137-5	38054-38058	that	_	
137-6	38059-38064	drugs	_	
137-7	38065-38067	of	_	
137-8	38068-38073	abuse	_	
137-9	38074-38083	sensitize	_	
137-10	38084-38087	the	_	
137-11	38088-38095	brain's	_	
137-12	38096-38103	natural	_	
137-13	38104-38110	reward	_	
137-14	38111-38118	pathway	_	
137-15	38119-38120	[	_	
137-16	38120-38128	Robinson	_	
137-17	38129-38132	and	_	
137-18	38133-38141	Berridge	_	
137-19	38141-38142	,	_	
137-20	38143-38147	2000	_	
137-21	38147-38148	]	_	
137-22	38148-38149	.	_	

#Text=In this light, alterations in the reward pathway may be due to neural sensitization that leads to greater attribution of incentive salience to drug‐related stimuli.
138-1	38150-38152	In	_	
138-2	38153-38157	this	_	
138-3	38158-38163	light	_	
138-4	38163-38164	,	_	
138-5	38165-38176	alterations	_	
138-6	38177-38179	in	_	
138-7	38180-38183	the	_	
138-8	38184-38190	reward	_	
138-9	38191-38198	pathway	_	
138-10	38199-38202	may	_	
138-11	38203-38205	be	_	
138-12	38206-38209	due	_	
138-13	38210-38212	to	_	
138-14	38213-38219	neural	_	
138-15	38220-38233	sensitization	_	
138-16	38234-38238	that	_	
138-17	38239-38244	leads	_	
138-18	38245-38247	to	_	
138-19	38248-38255	greater	_	
138-20	38256-38267	attribution	_	
138-21	38268-38270	of	_	
138-22	38271-38280	incentive	_	
138-23	38281-38289	salience	_	
138-24	38290-38292	to	_	
138-25	38293-38305	drug‐related	_	
138-26	38306-38313	stimuli	_	
138-27	38313-38314	.	_	

#Text=Our results showing greater response to cannabis cues in cannabis users relative to non‐users are aligned with this theory.
139-1	38315-38318	Our	_	
139-2	38319-38326	results	_	
139-3	38327-38334	showing	_	
139-4	38335-38342	greater	_	
139-5	38343-38351	response	_	
139-6	38352-38354	to	_	
139-7	38355-38363	cannabis	_	
139-8	38364-38368	cues	_	
139-9	38369-38371	in	_	
139-10	38372-38380	cannabis	_	
139-11	38381-38386	users	_	
139-12	38387-38395	relative	_	
139-13	38396-38398	to	_	
139-14	38399-38408	non‐users	_	
139-15	38409-38412	are	_	
139-16	38413-38420	aligned	_	
139-17	38421-38425	with	_	
139-18	38426-38430	this	_	
139-19	38431-38437	theory	_	
139-20	38437-38438	.	_	

#Text=Furthermore, the observed effect is specific to cannabis suggesting a direct effect of cannabis exposure on hyper‐responsivity of the reward system, which is in line with findings by [Wetherill et al., 2014].
140-1	38439-38450	Furthermore	_	
140-2	38450-38451	,	_	
140-3	38452-38455	the	_	
140-4	38456-38464	observed	_	
140-5	38465-38471	effect	_	
140-6	38472-38474	is	_	
140-7	38475-38483	specific	_	
140-8	38484-38486	to	_	
140-9	38487-38495	cannabis	_	
140-10	38496-38506	suggesting	_	
140-11	38507-38508	a	_	
140-12	38509-38515	direct	_	
140-13	38516-38522	effect	_	
140-14	38523-38525	of	_	
140-15	38526-38534	cannabis	_	
140-16	38535-38543	exposure	_	
140-17	38544-38546	on	_	
140-18	38547-38565	hyper‐responsivity	_	
140-19	38566-38568	of	_	
140-20	38569-38572	the	_	
140-21	38573-38579	reward	_	
140-22	38580-38586	system	_	
140-23	38586-38587	,	_	
140-24	38588-38593	which	_	
140-25	38594-38596	is	_	
140-26	38597-38599	in	_	
140-27	38600-38604	line	_	
140-28	38605-38609	with	_	
140-29	38610-38618	findings	_	
140-30	38619-38621	by	_	
140-31	38622-38623	[	_	
140-32	38623-38632	Wetherill	_	
140-33	38633-38635	et	_	
140-34	38636-38638	al	_	
140-35	38638-38639	.	_	
140-36	38639-38640	,	_	
140-37	38641-38645	2014	_	
140-38	38645-38646	]	_	
140-39	38646-38647	.	_	

#Text=Specifically, we found greater response to cannabis cues over fruit cue in the users but not the non‐users in areas within the mesocorticolimbic‐reward pathway (OFC, striatum, anterior cingulate gyrus, ventral tegmental area) in addition to the precuneus.
141-1	38648-38660	Specifically	_	
141-2	38660-38661	,	_	
141-3	38662-38664	we	_	
141-4	38665-38670	found	_	
141-5	38671-38678	greater	_	
141-6	38679-38687	response	_	
141-7	38688-38690	to	_	
141-8	38691-38699	cannabis	_	
141-9	38700-38704	cues	_	
141-10	38705-38709	over	_	
141-11	38710-38715	fruit	_	
141-12	38716-38719	cue	_	
141-13	38720-38722	in	_	
141-14	38723-38726	the	_	
141-15	38727-38732	users	_	
141-16	38733-38736	but	_	
141-17	38737-38740	not	_	
141-18	38741-38744	the	_	
141-19	38745-38754	non‐users	_	
141-20	38755-38757	in	_	
141-21	38758-38763	areas	_	
141-22	38764-38770	within	_	
141-23	38771-38774	the	_	
141-24	38775-38799	mesocorticolimbic‐reward	_	
141-25	38800-38807	pathway	_	
141-26	38808-38809	(	_	
141-27	38809-38812	OFC	_	
141-28	38812-38813	,	_	
141-29	38814-38822	striatum	_	
141-30	38822-38823	,	_	
141-31	38824-38832	anterior	_	
141-32	38833-38842	cingulate	_	
141-33	38843-38848	gyrus	_	
141-34	38848-38849	,	_	
141-35	38850-38857	ventral	_	
141-36	38858-38867	tegmental	_	
141-37	38868-38872	area	_	
141-38	38872-38873	)	_	
141-39	38874-38876	in	_	
141-40	38877-38885	addition	_	
141-41	38886-38888	to	_	
141-42	38889-38892	the	_	
141-43	38893-38902	precuneus	_	
141-44	38902-38903	.	_	

#Text=Notably, activation in the anterior cingulate gyrus was also observed when controlling for in‐scanner subjective craving ratings, suggesting that the difference found between groups in the anterior cingulate gyrus is related to subjective craving differences between users and non‐users.
142-1	38904-38911	Notably	_	
142-2	38911-38912	,	_	
142-3	38913-38923	activation	_	
142-4	38924-38926	in	_	
142-5	38927-38930	the	_	
142-6	38931-38939	anterior	_	
142-7	38940-38949	cingulate	_	
142-8	38950-38955	gyrus	_	
142-9	38956-38959	was	_	
142-10	38960-38964	also	_	
142-11	38965-38973	observed	_	
142-12	38974-38978	when	_	
142-13	38979-38990	controlling	_	
142-14	38991-38994	for	_	
142-15	38995-39005	in‐scanner	_	
142-16	39006-39016	subjective	_	
142-17	39017-39024	craving	_	
142-18	39025-39032	ratings	_	
142-19	39032-39033	,	_	
142-20	39034-39044	suggesting	_	
142-21	39045-39049	that	_	
142-22	39050-39053	the	_	
142-23	39054-39064	difference	_	
142-24	39065-39070	found	_	
142-25	39071-39078	between	_	
142-26	39079-39085	groups	_	
142-27	39086-39088	in	_	
142-28	39089-39092	the	_	
142-29	39093-39101	anterior	_	
142-30	39102-39111	cingulate	_	
142-31	39112-39117	gyrus	_	
142-32	39118-39120	is	_	
142-33	39121-39128	related	_	
142-34	39129-39131	to	_	
142-35	39132-39142	subjective	_	
142-36	39143-39150	craving	_	
142-37	39151-39162	differences	_	
142-38	39163-39170	between	_	
142-39	39171-39176	users	_	
142-40	39177-39180	and	_	
142-41	39181-39190	non‐users	_	
142-42	39190-39191	.	_	

#Text=These regions underlie processes relevant for encoding of learned association of the drug with relevant cues and, therefore, for evaluation of motivational salience [Filbey and DeWitt, 2012].
143-1	39192-39197	These	_	
143-2	39198-39205	regions	_	
143-3	39206-39214	underlie	_	
143-4	39215-39224	processes	_	
143-5	39225-39233	relevant	_	
143-6	39234-39237	for	_	
143-7	39238-39246	encoding	_	
143-8	39247-39249	of	_	
143-9	39250-39257	learned	_	
143-10	39258-39269	association	_	
143-11	39270-39272	of	_	
143-12	39273-39276	the	_	
143-13	39277-39281	drug	_	
143-14	39282-39286	with	_	
143-15	39287-39295	relevant	_	
143-16	39296-39300	cues	_	
143-17	39301-39304	and	_	
143-18	39304-39305	,	_	
143-19	39306-39315	therefore	_	
143-20	39315-39316	,	_	
143-21	39317-39320	for	_	
143-22	39321-39331	evaluation	_	
143-23	39332-39334	of	_	
143-24	39335-39347	motivational	_	
143-25	39348-39356	salience	_	
143-26	39357-39358	[	_	
143-27	39358-39364	Filbey	_	
143-28	39365-39368	and	_	
143-29	39369-39375	DeWitt	_	
143-30	39375-39376	,	_	
143-31	39377-39381	2012	_	
143-32	39381-39382	]	_	
143-33	39382-39383	.	_	

#Text=In terms of the precuneus, emergent studies suggest its role of processing externally‐driven, self‐relevant information, which in response to cannabis cues, would indicate a hyper‐arousal to the conditioned cues [DeWitt et al., 2015].
144-1	39384-39386	In	_	
144-2	39387-39392	terms	_	
144-3	39393-39395	of	_	
144-4	39396-39399	the	_	
144-5	39400-39409	precuneus	_	
144-6	39409-39410	,	_	
144-7	39411-39419	emergent	_	
144-8	39420-39427	studies	_	
144-9	39428-39435	suggest	_	
144-10	39436-39439	its	_	
144-11	39440-39444	role	_	
144-12	39445-39447	of	_	
144-13	39448-39458	processing	_	
144-14	39459-39476	externally‐driven	_	
144-15	39476-39477	,	_	
144-16	39478-39491	self‐relevant	_	
144-17	39492-39503	information	_	
144-18	39503-39504	,	_	
144-19	39505-39510	which	_	
144-20	39511-39513	in	_	
144-21	39514-39522	response	_	
144-22	39523-39525	to	_	
144-23	39526-39534	cannabis	_	
144-24	39535-39539	cues	_	
144-25	39539-39540	,	_	
144-26	39541-39546	would	_	
144-27	39547-39555	indicate	_	
144-28	39556-39557	a	_	
144-29	39558-39571	hyper‐arousal	_	
144-30	39572-39574	to	_	
144-31	39575-39578	the	_	
144-32	39579-39590	conditioned	_	
144-33	39591-39595	cues	_	
144-34	39596-39597	[	_	
144-35	39597-39603	DeWitt	_	
144-36	39604-39606	et	_	
144-37	39607-39609	al	_	
144-38	39609-39610	.	_	
144-39	39610-39611	,	_	
144-40	39612-39616	2015	_	
144-41	39616-39617	]	_	
144-42	39617-39618	.	_	

#Text=Because these areas are related to processing of general hedonic stimuli including food [Filbey et al., 2012a; Jiang et al., 2015], greater activation in response to cannabis cues in a system that represents inherently salient stimuli suggests a disruption in the natural reward system.
145-1	39619-39626	Because	_	
145-2	39627-39632	these	_	
145-3	39633-39638	areas	_	
145-4	39639-39642	are	_	
145-5	39643-39650	related	_	
145-6	39651-39653	to	_	
145-7	39654-39664	processing	_	
145-8	39665-39667	of	_	
145-9	39668-39675	general	_	
145-10	39676-39683	hedonic	_	
145-11	39684-39691	stimuli	_	
145-12	39692-39701	including	_	
145-13	39702-39706	food	_	
145-14	39707-39708	[	_	
145-15	39708-39714	Filbey	_	
145-16	39715-39717	et	_	
145-17	39718-39720	al	_	
145-18	39720-39721	.	_	
145-19	39721-39722	,	_	
145-20	39723-39728	2012a	_	
145-21	39728-39729	;	_	
145-22	39730-39735	Jiang	_	
145-23	39736-39738	et	_	
145-24	39739-39741	al	_	
145-25	39741-39742	.	_	
145-26	39742-39743	,	_	
145-27	39744-39748	2015	_	
145-28	39748-39749	]	_	
145-29	39749-39750	,	_	
145-30	39751-39758	greater	_	
145-31	39759-39769	activation	_	
145-32	39770-39772	in	_	
145-33	39773-39781	response	_	
145-34	39782-39784	to	_	
145-35	39785-39793	cannabis	_	
145-36	39794-39798	cues	_	
145-37	39799-39801	in	_	
145-38	39802-39803	a	_	
145-39	39804-39810	system	_	
145-40	39811-39815	that	_	
145-41	39816-39826	represents	_	
145-42	39827-39837	inherently	_	
145-43	39838-39845	salient	_	
145-44	39846-39853	stimuli	_	
145-45	39854-39862	suggests	_	
145-46	39863-39864	a	_	
145-47	39865-39875	disruption	_	
145-48	39876-39878	in	_	
145-49	39879-39882	the	_	
145-50	39883-39890	natural	_	
145-51	39891-39897	reward	_	
145-52	39898-39904	system	_	
145-53	39904-39905	.	_	

#Text=This pattern of neural response was associated with both basal subjective craving as well as cue‐induced subjective craving in reward as well as interoception regions (cluster‐threshold z = 2.3, P < 0.05 FWE‐corrected) (Table 4).
146-1	39906-39910	This	_	
146-2	39911-39918	pattern	_	
146-3	39919-39921	of	_	
146-4	39922-39928	neural	_	
146-5	39929-39937	response	_	
146-6	39938-39941	was	_	
146-7	39942-39952	associated	_	
146-8	39953-39957	with	_	
146-9	39958-39962	both	_	
146-10	39963-39968	basal	_	
146-11	39969-39979	subjective	_	
146-12	39980-39987	craving	_	
146-13	39988-39990	as	_	
146-14	39991-39995	well	_	
146-15	39996-39998	as	_	
146-16	39999-40010	cue‐induced	_	
146-17	40011-40021	subjective	_	
146-18	40022-40029	craving	_	
146-19	40030-40032	in	_	
146-20	40033-40039	reward	_	
146-21	40040-40042	as	_	
146-22	40043-40047	well	_	
146-23	40048-40050	as	_	
146-24	40051-40064	interoception	_	
146-25	40065-40072	regions	_	
146-26	40073-40074	(	_	
146-27	40074-40091	cluster‐threshold	_	
146-28	40092-40093	z	_	
146-29	40094-40095	=	_	
146-30	40096-40099	2.3	_	
146-31	40099-40100	,	_	
146-32	40101-40102	P	_	
146-33	40103-40104	<	_	
146-34	40105-40109	0.05	_	
146-35	40110-40123	FWE‐corrected	_	
146-36	40123-40124	)	_	
146-37	40125-40126	(	_	
146-38	40126-40131	Table	_	
146-39	40132-40133	4	_	
146-40	40133-40134	)	_	
146-41	40134-40135	.	_	

#Text=This correlation emerged despite the finding that cannabis users had greater subjective craving for cannabis when exposed to all types of cues (cannabis, natural reward, and, neutral) relative to non‐users.
147-1	40136-40140	This	_	
147-2	40141-40152	correlation	_	
147-3	40153-40160	emerged	_	
147-4	40161-40168	despite	_	
147-5	40169-40172	the	_	
147-6	40173-40180	finding	_	
147-7	40181-40185	that	_	
147-8	40186-40194	cannabis	_	
147-9	40195-40200	users	_	
147-10	40201-40204	had	_	
147-11	40205-40212	greater	_	
147-12	40213-40223	subjective	_	
147-13	40224-40231	craving	_	
147-14	40232-40235	for	_	
147-15	40236-40244	cannabis	_	
147-16	40245-40249	when	_	
147-17	40250-40257	exposed	_	
147-18	40258-40260	to	_	
147-19	40261-40264	all	_	
147-20	40265-40270	types	_	
147-21	40271-40273	of	_	
147-22	40274-40278	cues	_	
147-23	40279-40280	(	_	
147-24	40280-40288	cannabis	_	
147-25	40288-40289	,	_	
147-26	40290-40297	natural	_	
147-27	40298-40304	reward	_	
147-28	40304-40305	,	_	
147-29	40306-40309	and	_	
147-30	40309-40310	,	_	
147-31	40311-40318	neutral	_	
147-32	40318-40319	)	_	
147-33	40320-40328	relative	_	
147-34	40329-40331	to	_	
147-35	40332-40341	non‐users	_	
147-36	40341-40342	.	_	

#Text=Notably, the temporal analysis of the in‐scanner craving rating scores (i.e., trial‐by‐trial rating for all cues) did not show persisting craving over time (Supporting Information).
148-1	40343-40350	Notably	_	
148-2	40350-40351	,	_	
148-3	40352-40355	the	_	
148-4	40356-40364	temporal	_	
148-5	40365-40373	analysis	_	
148-6	40374-40376	of	_	
148-7	40377-40380	the	_	
148-8	40381-40391	in‐scanner	_	
148-9	40392-40399	craving	_	
148-10	40400-40406	rating	_	
148-11	40407-40413	scores	_	
148-12	40414-40415	(	_	
148-13	40415-40418	i.e	_	
148-14	40418-40419	.	_	
148-15	40419-40420	,	_	
148-16	40421-40435	trial‐by‐trial	_	
148-17	40436-40442	rating	_	
148-18	40443-40446	for	_	
148-19	40447-40450	all	_	
148-20	40451-40455	cues	_	
148-21	40455-40456	)	_	
148-22	40457-40460	did	_	
148-23	40461-40464	not	_	
148-24	40465-40469	show	_	
148-25	40470-40480	persisting	_	
148-26	40481-40488	craving	_	
148-27	40489-40493	over	_	
148-28	40494-40498	time	_	
148-29	40499-40500	(	_	
148-30	40500-40510	Supporting	_	
148-31	40511-40522	Information	_	
148-32	40522-40523	)	_	
148-33	40523-40524	.	_	

#Text=That is, trials of cannabis cue exposure do not elevate subsequent subjective craving responses during cannabis, neutral or natural cues.
149-1	40525-40529	That	_	
149-2	40530-40532	is	_	
149-3	40532-40533	,	_	
149-4	40534-40540	trials	_	
149-5	40541-40543	of	_	
149-6	40544-40552	cannabis	_	
149-7	40553-40556	cue	_	
149-8	40557-40565	exposure	_	
149-9	40566-40568	do	_	
149-10	40569-40572	not	_	
149-11	40573-40580	elevate	_	
149-12	40581-40591	subsequent	_	
149-13	40592-40602	subjective	_	
149-14	40603-40610	craving	_	
149-15	40611-40620	responses	_	
149-16	40621-40627	during	_	
149-17	40628-40636	cannabis	_	
149-18	40636-40637	,	_	
149-19	40638-40645	neutral	_	
149-20	40646-40648	or	_	
149-21	40649-40656	natural	_	
149-22	40657-40661	cues	_	
149-23	40661-40662	.	_	

#Text=How this enhanced pattern of neural response to cues relates to cannabis use behavior was demonstrated by positive correlations between response to cannabis in several regions and behavioral measures of cannabis use.
150-1	40663-40666	How	_	
150-2	40667-40671	this	_	
150-3	40672-40680	enhanced	_	
150-4	40681-40688	pattern	_	
150-5	40689-40691	of	_	
150-6	40692-40698	neural	_	
150-7	40699-40707	response	_	
150-8	40708-40710	to	_	
150-9	40711-40715	cues	_	
150-10	40716-40723	relates	_	
150-11	40724-40726	to	_	
150-12	40727-40735	cannabis	_	
150-13	40736-40739	use	_	
150-14	40740-40748	behavior	_	
150-15	40749-40752	was	_	
150-16	40753-40765	demonstrated	_	
150-17	40766-40768	by	_	
150-18	40769-40777	positive	_	
150-19	40778-40790	correlations	_	
150-20	40791-40798	between	_	
150-21	40799-40807	response	_	
150-22	40808-40810	to	_	
150-23	40811-40819	cannabis	_	
150-24	40820-40822	in	_	
150-25	40823-40830	several	_	
150-26	40831-40838	regions	_	
150-27	40839-40842	and	_	
150-28	40843-40853	behavioral	_	
150-29	40854-40862	measures	_	
150-30	40863-40865	of	_	
150-31	40866-40874	cannabis	_	
150-32	40875-40878	use	_	
150-33	40878-40879	.	_	

#Text=These positive associations suggest that the greater number of withdrawal symptoms, and, THC levels, the greater the neural response to cues that are greater than that of response to fruit cues.
151-1	40880-40885	These	_	
151-2	40886-40894	positive	_	
151-3	40895-40907	associations	_	
151-4	40908-40915	suggest	_	
151-5	40916-40920	that	_	
151-6	40921-40924	the	_	
151-7	40925-40932	greater	_	
151-8	40933-40939	number	_	
151-9	40940-40942	of	_	
151-10	40943-40953	withdrawal	_	
151-11	40954-40962	symptoms	_	
151-12	40962-40963	,	_	
151-13	40964-40967	and	_	
151-14	40967-40968	,	_	
151-15	40969-40972	THC	_	
151-16	40973-40979	levels	_	
151-17	40979-40980	,	_	
151-18	40981-40984	the	_	
151-19	40985-40992	greater	_	
151-20	40993-40996	the	_	
151-21	40997-41003	neural	_	
151-22	41004-41012	response	_	
151-23	41013-41015	to	_	
151-24	41016-41020	cues	_	
151-25	41021-41025	that	_	
151-26	41026-41029	are	_	
151-27	41030-41037	greater	_	
151-28	41038-41042	than	_	
151-29	41043-41047	that	_	
151-30	41048-41050	of	_	
151-31	41051-41059	response	_	
151-32	41060-41062	to	_	
151-33	41063-41068	fruit	_	
151-34	41069-41073	cues	_	
151-35	41073-41074	.	_	

#Text=Problems related to cannabis use was also positively associated with neural response to cues further indicating specificity of these brain alterations to processes related to cannabis exposure that could be a marker of transition from recreational use to problematic use.
152-1	41075-41083	Problems	_	
152-2	41084-41091	related	_	
152-3	41092-41094	to	_	
152-4	41095-41103	cannabis	_	
152-5	41104-41107	use	_	
152-6	41108-41111	was	_	
152-7	41112-41116	also	_	
152-8	41117-41127	positively	_	
152-9	41128-41138	associated	_	
152-10	41139-41143	with	_	
152-11	41144-41150	neural	_	
152-12	41151-41159	response	_	
152-13	41160-41162	to	_	
152-14	41163-41167	cues	_	
152-15	41168-41175	further	_	
152-16	41176-41186	indicating	_	
152-17	41187-41198	specificity	_	
152-18	41199-41201	of	_	
152-19	41202-41207	these	_	
152-20	41208-41213	brain	_	
152-21	41214-41225	alterations	_	
152-22	41226-41228	to	_	
152-23	41229-41238	processes	_	
152-24	41239-41246	related	_	
152-25	41247-41249	to	_	
152-26	41250-41258	cannabis	_	
152-27	41259-41267	exposure	_	
152-28	41268-41272	that	_	
152-29	41273-41278	could	_	
152-30	41279-41281	be	_	
152-31	41282-41283	a	_	
152-32	41284-41290	marker	_	
152-33	41291-41293	of	_	
152-34	41294-41304	transition	_	
152-35	41305-41309	from	_	
152-36	41310-41322	recreational	_	
152-37	41323-41326	use	_	
152-38	41327-41329	to	_	
152-39	41330-41341	problematic	_	
152-40	41342-41345	use	_	
152-41	41345-41346	.	_	

#Text=The significance of these studies is in determining the mechanisms that result in the transition toward problematic cannabis use.
153-1	41347-41350	The	_	
153-2	41351-41363	significance	_	
153-3	41364-41366	of	_	
153-4	41367-41372	these	_	
153-5	41373-41380	studies	_	
153-6	41381-41383	is	_	
153-7	41384-41386	in	_	
153-8	41387-41398	determining	_	
153-9	41399-41402	the	_	
153-10	41403-41413	mechanisms	_	
153-11	41414-41418	that	_	
153-12	41419-41425	result	_	
153-13	41426-41428	in	_	
153-14	41429-41432	the	_	
153-15	41433-41443	transition	_	
153-16	41444-41450	toward	_	
153-17	41451-41462	problematic	_	
153-18	41463-41471	cannabis	_	
153-19	41472-41475	use	_	
153-20	41475-41476	.	_	

#Text=Thus, how individuals process cannabis relative to non‐drug rewards not only advance our knowledge of these underlying mechanisms but also inform avenues for potential interventions.
154-1	41477-41481	Thus	_	
154-2	41481-41482	,	_	
154-3	41483-41486	how	_	
154-4	41487-41498	individuals	_	
154-5	41499-41506	process	_	
154-6	41507-41515	cannabis	_	
154-7	41516-41524	relative	_	
154-8	41525-41527	to	_	
154-9	41528-41536	non‐drug	_	
154-10	41537-41544	rewards	_	
154-11	41545-41548	not	_	
154-12	41549-41553	only	_	
154-13	41554-41561	advance	_	
154-14	41562-41565	our	_	
154-15	41566-41575	knowledge	_	
154-16	41576-41578	of	_	
154-17	41579-41584	these	_	
154-18	41585-41595	underlying	_	
154-19	41596-41606	mechanisms	_	
154-20	41607-41610	but	_	
154-21	41611-41615	also	_	
154-22	41616-41622	inform	_	
154-23	41623-41630	avenues	_	
154-24	41631-41634	for	_	
154-25	41635-41644	potential	_	
154-26	41645-41658	interventions	_	
154-27	41658-41659	.	_	

#Text=The knowledge that cannabis users are hyper‐responsive to cannabis due to the possibility of sensitization and disruption of natural reward processes suggests that behavioral interventions that target unconscious mechanisms may be more effective.
155-1	41660-41663	The	_	
155-2	41664-41673	knowledge	_	
155-3	41674-41678	that	_	
155-4	41679-41687	cannabis	_	
155-5	41688-41693	users	_	
155-6	41694-41697	are	_	
155-7	41698-41714	hyper‐responsive	_	
155-8	41715-41717	to	_	
155-9	41718-41726	cannabis	_	
155-10	41727-41730	due	_	
155-11	41731-41733	to	_	
155-12	41734-41737	the	_	
155-13	41738-41749	possibility	_	
155-14	41750-41752	of	_	
155-15	41753-41766	sensitization	_	
155-16	41767-41770	and	_	
155-17	41771-41781	disruption	_	
155-18	41782-41784	of	_	
155-19	41785-41792	natural	_	
155-20	41793-41799	reward	_	
155-21	41800-41809	processes	_	
155-22	41810-41818	suggests	_	
155-23	41819-41823	that	_	
155-24	41824-41834	behavioral	_	
155-25	41835-41848	interventions	_	
155-26	41849-41853	that	_	
155-27	41854-41860	target	_	
155-28	41861-41872	unconscious	_	
155-29	41873-41883	mechanisms	_	
155-30	41884-41887	may	_	
155-31	41888-41890	be	_	
155-32	41891-41895	more	_	
155-33	41896-41905	effective	_	
155-34	41905-41906	.	_	

#Text=Additionally, treatment schedules should correspond to the long recovery from sensitization that diminishes slowly and allows the potential for relapse.
156-1	41907-41919	Additionally	_	
156-2	41919-41920	,	_	
156-3	41921-41930	treatment	_	
156-4	41931-41940	schedules	_	
156-5	41941-41947	should	_	
156-6	41948-41958	correspond	_	
156-7	41959-41961	to	_	
156-8	41962-41965	the	_	
156-9	41966-41970	long	_	
156-10	41971-41979	recovery	_	
156-11	41980-41984	from	_	
156-12	41985-41998	sensitization	_	
156-13	41999-42003	that	_	
156-14	42004-42014	diminishes	_	
156-15	42015-42021	slowly	_	
156-16	42022-42025	and	_	
156-17	42026-42032	allows	_	
156-18	42033-42036	the	_	
156-19	42037-42046	potential	_	
156-20	42047-42050	for	_	
156-21	42051-42058	relapse	_	
156-22	42058-42059	.	_	

#Text=Limitations and Conclusions
#Text=The cross‐sectional nature of this study does not address directionality of these effects.
157-1	42060-42071	Limitations	_	
157-2	42072-42075	and	_	
157-3	42076-42087	Conclusions	_	
157-4	42088-42091	The	_	
157-5	42092-42107	cross‐sectional	_	
157-6	42108-42114	nature	_	
157-7	42115-42117	of	_	
157-8	42118-42122	this	_	
157-9	42123-42128	study	_	
157-10	42129-42133	does	_	
157-11	42134-42137	not	_	
157-12	42138-42145	address	_	
157-13	42146-42160	directionality	_	
157-14	42161-42163	of	_	
157-15	42164-42169	these	_	
157-16	42170-42177	effects	_	
157-17	42177-42178	.	_	

#Text=However, the correlation between patterns of greater activation for cannabis cues relative to non‐cannabis cues with measures of cannabis use behavior (THC levels) suggests that cannabis use is related to these changes.
158-1	42179-42186	However	_	
158-2	42186-42187	,	_	
158-3	42188-42191	the	_	
158-4	42192-42203	correlation	_	
158-5	42204-42211	between	_	
158-6	42212-42220	patterns	_	
158-7	42221-42223	of	_	
158-8	42224-42231	greater	_	
158-9	42232-42242	activation	_	
158-10	42243-42246	for	_	
158-11	42247-42255	cannabis	_	
158-12	42256-42260	cues	_	
158-13	42261-42269	relative	_	
158-14	42270-42272	to	_	
158-15	42273-42285	non‐cannabis	_	
158-16	42286-42290	cues	_	
158-17	42291-42295	with	_	
158-18	42296-42304	measures	_	
158-19	42305-42307	of	_	
158-20	42308-42316	cannabis	_	
158-21	42317-42320	use	_	
158-22	42321-42329	behavior	_	
158-23	42330-42331	(	_	
158-24	42331-42334	THC	_	
158-25	42335-42341	levels	_	
158-26	42341-42342	)	_	
158-27	42343-42351	suggests	_	
158-28	42352-42356	that	_	
158-29	42357-42365	cannabis	_	
158-30	42366-42369	use	_	
158-31	42370-42372	is	_	
158-32	42373-42380	related	_	
158-33	42381-42383	to	_	
158-34	42384-42389	these	_	
158-35	42390-42397	changes	_	
158-36	42397-42398	.	_	

#Text=There are other aspects of craving that were beyond the scope of this study but should be noted for future directions.
159-1	42399-42404	There	_	
159-2	42405-42408	are	_	
159-3	42409-42414	other	_	
159-4	42415-42422	aspects	_	
159-5	42423-42425	of	_	
159-6	42426-42433	craving	_	
159-7	42434-42438	that	_	
159-8	42439-42443	were	_	
159-9	42444-42450	beyond	_	
159-10	42451-42454	the	_	
159-11	42455-42460	scope	_	
159-12	42461-42463	of	_	
159-13	42464-42468	this	_	
159-14	42469-42474	study	_	
159-15	42475-42478	but	_	
159-16	42479-42485	should	_	
159-17	42486-42488	be	_	
159-18	42489-42494	noted	_	
159-19	42495-42498	for	_	
159-20	42499-42505	future	_	
159-21	42506-42516	directions	_	
159-22	42516-42517	.	_	

#Text=First, variations in reward expectancies may have confounded our observed effects.
160-1	42518-42523	First	_	
160-2	42523-42524	,	_	
160-3	42525-42535	variations	_	
160-4	42536-42538	in	_	
160-5	42539-42545	reward	_	
160-6	42546-42558	expectancies	_	
160-7	42559-42562	may	_	
160-8	42563-42567	have	_	
160-9	42568-42578	confounded	_	
160-10	42579-42582	our	_	
160-11	42583-42591	observed	_	
160-12	42592-42599	effects	_	
160-13	42599-42600	.	_	

#Text=Future studies should examine the direct effect of expectancies to determine how neural response to cannabis cues may be predictive of use.
161-1	42601-42607	Future	_	
161-2	42608-42615	studies	_	
161-3	42616-42622	should	_	
161-4	42623-42630	examine	_	
161-5	42631-42634	the	_	
161-6	42635-42641	direct	_	
161-7	42642-42648	effect	_	
161-8	42649-42651	of	_	
161-9	42652-42664	expectancies	_	
161-10	42665-42667	to	_	
161-11	42668-42677	determine	_	
161-12	42678-42681	how	_	
161-13	42682-42688	neural	_	
161-14	42689-42697	response	_	
161-15	42698-42700	to	_	
161-16	42701-42709	cannabis	_	
161-17	42710-42714	cues	_	
161-18	42715-42718	may	_	
161-19	42719-42721	be	_	
161-20	42722-42732	predictive	_	
161-21	42733-42735	of	_	
161-22	42736-42739	use	_	
161-23	42739-42740	.	_	

#Text=Second, future studies should measure reward valuation of stimuli to fully characterize the hedonic response to cannabis cues.
162-1	42741-42747	Second	_	
162-2	42747-42748	,	_	
162-3	42749-42755	future	_	
162-4	42756-42763	studies	_	
162-5	42764-42770	should	_	
162-6	42771-42778	measure	_	
162-7	42779-42785	reward	_	
162-8	42786-42795	valuation	_	
162-9	42796-42798	of	_	
162-10	42799-42806	stimuli	_	
162-11	42807-42809	to	_	
162-12	42810-42815	fully	_	
162-13	42816-42828	characterize	_	
162-14	42829-42832	the	_	
162-15	42833-42840	hedonic	_	
162-16	42841-42849	response	_	
162-17	42850-42852	to	_	
162-18	42853-42861	cannabis	_	
162-19	42862-42866	cues	_	
162-20	42866-42867	.	_	

#Text=To conclude, this study shows that (1) cannabis activates the brain's reward pathway more than natural rewards, and, (2) cannabis is associated with a divergent pattern of natural reward system processes in daily and long‐term cannabis using adults.
163-1	42868-42870	To	_	
163-2	42871-42879	conclude	_	
163-3	42879-42880	,	_	
163-4	42881-42885	this	_	
163-5	42886-42891	study	_	
163-6	42892-42897	shows	_	
163-7	42898-42902	that	_	
163-8	42903-42904	(	_	
163-9	42904-42905	1	_	
163-10	42905-42906	)	_	
163-11	42907-42915	cannabis	_	
163-12	42916-42925	activates	_	
163-13	42926-42929	the	_	
163-14	42930-42937	brain's	_	
163-15	42938-42944	reward	_	
163-16	42945-42952	pathway	_	
163-17	42953-42957	more	_	
163-18	42958-42962	than	_	
163-19	42963-42970	natural	_	
163-20	42971-42978	rewards	_	
163-21	42978-42979	,	_	
163-22	42980-42983	and	_	
163-23	42983-42984	,	_	
163-24	42985-42986	(	_	
163-25	42986-42987	2	_	
163-26	42987-42988	)	_	
163-27	42989-42997	cannabis	_	
163-28	42998-43000	is	_	
163-29	43001-43011	associated	_	
163-30	43012-43016	with	_	
163-31	43017-43018	a	_	
163-32	43019-43028	divergent	_	
163-33	43029-43036	pattern	_	
163-34	43037-43039	of	_	
163-35	43040-43047	natural	_	
163-36	43048-43054	reward	_	
163-37	43055-43061	system	_	
163-38	43062-43071	processes	_	
163-39	43072-43074	in	_	
163-40	43075-43080	daily	_	
163-41	43081-43084	and	_	
163-42	43085-43094	long‐term	_	
163-43	43095-43103	cannabis	_	
163-44	43104-43109	using	_	
163-45	43110-43116	adults	_	
163-46	43116-43117	.	_	

#Text=The relationship between response to cannabis cues and self‐reported marijuana problems suggests that this mechanism underlies the transition to problematic use or dependence via increased sensitivity to cannabis cues.
164-1	43118-43121	The	_	
164-2	43122-43134	relationship	_	
164-3	43135-43142	between	_	
164-4	43143-43151	response	_	
164-5	43152-43154	to	_	
164-6	43155-43163	cannabis	_	
164-7	43164-43168	cues	_	
164-8	43169-43172	and	_	
164-9	43173-43186	self‐reported	_	
164-10	43187-43196	marijuana	_	
164-11	43197-43205	problems	_	
164-12	43206-43214	suggests	_	
164-13	43215-43219	that	_	
164-14	43220-43224	this	_	
164-15	43225-43234	mechanism	_	
164-16	43235-43244	underlies	_	
164-17	43245-43248	the	_	
164-18	43249-43259	transition	_	
164-19	43260-43262	to	_	
164-20	43263-43274	problematic	_	
164-21	43275-43278	use	_	
164-22	43279-43281	or	_	
164-23	43282-43292	dependence	_	
164-24	43293-43296	via	_	
164-25	43297-43306	increased	_	
164-26	43307-43318	sensitivity	_	
164-27	43319-43321	to	_	
164-28	43322-43330	cannabis	_	
164-29	43331-43335	cues	_	
164-30	43335-43336	.	_	

#Text=These findings indicate that cannabis use may be associated with sensitization of mesocorticolimbic regions as well as disruptions of natural reward processes and lay the foundation for the development of more potent interventions that target this pathway.
165-1	43337-43342	These	_	
165-2	43343-43351	findings	_	
165-3	43352-43360	indicate	_	
165-4	43361-43365	that	_	
165-5	43366-43374	cannabis	_	
165-6	43375-43378	use	_	
165-7	43379-43382	may	_	
165-8	43383-43385	be	_	
165-9	43386-43396	associated	_	
165-10	43397-43401	with	_	
165-11	43402-43415	sensitization	_	
165-12	43416-43418	of	_	
165-13	43419-43436	mesocorticolimbic	_	
165-14	43437-43444	regions	_	
165-15	43445-43447	as	_	
165-16	43448-43452	well	_	
165-17	43453-43455	as	_	
165-18	43456-43467	disruptions	_	
165-19	43468-43470	of	_	
165-20	43471-43478	natural	_	
165-21	43479-43485	reward	_	
165-22	43486-43495	processes	_	
165-23	43496-43499	and	_	
165-24	43500-43503	lay	_	
165-25	43504-43507	the	_	
165-26	43508-43518	foundation	_	
165-27	43519-43522	for	_	
165-28	43523-43526	the	_	
165-29	43527-43538	development	_	
165-30	43539-43541	of	_	
165-31	43542-43546	more	_	
165-32	43547-43553	potent	_	
165-33	43554-43567	interventions	_	
165-34	43568-43572	that	_	
165-35	43573-43579	target	_	
165-36	43580-43584	this	_	
165-37	43585-43592	pathway	_	
165-38	43592-43593	.	_	

#Text=Supporting information
#Text=REFERENCES
#Text=Marijuana withdrawal among adults seeking treatment for marijuana dependence
#Text=Cannabis cue‐induced brain activation correlates with drug craving in limbic and visual salience regions: Preliminary results
#Text=Neural responses associated with cue‐reactivity in frequent cannabis users
#Text=Individual differences in decision making and reward processing predict changes in cannabis use: A prospective functional magnetic resonance imaging study
#Text=The hyper‐sentient addict: An exteroception model of addiction
#Text=Cannabis cue‐elicited craving and the reward neurocircuitry
#Text=Marijuana craving in the brain
#Text=Dopaminergic genes modulate response inhibition in alcohol abusing adults
#Text=Neural effects of positive and negative incentives during marijuana withdrawal
#Text=
#Text=Spatial Registration and normalization of images
#Text=Reward‐related brain response and craving correlates of marijuana cue exposure: A preliminary study in treatment‐seeking marijuana‐dependent subjects
#Text=Marijuana craving questionnaire: Development and initial validation of a self‐report instrument
#Text=Addiction and the brain: The neurobiology of compulsion and its persistence
#Text=Reward for food odors: An fMRI study of liking and wanting as a function of metabolic state and BMI
#Text=Cue‐induced craving for marijuana in cannabis‐dependent adults
#Text=Increased ventral striatal BOLD activity during non‐drug reward anticipation in cannabis users
#Text=The psychology and neurobiology of addiction: An incentive‐sensitization view
#Text=Comparison of extended versus brief treatments for marijuana use
#Text=Chronic effects of cannabis use on the human reward system: An fMRI study
#Text=Neural responses to subliminally presented cannabis and other emotionally evocative cues in cannabis‐dependent individuals
#Text=Cluster‐extent based thresholding in fMRI analyses: Pitfalls and recommendations
#Text=A unified statistical approach for determining significant signals in images of cerebral activation
#Text=Pretreatment measures of brain structure and reward‐processing brain function in cannabis dependence: An exploratory study of relationships with abstinence during behavioral treatment
166-1	43594-43604	Supporting	_	
166-2	43605-43616	information	_	
166-3	43617-43627	REFERENCES	_	
166-4	43628-43637	Marijuana	_	
166-5	43638-43648	withdrawal	_	
166-6	43649-43654	among	_	
166-7	43655-43661	adults	_	
166-8	43662-43669	seeking	_	
166-9	43670-43679	treatment	_	
166-10	43680-43683	for	_	
166-11	43684-43693	marijuana	_	
166-12	43694-43704	dependence	_	
166-13	43705-43713	Cannabis	_	
166-14	43714-43725	cue‐induced	_	
166-15	43726-43731	brain	_	
166-16	43732-43742	activation	_	
166-17	43743-43753	correlates	_	
166-18	43754-43758	with	_	
166-19	43759-43763	drug	_	
166-20	43764-43771	craving	_	
166-21	43772-43774	in	_	
166-22	43775-43781	limbic	_	
166-23	43782-43785	and	_	
166-24	43786-43792	visual	_	
166-25	43793-43801	salience	_	
166-26	43802-43809	regions	_	
166-27	43809-43810	:	_	
166-28	43811-43822	Preliminary	_	
166-29	43823-43830	results	_	
166-30	43831-43837	Neural	_	
166-31	43838-43847	responses	_	
166-32	43848-43858	associated	_	
166-33	43859-43863	with	_	
166-34	43864-43878	cue‐reactivity	_	
166-35	43879-43881	in	_	
166-36	43882-43890	frequent	_	
166-37	43891-43899	cannabis	_	
166-38	43900-43905	users	_	
166-39	43906-43916	Individual	_	
166-40	43917-43928	differences	_	
166-41	43929-43931	in	_	
166-42	43932-43940	decision	_	
166-43	43941-43947	making	_	
166-44	43948-43951	and	_	
166-45	43952-43958	reward	_	
166-46	43959-43969	processing	_	
166-47	43970-43977	predict	_	
166-48	43978-43985	changes	_	
166-49	43986-43988	in	_	
166-50	43989-43997	cannabis	_	
166-51	43998-44001	use	_	
166-52	44001-44002	:	_	
166-53	44003-44004	A	_	
166-54	44005-44016	prospective	_	
166-55	44017-44027	functional	_	
166-56	44028-44036	magnetic	_	
166-57	44037-44046	resonance	_	
166-58	44047-44054	imaging	_	
166-59	44055-44060	study	_	
166-60	44061-44064	The	_	
166-61	44065-44079	hyper‐sentient	_	
166-62	44080-44086	addict	_	
166-63	44086-44087	:	_	
166-64	44088-44090	An	_	
166-65	44091-44104	exteroception	_	
166-66	44105-44110	model	_	
166-67	44111-44113	of	_	
166-68	44114-44123	addiction	_	
166-69	44124-44132	Cannabis	_	
166-70	44133-44145	cue‐elicited	_	
166-71	44146-44153	craving	_	
166-72	44154-44157	and	_	
166-73	44158-44161	the	_	
166-74	44162-44168	reward	_	
166-75	44169-44183	neurocircuitry	_	
166-76	44184-44193	Marijuana	_	
166-77	44194-44201	craving	_	
166-78	44202-44204	in	_	
166-79	44205-44208	the	_	
166-80	44209-44214	brain	_	
166-81	44215-44227	Dopaminergic	_	
166-82	44228-44233	genes	_	
166-83	44234-44242	modulate	_	
166-84	44243-44251	response	_	
166-85	44252-44262	inhibition	_	
166-86	44263-44265	in	_	
166-87	44266-44273	alcohol	_	
166-88	44274-44281	abusing	_	
166-89	44282-44288	adults	_	
166-90	44289-44295	Neural	_	
166-91	44296-44303	effects	_	
166-92	44304-44306	of	_	
166-93	44307-44315	positive	_	
166-94	44316-44319	and	_	
166-95	44320-44328	negative	_	
166-96	44329-44339	incentives	_	
166-97	44340-44346	during	_	
166-98	44347-44356	marijuana	_	
166-99	44357-44367	withdrawal	_	
166-100	44369-44376	Spatial	_	
166-101	44377-44389	Registration	_	
166-102	44390-44393	and	_	
166-103	44394-44407	normalization	_	
166-104	44408-44410	of	_	
166-105	44411-44417	images	_	
166-106	44418-44432	Reward‐related	_	
166-107	44433-44438	brain	_	
166-108	44439-44447	response	_	
166-109	44448-44451	and	_	
166-110	44452-44459	craving	_	
166-111	44460-44470	correlates	_	
166-112	44471-44473	of	_	
166-113	44474-44483	marijuana	_	
166-114	44484-44487	cue	_	
166-115	44488-44496	exposure	_	
166-116	44496-44497	:	_	
166-117	44498-44499	A	_	
166-118	44500-44511	preliminary	_	
166-119	44512-44517	study	_	
166-120	44518-44520	in	_	
166-121	44521-44538	treatment‐seeking	_	
166-122	44539-44558	marijuana‐dependent	_	
166-123	44559-44567	subjects	_	
166-124	44568-44577	Marijuana	_	
166-125	44578-44585	craving	_	
166-126	44586-44599	questionnaire	_	
166-127	44599-44600	:	_	
166-128	44601-44612	Development	_	
166-129	44613-44616	and	_	
166-130	44617-44624	initial	_	
166-131	44625-44635	validation	_	
166-132	44636-44638	of	_	
166-133	44639-44640	a	_	
166-134	44641-44652	self‐report	_	
166-135	44653-44663	instrument	_	
166-136	44664-44673	Addiction	_	
166-137	44674-44677	and	_	
166-138	44678-44681	the	_	
166-139	44682-44687	brain	_	
166-140	44687-44688	:	_	
166-141	44689-44692	The	_	
166-142	44693-44705	neurobiology	_	
166-143	44706-44708	of	_	
166-144	44709-44719	compulsion	_	
166-145	44720-44723	and	_	
166-146	44724-44727	its	_	
166-147	44728-44739	persistence	_	
166-148	44740-44746	Reward	_	
166-149	44747-44750	for	_	
166-150	44751-44755	food	_	
166-151	44756-44761	odors	_	
166-152	44761-44762	:	_	
166-153	44763-44765	An	_	
166-154	44766-44770	fMRI	_	
166-155	44771-44776	study	_	
166-156	44777-44779	of	_	
166-157	44780-44786	liking	_	
166-158	44787-44790	and	_	
166-159	44791-44798	wanting	_	
166-160	44799-44801	as	_	
166-161	44802-44803	a	_	
166-162	44804-44812	function	_	
166-163	44813-44815	of	_	
166-164	44816-44825	metabolic	_	
166-165	44826-44831	state	_	
166-166	44832-44835	and	_	
166-167	44836-44839	BMI	_	
166-168	44840-44851	Cue‐induced	_	
166-169	44852-44859	craving	_	
166-170	44860-44863	for	_	
166-171	44864-44873	marijuana	_	
166-172	44874-44876	in	_	
166-173	44877-44895	cannabis‐dependent	_	
166-174	44896-44902	adults	_	
166-175	44903-44912	Increased	_	
166-176	44913-44920	ventral	_	
166-177	44921-44929	striatal	_	
166-178	44930-44934	BOLD	_	
166-179	44935-44943	activity	_	
166-180	44944-44950	during	_	
166-181	44951-44959	non‐drug	_	
166-182	44960-44966	reward	_	
166-183	44967-44979	anticipation	_	
166-184	44980-44982	in	_	
166-185	44983-44991	cannabis	_	
166-186	44992-44997	users	_	
166-187	44998-45001	The	_	
166-188	45002-45012	psychology	_	
166-189	45013-45016	and	_	
166-190	45017-45029	neurobiology	_	
166-191	45030-45032	of	_	
166-192	45033-45042	addiction	_	
166-193	45042-45043	:	_	
166-194	45044-45046	An	_	
166-195	45047-45070	incentive‐sensitization	_	
166-196	45071-45075	view	_	
166-197	45076-45086	Comparison	_	
166-198	45087-45089	of	_	
166-199	45090-45098	extended	_	
166-200	45099-45105	versus	_	
166-201	45106-45111	brief	_	
166-202	45112-45122	treatments	_	
166-203	45123-45126	for	_	
166-204	45127-45136	marijuana	_	
166-205	45137-45140	use	_	
166-206	45141-45148	Chronic	_	
166-207	45149-45156	effects	_	
166-208	45157-45159	of	_	
166-209	45160-45168	cannabis	_	
166-210	45169-45172	use	_	
166-211	45173-45175	on	_	
166-212	45176-45179	the	_	
166-213	45180-45185	human	_	
166-214	45186-45192	reward	_	
166-215	45193-45199	system	_	
166-216	45199-45200	:	_	
166-217	45201-45203	An	_	
166-218	45204-45208	fMRI	_	
166-219	45209-45214	study	_	
166-220	45215-45221	Neural	_	
166-221	45222-45231	responses	_	
166-222	45232-45234	to	_	
166-223	45235-45247	subliminally	_	
166-224	45248-45257	presented	_	
166-225	45258-45266	cannabis	_	
166-226	45267-45270	and	_	
166-227	45271-45276	other	_	
166-228	45277-45288	emotionally	_	
166-229	45289-45298	evocative	_	
166-230	45299-45303	cues	_	
166-231	45304-45306	in	_	
166-232	45307-45325	cannabis‐dependent	_	
166-233	45326-45337	individuals	_	
166-234	45338-45352	Cluster‐extent	_	
166-235	45353-45358	based	_	
166-236	45359-45371	thresholding	_	
166-237	45372-45374	in	_	
166-238	45375-45379	fMRI	_	
166-239	45380-45388	analyses	_	
166-240	45388-45389	:	_	
166-241	45390-45398	Pitfalls	_	
166-242	45399-45402	and	_	
166-243	45403-45418	recommendations	_	
166-244	45419-45420	A	_	
166-245	45421-45428	unified	_	
166-246	45429-45440	statistical	_	
166-247	45441-45449	approach	_	
166-248	45450-45453	for	_	
166-249	45454-45465	determining	_	
166-250	45466-45477	significant	_	
166-251	45478-45485	signals	_	
166-252	45486-45488	in	_	
166-253	45489-45495	images	_	
166-254	45496-45498	of	_	
166-255	45499-45507	cerebral	_	
166-256	45508-45518	activation	_	
166-257	45519-45531	Pretreatment	_	
166-258	45532-45540	measures	_	
166-259	45541-45543	of	_	
166-260	45544-45549	brain	_	
166-261	45550-45559	structure	_	
166-262	45560-45563	and	_	
166-263	45564-45581	reward‐processing	_	
166-264	45582-45587	brain	_	
166-265	45588-45596	function	_	
166-266	45597-45599	in	_	
166-267	45600-45608	cannabis	_	
166-268	45609-45619	dependence	_	
166-269	45619-45620	:	_	
166-270	45621-45623	An	_	
166-271	45624-45635	exploratory	_	
166-272	45636-45641	study	_	
166-273	45642-45644	of	_	
166-274	45645-45658	relationships	_	
166-275	45659-45663	with	_	
166-276	45664-45674	abstinence	_	
166-277	45675-45681	during	_	
166-278	45682-45692	behavioral	_	
166-279	45693-45702	treatment	_	
